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The  role  of  penicillin  binding  protein  4  in  β-lactam resistance in 
Staphylococcus aureus 
Ahang H. Mawlood 
Abstract 
Staphylococcus aureus possesses four native penicillin binding proteins PBPs 
(PBP1-4). Because of the structural resemblance between their natural substrate, the 
D-Ala-D-Ala end of the stem pentapeptide precursor, and penicillin-type antibiotics, 
the late stage peptidoglycan synthesizing enzymes are sensitive to penicillin. 
Resistance to penicillin-type antibiotics in S. aureus arises due to acquisition of an 
alternative PBP (PBP2A, encoded by mecA),   expression   of   β-lactamase, or point 
mutations in genes encoding endogenous penicillin binding proteins, which reduces 
penicillin binding to the enzyme active site. The reduced sensitivity to penicillin G 
and cefotaxime in vitro selected mutant RS1/19 cells is likely related to PBP4 
overproduction, because antibiotics that selectively inhibit PBP4 activity cause the 
greatest reduction in penicillin G MIC (minimum inhibitory concentration), when 
used in combination.   
 
To test whether PBP4 overproduction is sufficient and necessary for the penicillin 
resistance observed in RS1/19, the pbp4 gene was cloned into a high copy number 
plasmid and introduced into different genetic backgrounds of S. aureus. Antibiotic 
sensitivity testing showed that there was no difference in the minimum inhibitory 
concentration (MIC) of penicillin G or oxacillin, this means that increased PBP4 
activity is not sufficient for resistance. Allelic replacement using double cross-over 
event was used to delete pbp4 in the background of RS1/19 strain. RS1/19∆ pbp4 
tested in this study have a moderately increased sensitivity to cefoxitin and 
cefsoludin, but a marked increase in sensitivity to cefotaxim, oxacillin, and penicillin 
G compared to RS1/19. These data lead to the conclusion that PBP4 is necessary for 
the penicillin and methicillin resistance phenotype in RS1/19.  
 
In addition, PBP4 must work with a network of genes that collectively associates 
with the resistance observed in RS1/19 strain. The data presented here clearly shows 
that PBP4 is not the only factor involved in resistance in RS1/19, but that it is 
ii 
 
necessary for the full expression of resistance.  It has been concluded that deletion of 
monofunctional trasglycosylase mgt is not essential for viability and expression of 
resistance in both wild-type and RS1/19strains. Future studies of RS1/19 are likely to 
uncover other factors that are essential for full expression of methicillin resistance in 
mecA negative strains of S. aureus.  
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General Introduction 
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1. 1. General Characteristics of Staphylococcus aureus  
S. aureus was first isolated and characterized by Alexander Ogston, in 1880, in pus 
of surgical absce, who reported that it was different in appearance to the previously 
characterized Streptococcus genus (Ogston, 1882).  The word Staphylococcus is 
derived from the Greek word staphylos, meaning  a  “bunch  of  grapes”, and indicates 
that S. aureus divides in more than one plane, forming clusters looking like grape 
bunches under the light microscope (Kloos et al., 1998).   
 
Historically, scientists faced difficulties in differentiating staphylococci from other 
cocci shaped bacteria, especially those forming clusters, like the genus Micrococcus. 
Later, it was discovered that micrococci were different from staphylococci as they 
show a consistently high resistance to novobiocin, the presence of multiple 
menaquinones in the membrane, and lack the ability to ferment glucose 
anaerobically (Cohen. 1972). Additionally, the G+C content in staphylococcal DNA 
was found to be much less than that of micrococci (Silvestri, L and Hill., 1965). As 
new technologies became available in the 1990s which allowed more detailed 
biochemical, morphological, and physiological insights into bacterial phylogeny, the 
staphylococcal species became easier to distinguish in the laboratory and clinic from 
closely related bacteria (Schleifer and Kroppenst., 1990; Crossley and Archer., 
1997). 
 
There are 32 species and eight sub-species in the genus Staphylococcus, many of 
which preferentially colonise the human body (Kloos and Bannerman, 1994). S. 
aureus has long been recognised as one of the major human pathogens and is by far 
one of the most common nosocomial organisms, being responsible for most post-
surgical infections. It is an opportunistic bacterium frequently part of human micro 
flora, causing disease when the immune system becomes compromised (de Sousa 
and de Lencastre, 2004). 
 
S. aureus is non-motile, non-spore forming Gram-positive cocci with a diameter of 
approximately   1μm   (Kloos et al., 1998). Colony morphology appears as raised, 
smooth, and glistening with complete margins (Schleifer and Bell, 2009). S. aureus 
can be distinguished from other staphylococcal species on the basis of gold 
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pigmentation of colonies due to the production of staphyloxanthin, a membrane-
localized carotenoid pigment that gives S. aureus its characteristic golden colour. 
Nevertheless, some strains make little to no pigment and appear white or grey in 
colour (Pelz et al., 2005). Staphylococci are tolerant to high concentrations of salt 
(Wilkinson, 1997) and show resistance to heat (Kloos and Lambe 1991). They are 
usually facultative anaerobes, growing better under aerobic than anaerobic 
conditions, capable of both respiration and fermentation. The genus is susceptible to 
lysis by lysostaphin, which cleaves the interpeptide glycine bridge of its 
peptidoglycan, and is relatively resistant to lysozyme (Kloos et al., 1998).   
 
S. aureus is a one of the leading causes of healthcare-associated infections and is 
responsible for a substantial burden of disease in hospitalized patients. Despite 
increasingly severe infection control guidelines, the prevalence and corresponding 
negative impact of S. aureus infections remain considerable (Anderson et al., 2012).  
 One of the most important risk factors associated with increased occurrence of 
surgical site infection (SSI) is nasal colonization with either S. aureus or methicillin 
resistant S. aureus (MRSA). In addition there is an economic cost related to SSI 
following orthopaedic surgery, due to longer hospital stays and increased hospital 
costs (Goyal et al., 2013). The Department of Health, England (DoH) reported that 
about 9% of patients in hospitals in the UK acquire health care associated infections 
(HAIs), including those caused by MRSA costing the National Health Service 
(NHS) about £1 billion per annum (Collins et al., 2011). Furthermore, approximately 
19, 000 patient die annually from infections caused by MRSA in the USA alone, 
resulting in approximately $3–4 billion of additional health care costs per year. In 
2005, the U.S. The press have described  MRSA   as   a   “superbug” that killed more 
people than AIDS. Moreover, MRSA has been identified as one of most out-of-
control antimicrobial-resistant pathogens in hospitals. Therefore, the rapid and 
reliable detection of MRSA strains is crucial not only for infection control, but also 
for effective patient treatment at early stages of infection (Chen et al., 2013). 
 
1. 2. Treatment of S. aureus Infections and Antibiotic Resistance 
Morbidity and mortality attributed with staphylococcal infections is connected to a 
combination of two important factors; the aggressive virulence potential of the 
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pathogen and its remarkable ability to become resistant to antibiotic treatments (Otto 
M., 2010). To date S. aureus has acquired resistance to all clinically relevant classes 
of antibiotics by means of both horizontal DNA transfer such as transduction, 
conjugation or transformation, and antibiotic-driven chromosomal mutation (Berger-
Bächi, 2002 ; Chambers and Deleo, 2009). S. aureus is associated with a wide 
variety of infections, from minor skin infections and chronic bone infections to 
devastating septicaemia and endocarditis (Howden et al., 2010). More than 60% of 
nosocomial S. aureus isolates are now resistant to methicillin, and some strains have 
developed resistance to more than 20 different antimicrobial agents in some 
countries (Liu et al., 2011). The acquisition of antimicrobial resistance and changing patterns of staphylococcal disease has been common themes in the staphylococcal literature over the past 50 years (Howden et al., 2010). Therefore, the need to develop novel antibiotics to treat these organisms is a big 
challenge. 
 
 The cell wall biosynthesis pathway is one of the most important pathways to be 
exploited for antibiotic treatment because the target molecules are localized on the 
outside of the bacterial cytoplasmic membrane, so that the antibiotics do not have to 
cross the membrane to reach the target. The importance of this feature for antibiotic 
development was recently highlighted when potent inhibitors of enzymes, identified 
by genomic strategies as potential antibiotic targets, proved inactive due to their 
inability to reach the cytoplasmic target (Schneider and Sahl, 2010).  
 
To reduce the emergence of resistant bacteria developing during selective pressure, 
antimicrobial agents must be used carefully. Therefore using an appropriate drug at 
the appropriate dosage and for appropriate duration is an important clinical 
consideration (Tenover et al., 2006). Multidrug resistance is now the norm among 
many pathogens and S. aureus is perhaps the pathogen of greatest concern because 
of its intrinsic virulence, its ability to cause a diverse array of life-threatening 
infections, and its adaptability. All S. aureus strains were susceptible to penicillin G 
when the latter was initially introduced in the early 1940s, but by 1942 the first 
report of penicillin-resistant S. aureus had already appeared (Rammelkamp and 
Keefer, 1942), and today virtually all strains of S. aureus are resistant to natural 
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penicillins, aminopenicillins, and antipseudomonal penicillins (Rice, 2006). 
Resistance to these drugs occurred because of the acquisition of genes that encode 
drug-inactivating enzymes (Figure 1. 1), initially known as penicillinases and now 
called  β-lactamases (Rice, 2007). blaZ is the  gene  that  encodes  β-lactamase, which is 
an extracellular enzyme, synthesized when staphylococci are exposed   to   β-lactam 
antibiotics; it hydrolyses the  β-lactam ring, and renders the  β-lactam inactive. blaZ is 
under the control of two adjacent regulatory genes,  the anti-repressor blaR1 and the 
repressor blaI.  The   signalling   pathway   responsible   for   β-lactamase synthesis 
requires sequential cleavage of the regulatory protein blaR1 and blaI (Lowy, 2003).  
 
Due to the rapid increase of the emergence of penicillin resistant S. aureus, the semi-
synthetic   penicillin   “methicillin”   was   introduced   in   1959   as   a   therapeutic agent 
active against infections caused by penicillin-resistant S. aureus. Less than two years 
later there were reports, from the UK, of S. aureus isolates that had acquired 
resistance to methicillin (Jevons, 1961). In MRSA, resistance is mediated by the 
mecA gene encodes a penicillin binding protein, PBP2a, which reacts  with  β-lactams 
extremely slowly. The acylation efficiency of PBP2a by penicillin G, characterized 
by the second-order rate constant k2/Kd=15   Mˉ¹   s   ˉ¹,   is   one   to   three   orders   of  
magnitude slower than that of the four native PBPs from S. aureus. The acylation 
rate of PBP2a at therapeutic concentrations of β-lactams is thus negligible compared 
with the bacterial generation time (t½ for acylation > 1 h with 10 µM of penicillin) 
(Zapun et al., 2008). Therefore, the PBP encoded by mecA can compensate for 
reduced muropeptide cross-linking and cell wall destruction due to PBPs inhibition 
(Deurenberg et al., 2007). The genes, mecI and mecR1, regulate the mecA response 
to  β-lactam antibiotics in a pattern similar to that of the regulation of blaZ, by the 
genes blaR1 and blaI following exposure to penicillin (Lowy F., 2003). 
 
Vancomycin is a glycopeptide antibiotic that has as its primary targets the D-Ala-D-
Ala subunits of the Gram positive cell wall, which causes cell death by inhibiting 
cell wall cross-linking. The first MRSA strains that became resistant to vancomycin 
occurred in Japan in 1996 (Hiramatsu et al, 1997) and subsequently several 
vancomycin intermediate S. aureus (VISA) strains developed in other countries 
(Hiramatsu, 2001). VISA is not mediated by a simple mechanism (e.g. target site 
modification, production of antibiotic-modifying enzyme, drug efflux or 
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impermeability) (Mainardi et al., 2008). Rather, it is characterized by the presence of 
a thickened cell wall, reduced degree of cross-linking in the peptidoglycan, and the 
abundance of the D-Ala-D-Ala termini on the pentapeptide of the glycan chain. In 
addition to reduced or non-existence of pbp4 expression, which has both 
transpeptidase and DD,carboxypeptidse activity and is require to catalyse highly 
cross-linked peptidoglycan. Change in the expression of pbp4 may be associated 
with altered and thickening of the cell wall and these strains usually exhibit a VISA 
phenotype (Wootton et al., 2005).  
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Figure  1.  1.  Induction  of  Beta-lactamase  andPBP2a  synthesis  in  the  presence  of  the  
β-lactam  antibiotics.  Mechanism of S. aureus resistance to penicillin and methicillin 
proceeds in a similar fashion.  Binding  of  β-lactam  antibiotics  to  the  transmembrane  
sensor-transducer  BlaR1and  MecRI results in cleavage of the BlaI/MecRI repressors 
and transcription of blaZ (β-lactamase) and mecA (PBP2a). The  extracellular enzymes 
hydrolyse  the  β-lactam ring of the antibiotics,  thereby  rendering  β-lactams  inactive.  
Images  taken  from  McCallum  et  al.,  (2010). 
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1. 3. The Staphylococcal Cell Wall 
The staphylococcal cell is surrounded by a net like structure of about 20-40nm thick, 
called peptidoglycan (PG) or murein that is composed of a series of short glycan 
chains of approximately 20 alternating N-acetylmuramic acid and β-(1,4)-N-
acetylglucosamine residues (Figure 1. 2) Attached to each N-acetylmuramic acid 
residue a stem peptide. Some glycan chains in peptidoglycan are linked together via 
the last glycine residue of the pentaglycine cross bridge attached to the L-lysine 
residue (position 3) on one stem peptide and the D-alanine residue (position 4) on 
another (Stapleton and Taylor, 2002). The main function of this cell-sized 
macromolecule is to protect cell integrity by withstanding turgor (Sauvage et al., 
2008). This strong, yet flexible structure provides the framework of the bacterial cell 
wall, withstanding the high osmotic pressure and maintaining cell shape, (Pereira et 
al., 2009) and serves as a platform for anchoring other cell envelope components 
such as proteins and teichoic acids. It is intimately involved in the processes of cell 
growth and cell division (Vollmer et al., 2008).  
 
Teichoic acids (TA) are composed of repetitive polyol phosphate subunits such as 
ribitol phosphate (Rbo-P) or glycerol phosphate (Gro-P). S. aureus wall teichoic acid 
(WTA) is covalently linked to the 6-OH of N-acetyl muramic acid (MurNAc) via a 
disaccharide composed of N-acetylglucosamine (GlcNAc)-1-P and N-
acetylmannosamine (ManNAc), which is followed by two units of Gro-P (Brown et 
al., 2008).  Lipoteichoic acid (LTA) polymers are attached to the cytoplasmic 
membrane via a glycolipid anchor, which is a diglucosyl diacylglycerol in S. aureus 
and most other staphylococcal species (Dreisbach et al., 2011). WTA has an 
important role in processes such biofilm formation, phage infectivity, and 
pathogenesis (Brown et al., 2012). Furthermore, enzymes that participate in wall 
teichoic acid biosynthesis are localized at the septum (Atilano et al., 2010). They act 
as regulators for penicillin binding protein 4 (PBP4) localization that is required for 
the production of highly cross-linked peptidoglycan (Figure 1. 3; Farha et al., 2013). 
Besides, wall teichoic acid mediates the localization of the major autolysin, AtlA, in 
the division septum. Therefore, wall teichoic acid plays an important role in 
regulation of both biosynthesis and degradation of nascent peptidoglycan in the 
septum (Atilano et al., 2010).  
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Additionally surface proteins of S. aureus are linked to the cell wall by sortase, a 
transpeptidase enzyme that cleaves polypeptidesn between the Gly and Thr of the 
LPXTG (Leu-Pro-any-Thr-Gly) and catalyses the formation of an amid bond 
between the carboxyl-group of threonine and the amino-group of the cell wall 
peptidoglycan (Maresso and Schneewind, 2008).  
 
1. 4. Peptidoglycan Biosynthesis  
Peptidoglycan biosynthesis is a complex process involving the coordination of both 
biosynthetic and degradation pathways. Peptidoglycan synthesis occurred through 
several steps which are: nucleotide-linked precursors, lipid II, and polymerization 
and cross-linking, and peptidoglycan manufacture (Stapleton et al., 2007).  
 
1. 4. 1. Nucleotide Precursor Synthesis  
The biosynthesis of peptidoglycan is a complex process involving approximately 20 
enzyme reactions, which likely work in a coordinative, dynamic but, as yet, largely 
uncharacterized association (Lovering et al., 2012). Synthesis of the nucleotide 
precursors takes place in the cytoplasm, while synthesis of lipid linked intermediates 
and polymerization reactions takes place at the inner and outer surfaces of the 
cytoplasmic membranes respectively (van Heijenoort J., 2001; Figure 1. 4). 
Cytoplasmic steps can be divided into four main sets of reactions:  
1. Formation of UDP-Glc NAc from fructose-6-phosphate.  
2. Formation of UDP-Mur-NAc from UDP-Glc NAc.  
3. Assembly of the peptide stem leading to UDP-Mur NAc-pentapeptide.  
4. Side pathways of synthesis of D-glutamic acid and the dipeptide D-alanyl-D-
alanine. The end product of these reactions is the synthesis of phosphor-MurNAc-
pentapeptide (Barreteau et al., 2008). 
  
1. 4. 2. Assembly of Lipid II on the Inner Cytoplasmic Membrane   
The first membrane- associated  step begin with the transfer of the phosphor-
MurNAc-pentapeptide from the cytoplasmic precursor to the membrane acceptor 
undecaprenyl phosphate (C55-P), a reaction catalyzed by the integral membrane 
protein MraY, yielding undecaprenyl-pyrophosphate-Mur-NAc- (pentapeptide) or 
called lipid I.  
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Figure  1.  2.  Schematic  diagram  of  the  cell  wall  architecture  of  S.  aureus.    The  cell  
wall   is   composed   of   a   thick   layer   of      peptidoglycan  which   comprises   approximately  
90%   of   the   cell   wall   structure   as   well   as   lipoteichoic   acid   and   wall   teichoic   acid.  
Peptidoglycan   is   a   Polymer   of   β-(1-4)-N-Acetyl-D-glucosamine   units.   Alternating  
residues  are  modified  to  form  N-acetylmuramic  acid  with  the  addition  of  lactate  which  
is  covalently  linked  to  a  tetrapeptide.  The  tetrapeptides  of  adjacent  polymers  are  linked  
by   penta-glycine   bridges.  The   cross-linked   peptidoglycan   polymers   form   a  mesh-like  
network  over  a  phospholipid  bilayer  plasma  membrane.  Image  taken  from  Niwa  et  al.,  
2005). 
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Figure   1.   3.  Role   of   teichoic   acids   (TA)   synthesis   in   PBP4   localization   to   the  
mid-cell.   The   early   cell-wall   synthetic   machinery   assembles   at   the   division   site,  
leading   to   the   synthesis   of   new   peptidoglycan,   with   low   levels   of   crosslinking  
(Left).  TagO,  which   is   the   first   enzyme   in   the   teichoic   acid  biosynthetic  pathway,  
together   with   other   WTA   synthetic   enzymes   is   localized   to   the   septum   by   an  
unknown   mechanism,   leading   to   the   synthesis   of   intermediate   molecules   in   TA  
biosynthesis   (Center).   These   intermediates   (or   another   cellular   component  
dependent   on   TA   biosynthesis)   function   as   a   temporal   and   spatial   cue   for   PBP4  
recruitment   to   the   division   septum,   allowing   the   synthesis   of   highly   cross-linked  
Peptidoglycan  to  occur  in  a  regulated  manner  (Right).  Image  taken  from  Atilano  et  
al.,  (2010). 
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Subsequently, beta-N- acetylglucosaminyltransferase (murG) adds GlcNAc from 
UDP-N-acetylglucosamine to lipid I to form undecaprenyl-pyrophosphate-Mur-
NAc- (pentapeptide)-GlcNAc  or called lipid II (Bouhss et al., 2008).  
 
The formation of the pentaglycine cross-link in S. aureus requires glycyl tRNA and 
lipid II. The femABX genes encode proteins involved in the addition of the 
pentaglycine bridge; FemX is responsible for addition of the first glycine, FemA the 
next two glycines; and FemB the final two glycines (Bouhss et al., 2007). The final 
step in the inner cytoplasmic membrane for peptidoglycan synthesis is to flip the 
lipidII building block to the outer side of the cytoplasmic membrane (Lovering et al., 
2012).  Recently a role for an essential division protein has been implicated in lipid 
II transport; in Escherichia coli model membrane vesicles and trans-bi-layer 
movement of lipid II requires the presence of FtsW. However, the mechanism 
underlying this function and governing molecular feature in cell wall biosynthesis 
remain unknown (Mohammadi et al., 2011).  
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Figure  1.  4.    Steps  of  peptidoglycan  biosynthesis  in  S.  aureus.  UDP-MurNAc-
stem  peptide   synthesized   in   the  cytoplasm,   then   transferred   to   a   lipid   carrier   in  
the  membrane   to   form   lipid   I  which  modified   to   generate  Lipid   II.   Lipid   II   is  
flipped  to  the  inner  face  of  the  cell  wall.  The  peptidoglycan  monomers  are  then  
cross-linked  by   the  action  of  PBPs,   through  glycosylation   in  which  MurNAc  of  
the  nascent  PG  are  covalently  linked  to  the  GlcNAc  of  lipid  II  precursor.  A  sub-
set  of  PBPs  can  also   cross-link   the   lipid   II  pentapetide   to  a  pentaglycine  cross-
bridge   via   transpeptidation   reaction.   Images   taken   from   (Schneider and Sahl, 
2010) 
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1. 4. 3. Polymerization and Cross-linking  
After the completion of the cellular stages of peptidoglycan synthesis, the subsequent 
extracellular steps require the energy of bonds present in lipid II monomer to drive 
reactions forward (Lovering et al., 2012). This occurs through two main reactions; 
first polymerization involves the covalent cross-linking of nascent lipid II subunits to 
the growing peptidoglycan strand on the outer face of the cell membrane. Two 
glutamate residues in the (glycosylation) GT domain active site of membrane bound 
monofunctional and bifunctional proteins are responsible for the formation of 
covalent  β-1, 4 linkages between the MurNAc precursor of the nascent PG and the 
GlcNAc precursor of the lipidII (Goffin and Ghuysen, 1998 ; Sauvage et al., 2008).  
Cross-linking of peptidoglycan occurs via transpeptidation (TP) reaction of peptide 
units in adjacent glycan strands. The cross-linkage extends from the amino group of 
the side-chain of the residue at position 3 of one peptide subunit (acyl acceptor) to 
the carboxyl group of D-Ala at position 4 of another (acyl –donor) (3-4 cross-
linkage), through an interpeptide bridge (Magnet et al., 2007). There is a 
considerable variation in the degree of cross-linkage, for example in S. aureus, the 
percentage of monomers is low (10%), most peptidoglycan units being present as 
oligomers (Vollmer et al., 2008).  
 
1. 4. 4. Peptidoglycan Manufacture  
The  growth  model  of  peptidoglycan  in  Gram  positive  bacteria  is  “inside-to-outside”  
growth, which means that new glycan strands are inserted on the inner face of the 
wall, where the PBPs are localised (Reith and Mayer, 2011). According to the 
surface stress theory, newly synthesized cell wall material is deposited to the inner 
face of the cell wall in a relaxed conformation. As peptidoglycan polymerization 
progresses, the wall moves outwards and become stretched bearing the stress due to 
hydrostatic pressure. According to the inside-to-outside model of growth, the cell 
wall is never weakened since new covalently layers of the murein are formed before 
the older and outer ones are breached (Scheffers and Pinho, 2005).  
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1. 4. 5. Cell Division and Separation of Daughter Cells in S. aureus  
S. aureus is a spherical shaped bacterium that appears to have only one mode of cell 
wall synthesis at the mid-cell (Scheffers and Pinho, 2005 ; Strauss et al., 2012) and 
cell division planes are built perpendicular to previous plane (Tzagoloff and Novick, 
1977 ; Periera et al., 2009).  A division plane has to be tightly coordinated with 
chromosome segregation to avoid bisection of the nucleoid by the septum (Veiga et 
al., 2011).  
 
The divisome is a macro-molecular complex that is formed during cell division, it 
consists of two major components including positive regulators and negative 
regulators that regulate the construction of an essential cytosekeleton protein Fts Z 
into a ring-like structure called the Z-ring (Figure 1. 5; Son and Lee, 2013).  Proteins 
that are known or are thought to participate in divisome formation in S. aureus are 
FtsZ, FtsA, EzrA, GpsB, SepF, PBP1, PBP2, PBP3, DivIB, DivIC, FtsL, FtsW 
(Steele et al., 2011).  Following the Z-ring formation the cells synthesize a nascent 
layer of peptidoglycan at the mid-cell in a form that is surrounded by membrane 
invaginations, this layer of peptidoglycan is called the cross-wall. It has been shown 
that deletion of FtsZ leads to delocalization of the peptidoglycan biosynthesis results 
in cell enlargement and lysis (Pinho et al., 2003). It has been reported that S. aureus 
at the septum has five zones of alternating densities between the membrane of the 
two daughter cells, which consist of two high density zones appearing to be 
sandwiched by three low density zones (figure 1. 6) (Matias and Beveridge, 2006).  
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Figure  1.  5.  Proposed  models  for  cell  wall  assembly  in  spherical  cocci  
S.aureus.  The  parental  cell  wall  is  in  black,  the  new  cell  wall  of  septal  origin  is  
in  light  gray,  septal  peptidoglycan  synthesis  machinery  is  in  green,  and  the  
splitting  machinery  is  in  cyan,  with  a  jaw  to  indicate  activity.  This  diagram  
shows  that  in  staphylococci  it  synthesizes  the  cell  wall  at  the  division  site  using  
one  septal  machinery.  Image  taken  from  Zapun  et  al.,  (2008). 
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The most distinctive feature in the centre of the nascent cross wall was a thin 
electron-dense layer, called the splitting system of the cross wall, is 7 to 10 nm wide 
and has shown to consist of a concentrically arranged system of about 14 to 18 ring-
shaped tubuli, each 7 to 10 nm in diameter. It has been assumed that teichoic acid-
like material and lipoteichoic acid is the chemical composition of the splitting system 
(Giesbrecht et al., 1998; Scheffers and Pinho, 2005). Additionally, minute vesicular 
structures 50 to 60 nm in diameter, that creates a row of holes in the peripheral cell 
wall above closed cross walls, possessing a high autolytic activity capable of 
hydrolysing adjacent peptidoglycan and lead to the splitting of daughter cells. It is 
suggested that these murosomes are formed due to the autolytic activity of Atl, 
which forms around 30 holes around the bacterial circumference (Touhami et al., 
2004). 
 
After completing the synthesis of the cross-wall, the cells must cleave the nascent 
septa in a highly regulated manner to form two daughter cells; this is mediated by 
autolysins, which are peptidoglycan hydrolases that are active during cell growth, 
cell turnover, and cell division and separation (Singh et al., 2010). There are five 
types of peptidoglycan hydrolases which are: N-acetyl muramidase, N-acetyl 
glucosaminidase, N-acetylmuramyl-L-alanine amidase, endopeptidase and 
transglycosylases (Figure 1. 7) (Liu et al., 2011). Lytic transglycosylases are a 
further   class   of   autolysins   which   cleave   the   β-1,4 glycosidic bond between N-
acetylmuramic acid and N-acetylglucosamine residues of peptidoglycan, with 
concomitant formation of 1,6-anhydromuramic acid residues (Stapleton et al., 2007). 
AtlA which is the major extracellular autolysin that is encoded by the atl gene. This 
autolysin undergoes cleavage to generate amidase and glucosaminidase.   Three 
peptidoglycan hydrolases AtlA, LytN and Slel are directly involved in splitting of 
daughter cells, however, cells remain connected by a small fragment of 
peptidoglycan (Frankel et al., 2011). Furthermore, sister cells usually change 
location according to each other while still remaining connected. These factors are 
apparently responsible for this characteristic formation of irregular cell groups 
(Tzagoloff and Novick, 1977).   
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Figure   1.   6.   Frozen-hydrated   section   at   high   magnification   showing   the   S.  
aureus  cell  envelope.    At  non-septal  regions,  the  plasma  membrane  (PM)  is  bound  
by  a  bipartite  wall;;  a   low-density   inner  wall  zone  (IWZ)  precedes  a  high-density  
outer  wall  zone  (OWZ).  (B)  At  the  septum,  five  different  zones  of  alternating  low  
(white  arrows)  and  high  (black  arrows)  densities  are  distinguished  between  the  two  
membranes   of   the   septum   (arrowheads).   Both   images   are   shown   at   the   same  
magnification.  Bar  50  nm.  Image  taken  from  Matias,et  al.,  (2006). 
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Figure  1.  7.    Site  of  cleavage  of  peptidoglycan  hydrolases.  Schematic  illustration  
of  cell  wall  peptidoglycan  with  selected  enzymatic  cleavage  site.  Image  taken  from  
Frankel  et  al.,  (2011). 
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The key regulator of peptidoglycan degradation is the two component system 
walK/walR. The phosphorylated response of walR activates the expression of genes 
that encode for peptidoglycan hydrolases and supress the genes that inhibit 
hydrolysis (Uehara and Bernhardt, 2011). Hence, a proper balance is required 
between synthesis and degradation of peptidoglycan to maintain this network 
(Biswas et al., 2006).  During peptidoglycan degradation the stem peptide is 
hydrolysed by the activity of the amidases and carboxypeptidase, amino sugars and 
peptides are released during activity of these enzymes in the cell wall compartment. 
Subsequently, uptake of the cell wall amino sugars such as GlcNAc and MurNAc  by 
the phosphotransferase system (PTS) transporters NagE and MurP, respectively and 
cell wall-derived peptides such as muropeptides by mpp/opp-like ABC transporters, 
both well conserved in S. aureus, form the major pathway for recycling of cell wall 
components (Reith and Mayer, 2011).     
 
1. 5. Penicillin Binding Proteins (PBPs)  
Bacterial cells; except mycloplamas species; possess a variable number of penicillin 
binding proteins, which act as cell wall biosynthetic enzymes (Macheboeuf et al., 
2006).  PBPs that catalyse the polymerization of the glycan strand called 
transglycosylation (TG) and the cross-linking between glycan chains called 
transpeptidation (TP). Some PBPs can hydrolyze the last D-ala of stem 
pentapeptides called DD-carboxypeptidation (CP), or hydrolyze the peptide bond 
connecting two glycan strands called endopeptidation (EP) (Sauvage et al., 2008).  
 
Penicillin binding proteins are classified according to their molecular weight as low 
molecular mass (LMM) or high molecular mass (HMM) PBPs (Figure 1. 8). 
Moreover, depending on the architecture and the catalytic activity of their N-terminal 
domain, HMM enzymes are subdivided to either class A (bifunctional, having both 
TG and TP activity) or class B (monofunctional) PBPs having only TP activity.  In 
class B enzymes, the N-terminal domain is believed to play a role in cell 
morphogenesis by interacting with other proteins involved in the cell cycle (Sauvage 
et al., 2008).  The C-terminal penicillin binding (PB) domain of both classes has a 
transpeptidase activity, (Sauvage et al., 2008 ; Terrak and Nguyen- Distĕche, 2006). 
LMM PBPs are commonly DD- carboxypeptidase or endopeptidases, and therefore 
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create their own subfamily (Goffin and Ghuysen, 2002). Antibiotics that target 
TPase or TGase activity lead to cell wall weakness, inhibit cell division, and 
subsequently cause cell lysis.  Moenomycin is the only known natural product that 
directly inhibits TGase activity. Unfortunately, this antibiotic cannot be used for 
therapeutic property because of it is toxicity to human (Walsh, 2003).  
 
The numbering system used for PBP naming is based on the membrane protein 
profile seen when PBP proteins are labelled with either radioactive or fluorescent 
penicillin analogues subjected to SDS-PAGE separation. The highest molecular 
weight PBP is designated as number 1 and the remaining of the PBPs are numbered 
sequentially according to reducing size (Spratt and Cromie, 1988). Thus, PBP 
numbering is completely species-specific, which means that the number does not 
indicate what structure or function that an enzyme has; for example. E. coli PBP2 is 
most similar to S.aureus PBP3 (Kong et al., 2010). 
  
Class A PBPs can be found in two main types, the majority display GT and TP 
domains that are interconnected by a linker of different length, followed by a short 
C-terminal sequence (Macheboeuf et al., 2006). When other protein families, such as 
a fibronectin-binding domain, follow the C-terminal domain-binding domain it 
forms the second type of arrangement (Ghuysen, J., 1994). 
 
Class B PBPs can be divided into four main groups, but the most frequent one has 
the simplest structure. It consists of an N-terminal secretion signal followed by the 
TP domain. Two groups are characterized by the presence of an additional region of 
unknown function positioned after the TP domain. Interestingly, this region contains 
three motifs with homology to the inter-domain linker in class A PBPs, and folds 
into a very similar structure. It most likely provides support between the N-terminal 
domain and the TP domain. This region is sometimes called PASTA (PBP and 
Ser/Thr kinase attached) domains and it has been suggested that PASTA binds 
unlinked peptidoglycan and also acting as a peptidoglycan-sensing molecule (Yeats 
et al., 2002). The final group of class B enzymes carries an NTF2 (nuclear transport 
factor 2)-like domain positioned before the N-terminal end. NTF2 has been found in 
staphylococcal PBP2a, but the function of this domain is unclear (Lim and 
Strynadka, 2002 ; Macheboeuf et al., 2006).   
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Figure  1.  8.  Architecture  of  penicillin  binding  proteins  (PBPs).     There  
are  at   least  10   types  of  arrangement  of  PBPs   in  213  eubacterial  genomes  
identified.   All   PBPs   are   connected   to   the   membrane   by   means   of   a  
transmembrane  helix  (TM)  or  an  amphipathic  helix,   in   the  case  of  LMM  
PBPs.  Images  taken  from  Macheboeuf  et  al.,  (2006). 
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LMM PBPs are unusual because the TP domain is encoded after a signal peptide and 
their membrane association is accomplished by either a transmembrane or 
amphipathic helix, both located at the C-terminal end. (Macheboeuf et al., 2006). 
 
1. 5. 1. The Penicillin Binding Proteins in S. aureus  
S. aureus possess four types of PBPs, namely PBP1-4, that differ in their cell wall 
biosynthesis function and  affinity  to  β-lactam antibiotics (Chambers et al., 1994). In 
addition, this species also contains two monofunctional transglycosylases: MGT and 
SgtA (Reed et al., 2011). Methicillin resistant S. aureus (MRSA) possess a 78 kDa 
PBP2 variant, which has a low affinity for penicillin. This protein is called PBP2a 
and is encoded by the mecA gene (de Lencastre et al., 2007) that is carried by a 
mobile genetic element, SCCmec.  The mecA gene has been acquired from 
commensal staphylococcal species, such as S sciuri (Couto et al., 2003) or S 
epidermidis (Basset et al., 2009) upon horizontal transfer (Hiramatsu et al., 2001). 
The mecA gene complex is widely distributed among S. aureus strains as well as 
among other staphylococcal species collectively called coagulase negative 
staphylococci. Therefore, mecA may be freely transmissible among staphylococcal 
species, crossing the staphylococcal species barrier (Ito et al., 1999). 
 
PBP1 is the largest PBP in S. aureus, (85 kDa) and is a class B, monofunctional, 
transpeptidase. The function of PBP1 is mainly correlated to cell division. It 
possesses an N-terminal domain, followed by the TPase domain and two PASTA 
domains terminated by the C-terminal region (Pereira et al., 2009). PBP1 does not 
play a major role in the cross-linking of S. aureus peptidoglycan, and the main 
phenotypic consequences of PBP1 depletion in S. aureus occurs at the level of 
septum formation, a dramatic increase in cell mass, and a complete loss of cell 
division resulting in cell lysis. This finding together with the localization of PBP1 in 
the septum, strongly suggests that the essential role of PBP1 in S. aureus is linked to 
some specific function of this protein in cell division (Pereira et al., 2007).  
Interestingly, a point mutation made in the TP domain active site, which inhibits the 
activity of the enzyme and binding to penicillin, led to abnormality in growth and 
peptidoglycan composition but did not cause complete inhibition of septum 
formation or cell lysis. Therefore, it has been suggested that PBP1 has two important 
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roles in the cell cycle of S. aureus, as a protein required for septation and also as a 
transpeptidase that generates a critical signal for cell separation at the end of 
cytokinesis (Pereira et al., 2009).  
 
PBP2 is the only bifunctional HMM class A PBP (81 kDa); it has two protein 
domains, an N-terminal TGase and a C-terminal TPase domain (Figure 1. 9). This 
HMM PBP is essential for growth and viability of the bacteria. During the first steps 
of cell division, PBP2 is positioned at the septum to form a ring around the future 
division plane (Pinho and Errington, 2005). Acylation of the TPase domain of PBP2 
with oxacillin leads PBP2 to move from the septum to the entirety of the cell wall 
(Pinho and Errington, 2003).  S. aureus is distinguished from other bacterial species 
that it has only one class A PBP, but it has been shown that its TGase activity in S. 
aureus is six times higher than that of class A PBPs of other bacterial species 
(Barrett et al., 2005).  The essentiality of TGase activity of PBP2 in S. aureus 
appears to depend on the strain and the presence of PBP2a. It has been reported that 
in the MRSA strain COL, mutations in the active site of the TPase domain had no 
effect on the viability of the cells and did not alter their sensitivity to methicillin, due 
to the presence of PBP2a which also has a transpeptidase activity. In contrast, a point 
mutation made to the active site of the TGase domain in the same strain caused a 
dramatic increase in methicillin sensitivity  as well as the presence of very short 
peptidoglycan chain (Pinho et al., 2001), demonstrating that PBP2 TGase activity is 
crucial for appropriate peptidoglycan biosynthesis.  
 
 Insertional inactivation of PBP2 causes a reduced MIC in MRSA strain COL, 
suggesting that even in the presence of the active TPase of PBP2a the TGase activity 
of PBP2 is crucial for appropriate cell wall synthesis (Pinho et al., 1997). 
Nevertheless, in MSSA mutations made in the active site of the TGase domain did 
not affect the viability as do strains with inactivated PBP2, suggesting that TPase 
activity of PBP2 may be also essential in these cells (Pinho et al., 2001). Afterwards 
it was found that the monofunctional transglycosylase activity of MGT, can replace 
the TGase activity in both COL  Δpbp2 and in MSSA TGase domain mutants. MGT 
activity is only essential in the absence of PBP2 (Reed et al., 2011).  
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Figure  1.  9.  Structure  of  class  A  PBP2  in  Staphylococcus  aureus.    Overall  view  of  
the   structure   of   Staphylococcus   aureus   PBP2.   The   PB/transpeptidase   domain   is  
coloured  by  secondary  structures,  the  linker  region  is  coloured  green,  and  the  big  and  
small   lobes   of   the   transglycosylase   domain   are   coloured   yellow   and   salmon  
respectively.   Ct,   C-terminus;;   Nt,   N-terminus.   Images   taken   from   Sauvage   et   al.,  
2008). 
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Similar to PBP1, PBP3 is a HMM class B protein, (75 kDa), and has monofunctional 
transpeptidase activity, but PBP3 does not possess PASTA domains at its C-terminal 
region (Macheboeuf et al., 2006). PBP3 may be involved with septum formation and 
cell separation but PBP3 mutant cells grow normally. In the presence of a sub-MIC 
levels of methicillin cells have an abnormal size and shape and have disoriented 
septa. These data are consistent with idea that the TPase activity of PBP3 may be 
taken over by other PBPs (PBP1 and PBP2) when PBP3 is not available or is under 
antibiotic pressure (Pinho et al., 2000 ; Georgopadakou et al., 1982).  
 
PBP4 is the only LMM PBP that belongs to class B protein in S. aureus (45 kDa), 
and is differs from other proteins in this class because it is bifunctional, catalysing 
both DD-carboxypeptidase and transpeptidase activity (Figure 1. 10) (Navratna et 
al., 2010). PBP4 is not essential for survival, because cells with depleted or mutated 
PBP4 continue to grow normally (Leski and Tomasz, 2005 ; Navratna et al., 2010). 
In most species, the LMM TPases have a low level of carboxypeptidase activity, but 
PBP4 in S. aureus is efficient at both reactions (Kozarich, and Strominger, 1978). A 
recent report indicates that the biochemical characteristics and conformational 
features of the active site of PBP4 suggest that this protein also has a β-lactamase 
activity. This conclusion was supported by several lines of evidence, including mass 
spectra showing hydrolysed β-lactam antibiotics, electron density at the active site of 
PBP4, and a nitrocefin-based   assay   for   β-lactamase activity. This implies that the 
active   site   of   this   enzyme   can   remain   free   even   in   the   presence   of   β-lactam 
antibiotics (Navratna et al., 2010)  
 
TP is the main function of PBP4 in vitro, because the level of unlinked 
peptidoglycan resulting from CP is low approximately (10-15%) (Navratna et al., 
2010). Additionally, recent studies have suggested that wall teichoic acid has an 
important role in localization of PBP4 in the division septum (Figure 1. 2). Usually, 
the correlation between WTA and peptidoglycan prevents carboxypeptidation 
occurring at the division septum (Atilano et al., 2010 ;  Farha et al., 2013).  
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Figure  1.  10.  Structural  features  of  S.  aureus  PBP4.  (A)  Sequence  conservation  of  
PBP4  is  shown  in  the  context  of  the  crystal  structure.  Of  the  two  domains  in  S.  aureus  
PBP4,  the  β-lactamase  domain  at  the  N  terminus  is  very  well  conserved,  whereas  the  
all-β  domain  at  the  C  terminus  is  not.    Images  taken  from  (navartna  et  al.,  2010). 
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There is a very little information available regarding the regulation of PBP 
production and the activity of their coding genes, along with other non-pbp-related 
genes, which are indicated to be associated  with  intrinsic  β-lactam resistance. It was 
shown that a 90 bp deletion near to abcA region correlates with an   increase   to   β-
lactam resistance as a result of overproduction of PBP4, wherease the level of 
transcription of abcA was only slightly higher than that of its parent. It was 
concluded that 90 bp deletion of the promoter region, even though it is closer to the 
abcA ORF, mainly affected pbp4 transcription (Schrader-Fischer and Berger-Bächi, 
2001). Interestingly, an increased level of PBP4 transcripts was noticed in an abcA 
knockout mutant, therefore it has been suggested that S. aureus abcA regulates PBP4 
production (Domanski et al., 1997). Recently it was suggested that AbcA is one of 
the efflux pumps family which are capable of extruding antibiotics, leading to 
multidrug resistance (Qin et al., 2013). AbcA overexpression associated with 
fourfold increase in resistance to methicillin, cefotaxime, penicillin, and nafcillin 
(Truong-Bolduc and Hooper, 2007). 
 
On the other hand, it was reported that abcA and pbp4 are regulated independently 
due to their different expression patterns during growth; transcription of pbp4 later in 
the exponential growth phase. Furthermore, the increased abcA transcription during 
exposure to methicillin suggested that AbcA has a protective role against methicillin 
(Schrader-Fischer and Berger-Bächi, 2001). 
 
The global regulatory systems agr and sar are involved in regulation of virulence 
determinants in S. aureus (Novick et al., 2003). While agr is known to control toxin 
and exoprotein production, the sar locus was suggested to be essential for the 
optimal expression of agr. Although, abcA expression is under the control of the 
global regulator agr, neither agr nor sar had any effect on pbp4 expression nor an 
effect on the PBP4 protein level. Also methicillin induced abcA expression but had 
no effect on pbp4 expression (Schrader-Fischer and Berger-Bächi, 2001). 
 
Methicillin resistant strains lacking the mecA gene have previously been generated, 
in vitro by three research groups and in each case the resistance mechanism is 
different, indicating that the genome is able to respond in several ways to subtly 
different selection pressures. The group of Brigitte Berger-Bächi reported that high-
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level expression of pbp4, caused by a deletion in the region upstream of this gene, 
resulted in an increase in PBP4 protein in cell membranes, an increase in the 
thickness of the cell wall and translated to low-level PBP4-linked  intrinsic  β-lactam 
resistance in MSSA (Henze and Berger-Bächi, 1996). Recently, Banerjee at al., 
reported that methicillin resistance in an in vitro generated strain is due in part to an 
amino acid change at the entrance to the binding pocket of PBP4 (Banerjee et al., 
2010). CWD S. aureus were previously generated in our lab on a medium with an 
increased osmolality and in the presence of sub-lethal levels of penicillin G; on 
reversion to cell wall competent (CWC) form, the cells were remained resistant. 
Membrane preparations showed a high level of PBP4 in the CWC strains, indicating 
that the cells have undergone stable genotypic changes that allow them to avoid the 
action  of  β-lactam antibiotics (Fuller et al., 2005).  
 
Furthermore, inactivation of PBP4 caused a marked decrease in highly cross-linked 
muropeptide components of the cell wall of wild-type and mutants of S. aureus 
strains. (Sieradzki et al., 1999). Deletion of PBP4 in hospital acquired methicillin 
resistant S. aureus (HA-MRSA) strains  did  not  alter  the  MIC  of  β-lactam antibiotics 
(Katamaya et al., 2003).  However,  PBP4  has  an  important  role  in  mediating  β-lactam 
and methicillin resistant in community acquired methicillin resistant S. aureus (CA-
MRSA), PBP4 inactivation in MRSA strains USA300 and MW2 is sufficient to 
cause a 16-fold reduction in oxacillin and nafcillin resistance. Therefore PBP2a, is 
not the only determinant of methicillin resistance in CA-MRSA and it has been 
clearly demonstrated that   PBP4   is   a   key   element   in   β- lactam resistance in CA-
MRSA strains (Memmi et al., 2008).  
 
In clinical isolates of vancomycin intermediate S. aureus (VISA), PBP4 inactivation 
was found to increase vancomycin resistance, due to an altered peptidoglycan 
composition, a thickened cell wall, and decreased autolytic activity (Sieradzki and 
Tomazs, 1997; Howden et al., 2010). This is in agreement with the function of PBP4 
that mediates secondary transpeptidation necessary for highly cross-linked 
peptidoglycan (Sieradzki and Tomazs, 2003).  In addition to clinical isolates of 
VISA, in vitro selection for resistance to glycopeptide antibiotics (vancomycin and 
teicoplanin) produces altered peptidoglycan. Membrane protein profile of VISA 
strains shows no detectable PBP4 and reduced level of cross-linking. HPLC analysis 
30 
 
showed increased glycan chain lengths and monomer-rich peptidoglycan. The 
monomer precursors in the peptidoglycan component of the cell wall are non-lethal 
target for glycopeptide antibiotics (vancomycin), therefore, binding to these targets 
prevents access of vancomycin molecules to the lethal target adjacent to the plasma 
membrane (Sieradzki et al., 1999). Although these reports show that low level or 
inactivation of PBP4 correlates with increased vancomycin resistance not all strains 
of clinical VISA have altered PBP4 production and it might be strain specific. This 
means that PBP4 may be associated with vancomycin resistance in only some strains 
of S. aureus (Woottoon, M. 2005). 
 
Some species of bacteria possess membrane bound proteins that are capable of 
catalysing glycan chain polymerization from lipid II called monofunctional 
glycosyltransferases MGTs; (Terrak and Nguyen-Disteche, 2006).  Using genome 
sequences to search for GTase domains in S. aureus, only three genes were 
suggested to have TGase activity PBP2, MGT, and SgtA (Wang et al., 2001). Both 
the GT domain of class A PBPs and MGTs show high sequence similarity and 
belong to the GT51 family, which is characterized by five conserved motifs and uses 
lipid II as substrate (Spratt, et al., 1996). In addition MGT is enzymatically active, 
because purified MGT protein, isolated from S. aureus, has the ability to catalyse 
polymerisation of un-cross-linked glycan chains (Wang et al., 2001). 
 
Classification of SgtA as a transglycosylase was previously based only upon 
sequence homology to other known glycosyltransferase activity (Kuroda et al., 
2001). SgtA has been shown to be non-essential in the background of the MSSA 
strain NCTC8325-4, even in the absence of the TGase activity of PBP2; the 
functioning of SgtA as a transglycosylase in S. aureus has remained largely 
uncharacterized (Reed et al., 2011). 
 
1. 5. 2. Affinity  of  PBPs  to  β-lactam Antibiotics 
All PBPs contain a domain which uses D-Ala-D-Ala dipeptide on the C-terminal end 
of the lipid II pentapeptide as a substrate for peptidation reactions. In PBPs mediated 
peptidation the peptidase domain forms a complex with the D-Ala D-Ala, followed 
by acylation of the C-terminal alanine residue by serine residue in the peptidase 
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domain active site. This forms  a covalent acyl-enzyme complex, which is resolved 
by a rate limiting deacylation reaction in the final enzymatic step. In transpeptidases, 
amino group on the pentaglycine bridge serves as the proton acceptor of the reaction, 
resulting in cross-linking of two peptidoglycan strands. In DD-carboxypeptidase, the 
acyl-enzyme intermediate is hydrolysed; which results in perminantly shortend stem 
peptide that is unable to be cross-linked. The proton is then back-donated to the 
active site, breaking the acyl-enzyme bond and recharching the PBP for another 
reaction (Zapun et al., 2008).  
 
 β-lactam antibiotics mimic the D-Ala-D-Ala dipeptide in an elongated 
conformation, particularly regarding the distribution of three electrostatic negative 
wells (Figure 1. 11), forming a stable inhibition complex. The half-life of the 
covalent acyl-enzyme complex, which is formed between PBP and the penicillin 
analogue, is much longer than that of the PBP and its natural substrate (Chambers et 
al., 1994). This is because the acylation of the active site serine generate a massive 
leaving group that remains part of the acyl-enzyme, limiting access of the acceptor 
group.  As a result, only water has access to the active site and can attach the acyl-
enzyme (Ghuysen, 1991).  The active sites of PBPs have varying affinity for β-
lactams depending upon the particular PBP, the type of β-lactam used, and kinetics 
of the deacylation reaction. For example, in case of penicillin Km values for 
interactions with  staphylococcal PBPs ranges from 0.01-5µM and PBP-
pencilloylation ranges from 10-90% depending on the PBP. This wide variation in 
binding kinetics explains the observation that different β-lactam antibiotics have 
different concentration ranges at which they can damage bacterial cells, even though 
they have the same target (Tomasz, 1979). The inhibitory efficiency of a β-lactam 
for a PBP is given by the C50, which is the antibiotic concentration needed to inhibit 
half of the PBP molecule at a steady state (when the acylation and deacylation 
reactions proceed at the same rate) (Zapun et al., 2008).  
 
 
 
 
 
 
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  1.  11.  Shows  the  resemblance  between  β-lactams  and  the  D-Ala-D-Ala   
dipeptide   in   the   lipid   II,   particularly   regarding   the   distribution   of   three  
electrostatic-negative   wells.      The   regions   of   negative      electrostatic   potential   are  
indicated  by  arcs.  Images  taken  from  Zapun  et  al.,  (2008).     
N-Acyl-D-Alanyl-D-Alanine  peptide Penicillin  backbone 
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1. 6. Cell Wall Defective Bacteria 
S. aureus is characterized by the formation of variants both in vivo and in vitro as a 
result of stress response adaptation. The mechanisms contributing to developing this 
population heterogeneity are poorly understood (Marcova et al., 2008). Long term 
incubation of bacteria in the presence of cell wall inhibiting antibiotic can lead to the 
formation  of  abnormal  “fried  egg  shape”  colonies; these adapted cells are called L-
forms, stain Gram negative and are osmosensitive variants (Tsai et al., 2011).   
 
Isolation of L-form in vitro requires high osmotic pressure; therefore these cells 
provided with certain feature that supports growth and survival in the cells 
(Morikawa et al., 2010). The division of the L-form in the apparent absence of 
peptidoglycan is paradoxical (Joseleau-Petit et al., 2007).Several different methods 
for replication by L-form bacteria have been reported including budding, filamentous 
growth and binary fission, (Onwuamaegbu et al., 2005). Interestingly, propagation of 
L-form in Bacillus subtilus does not require the normal FtsZ-dependant division 
machine but occurs by a remarkable extrusion (Leaver et al., 2009). However, it has 
been observed that peptidoglycan polymer is required for L-forms survival (Yong, 
2007). Similarly, it has been reported that the propagation of these L-form bacteria 
requires D-glutamate, DAP, and Mur activity, all specific to peptidoglycan 
biosynthesis. L-form bacteria contain approximately 7% of peptidoglycan 
component in the cells (Joseleau-Petit et al., 2007).  
 
It has been shown that the first essential step in l-form generation involves escape of 
the cell protoplast from its enveloping cell wall. Therefore mutations in two different 
genes walR and sepF contribute to this feature. walR is a transcriotional regulator 
involved in cell wall homeostasis, and sepF, required for accurate and efficient cell 
division. The walR mutation renders the activity of the protein partially constitutive, 
inappropriately upregulating the acivity of autolytic enzymes that weaken the cell 
wall. The sepF mutation probably works by perturbing the formation of a properly 
constructed division septum, generating a mechanical breach in the cell wall 
(Dominguez-Cuevas et al., 2011). Recently it has been reported that l-form does not 
depend on the well-characterized cytoskeletal systems that are pivotal for cell shape, 
elongation, and division of walled cells, but that it does depend on having a 
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particular state of membrane fluidity. This provides biological support for the 
“membrane   only”   model   and   highlights   the likely importance of the dynamic 
biological properties of membranes in cell reproduction (Mercier et al., 2012). 
Impairing branched chain fatty acid synthesis, which is important for providing a 
particular state of membrane fluidity, leaded the l-form proliferation to be virtually 
abolished but growth of walled cells were unaffected. This indicated that mutant 
cells with reduced membrane fluidity were able to grow in size, but they did not 
undertake the final membrane scission step needed to generate separate progeny cells 
(Errington, 2013).     
 
 
In vivo, L-form bacteria have been reported to persist within cells because they can 
inhibit phagocytosis (Schmitt-Slomska et al., 1973), however others have suggested 
that L-form persist in cells as an adaptation response to antibiotic pressure 
(Onwuamaegbu et al., 2005). Interestingly, an established E. coli L-form line 
(LW1655F1), isolated nearly 40 years ago has acquired mutations in several genes 
required for peptidoglycan synthesis, the analysis revealed mutations in ftsQ and 
mraY genes in this strain, which are responsible for cell division and peptidoglycan 
biosynthesis respectively in all bacteria with a peptidoglycan-based cell wall 
(Siddiqui et al., 2006). Studies have shown that subtle changes in the primary 
structure of cell division proteins can render other division functions dispensable 
which were believed to be essential {e.g., FtsA can compensate for ZipA (Geissler et 
al., 2003)}.  
 
A number of bacterial species have been reported to be able to grow and replicate as 
L-form variants. Cell wall deficient CWD forms of S. aureus have been identified 
clinically in patients with recurrent skin lesions, meningitis, endocarditis, arthritis 
and other diseases (Stoitsova et al., 2000). When L-form of S. aureus was injected to 
rats the inflammatory response was less intense and the infection appeared later and 
continued for a long period, compared to the wild strain. This is because these cells 
did not have cell wall envelope and antigen signals in the protoplast, leading to 
unsuccessful phagocytosis; as a result they survive and persist for a long time in the 
host cells or lead to failure of antibiosis therapy and consequential chronic infection 
(Michailova et al., 2007).   
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2. 1. Bacterial Strains and Plasmids  
Bacterial strains and plasmids used in this study are listed in (Table 2. 1 & Table 2. 
2).  
Table 2. 1. Bacterial strains used in this study. 
S. aureus strains name                    Genotype                                            Refrence    
Oxford ATCC 9144                          wild-type reference strain                           Kearns et al., 2006 
RS1/19                                   revertant strain originated from Oxford 
strain.   
Fuller et al., 2005.  
T12                                       revertant strain originated from Oxford   This study 
RN4220                                                          restriction deficient derivative of  
Oxford strain       
Kreiswirth et al., 
1983. 
8325-4                                     Wild type 8325 cured of prophages     Novick R.P., 1967 
SH1000                                 NCTC8325-4 derivative; rsbU+ agr+     Horsburgh et al., 
2002 
RN4220(pGL485-pbp4)       pbp4 overexpression transductant             This study 
Oxford(pGL485-pbp4)         pbp4 overexpression  transductant            This study 
8325-4(pGL485-pbp4)         pbp4 overexpression transductant             This study 
SH1000(pGL485-pbp4)       pbp4 overexpression  transductant              This study 
RN4220(pMAD-Δpbp4)      pbp4 single deletion mutant in vector        This study 
RN4220(pMAD-Δmgt)       Δmgt single deletion mutant in vector         This study 
RS1/19(Δpbp4)                    pbp4 single deletion mutant                        This study 
RN4220(Δmgt)                    Δmgt single deletion mutant   This study 
Oxford(Δmgt)                      Δmgt single deletion mutant. This study 
RS1/19(Δmgt)                                          Δmgt  single  deletion  mutant       This study 
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E. coli XL-1 Blue               General laboratory cloning strain                 Sambrook et al., 
1989 
 
Table 2. 2. Plasmids used in this study. 
 
 
Name                                                  Genotype                                          Refrence  
pGL485                                   Expression  shuttle vector Cooper et al., 
2009 
pGL485(pbp4)                          Structural gene of pbp4    This study     
PCR-Blunt II-TOPO                TOPO cloning vector kanR bla                                             Invitrogen
pGEM-3Zf(+)                                                       Standard cloning vector  Promega  
(pGEM-3Zf (+) (5  ′pbp4))       pbp4 upstream region                                This study 
pGEM-3Zf + (5  ′pbp4+spc)    pbp4 upstream region and 
spectionmycin spc resistance cassette 
gene 
This study 
pGEM-3zf  (+)  (Δpbp4)  pbp4 disrupted by spc gene This study 
pMAD                                   Vector for allelic replacement in low 
GC Gram positive bacteria ermC bla     
Arnaud et al., 
(2004). 
pMAD  Δpbp4                       pbp4 upstream and downstream 
region  ligated through spc gene        
This study. 
pBluescript SK( +)               High copy cloning vector                               Fermentas. 
pBlue(5  ′mgt)                                               mgt upstream  region                                                                           This  study. 
pBlue(5  ′mgt+cm)                                 mgt upstream  region  with  cm                                               This  study. 
pBlue(Δmgt)                                                 mgt  upstream  and  downstream  region  
disrupted  by  Cm. 
This  study. 
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pMAD Δmgt                         mgt  upstream  and  downstream  region  
disrupted  by  Cm.       
This  study 
pBlue(pbp1)                           pbp1 region with upstream  and 
downstream region.             
This study. 
pBlue(pbp2)                           pbp2 region with upstream  and 
downstream region   
This study 
 pBlue(pbp3)                           pbp3 region with upstream  and 
downstream region 
This study 
pBlue(Δpbp1)                             pbp1 gene disrupted by spc                            This study    
pBlue(Δpbp2)                         pbp2 gene disrupted by spc                           This study 
pBlue(Δpbp3)                              pbp3 gene disrupted by spc                             This study  
pMAD(Δpbp1)                          pbp1 gene disrupted by spc                          This study   
pMAD(Δpbp2)                      pbp2 gene disrupted by spc.    This study   
pMAD(Δpbp3)                        pbp3 gene disrupted by spc.  This study   
pBlue(5’SgtA)                      SgtA upstream region . This study   
pBlue(5’SgtA+spc)               SgtA upstream region with spc 
cassette gene                      
This study   
pBlue(ΔSgtA)                        SgtA upstream and downstream 
region with spc cassette gene.  
This study   
pMAD(ΔSgtA)                     SgtA gene disrupted by spc                             This study 
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2. 2. Growth Media and Antibiotics  
All growth media was sterilised by autoclaving at 121°C, 20 min at 15 p.s.i. unless 
otherwise stated. 
 
2. 2. 1. Brain Heart Infusion Broth (BHI) 
BHI broth was prepared as 37 g/L of brain heart infusion medium (Oxoid, UK). BHI 
agar was prepared by the addition of 15 g/L No. 1 Bacteriological Agar (Oxoid) to 
BHI broth.  
 
2. 2. 2. Cell Wall Deficient Media (CWD) 
CWD media consists of BHI medium supplemented with 5% (w/v) sucrose, 0.5 % 
(w/v) yeast extract and 0.2% (w/v) MgSO4.7H2O as established in previous work 
(Fuller et al., 2005). After autoclaving and once the mixture had cooled to around 50 
ºC, 10 %( v/v) sterile horse serum was added aseptically.  
  
2. 2. 3. Luria Bertani Medium (LB) 
 Luria Bertani (LB) broth was prepared as described by Sambrock et al (1989) and 
consisted of 10 g/L tryptone (Oxoid) 5 g/L yeast extract (Berton, Dikinson and 
company) and 10 g/L NaCl (Fisher Scientific). LB agar was prepared by the addition of 
15 g/L No. 1 Bacteriological Agar (Oxoid) to LB broth. 
 
2. 2. 4. Iso-Sensitest Media (ISS) 
ISS broth was prepared as 31.4 g/L of ISS medium (Oxoid, UK). ISS agar was 
prepared by the addition of 15 g/L No. 1 Bacteriological Agar (Oxoid) to ISS broth.  
  
2. 2. 5. B2 Medium 
B2 broth consisted of 10 g/L Bacto Casamino Acids (Becton, Dickinson and company) 
25 g/L Yeast Extract (Becton, Dickinson and company) 1 g/L K2HPO4 (Sigma) 25 g/L 
NaCl (Fisher Scientific). After autoclaving the sterilised medium was supplemented with 
25 ml/L of filter sterilised 20% glucose (Sigma). 
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2. 2. 6. LK Medium  
 LK broth consists of 10 g/L tryptone (Oxoid) 5 g/L Yeast extract (Becton, Dickinson 
and company) and 7 g/L KCl (sigma). LK agar was prepared by addition of 15 g/L No. 1 
Bacteriological Agar (Oxoid) to LK broth.  
 
2. 2. 7. SMMP  
SMMP medium was prepared as 55ml 2×SMM, 40 ML 4×Penassay broth, and 5 ml 10 
%( w/v) bovine albumin; adjust pH the  to 7.0; then filter sterilized. 
 
2. 2. 8. 2×SMM 
 25 ml 0.2 M sodium hydrogen maleate, 40 ml 0.1N NaOH; adjust the pH to 6.5. Add 5 
ml 1 M MgCl2, 42.7 g sucrose; dissolve and bring volume to 125 ml. filter sterilize.  
 
2. 2. 9.  4×Penassay Broth  
17.5 g Antibiotic medium 3 (Becton Dickinson) dissolved in 250 ml water.  
 
2. 2. 10. 0.2 M Sodium Hydrogen Maleate:  
13.7 g maleic acid, 4 g NaOH; dissolve in 500 ml water. 
 
2. 2. 11. Phage Agar (1L) 
Consists of 3 g casamino acids, 3 g yeast extract 5.9 g NaCl then add 10 g No. 1 
bacteriological agar (for Bottom agar) or 3.3 g agar (for Top agar). 
 
2. 2. 12. Phage Buffer (1L) 
 1 ml of 1M MgSO4, 4 ml of 1M CaCl2, 50 ml of 1M Tris-HCl ph 7.8, 5.9 g of NaCl, 
and 1g of gelatin. Adjust pH to 7.8.   
 
2. 2. 13.  Antibiotics 
Growth media for E. coli was supplemented as required with: ampicillin (Amp) at 100 
μg/ml, spectinomycin (spc) at 100µg/ml, or   kanamycin   (Kan)   at   50   μg/ml.   Growth  
media for S. aureus was supplemented as required with the following: Erythromycin 
(Ery) 5 μg/ml, chloramphenicol  (Cm)  at  10  μg/ml  or  spectinomycin (spc) at 100 μg/ml.  
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2. 3.  Microbial Growth and Storage Conditions  
E. coli and S. aureus were grown at 37°C unless otherwise stated. E. coli and S. aureus 
liquid cultures were grown in broth with agitation at 200 rpm unless otherwise stated. 
For short term storage agar slopes were used by inoculation isolated colonies from the 
agar plate into deep agar slant and incubated overnight at 37°C, and then stored at 4°C. 
For long term storage, single colonies were grown in BHI broth media and suspended in 
BHI liquid medium plus 20% glycerol (v/ v) fast frozen in liquid nitrogen and stored as 
aliquots in sterile plastic vials at -80°C. Phage stocks were stored at 4°C. 
 
2. 4. Staphytect Test 
The latex slide agglutination test staphytect plus (Oxoid, Basingstoke, United 
Kingdom) was used to identify coagulase-positive S. aureus. The staphytect test 
identifies whether an organism is S. aureus or not by testing for the presence of 
clumping factor , protein A or certain capsular polysaccharides , if one or more of 
these are present agglutination occurs and the test is positive. Staphytect plus uses 
blue latex coated with porcine fibrinogen and rabbit immunoglobulin G including 
specific polyclonal antibodies raised against capsular polysaccharides of S. aureus. 
When the test reagents mixed  on a card at room temperature with colonies of S. 
aureus , rapid agglutination occur through the reaction between fibrinogen and 
clumping factor, FC portion of IgG and protein A, or specific IgG and capsular 
polysaccharide. This is compared to control reagent and a positive result being the 
presence of agglutination within 20 seconds indicating S. aureus. 
 
2. 5. Gram Staining 
Gram staining uses dyes to stain a bacterial cell so it stands out from its background. 
It differentiates between Gram-positive and Gram-negative bacteria due to their 
differing cell wall structure. The specimen is mounted and fixed on a slide before it 
is stained. The reagents used are crystal violet, the primary stain; Lugol iodine, the 
mordant; ethanol, the decolouriser and safranin, the counter stain. Gram-positive 
bacteria incorporated little or no counter stain and will remain blue-violent in colour 
from the crystal violet whilst Gram-negative bacteria take on the pink colour of the 
counter stain. The staining procedure from agar plates has been performed by mixing 
a couple of colonies with a few drops of MQ (deionised and distilled water) on a 
42 
 
glass slide. The smear was allowed to air dry and then the organisms heat-fixed by 
passing it through a flame several times. Crystal violet was added to the dried smear 
for 1 min, washed off with MQ and Lugol iodine added for 1 min, which was blotted 
off. A solution of 95% ethanol was agitated over the stain for 30s and washed off 
with MQ, and finally a counter stain of Safranin was added for 5s and again washed 
off with MQ. A mixture of air-drying and blotting dried the Gram stain. While from 
liquid   media,   it   was   carried   out   by   spinning   a   500μl   aliquot   of the culture at 
13,000rpm for 5 min and washed in 500µl MQ once, to remove the media allowing a 
clearer Gram stain. The pallet was re-suspended fully in 100µl MQ. Of this solution 
10µl was added to 10µl MQ and mixed on a slide. The Gram stain then proceeded as 
above. 
 
2. 6. Antibiotic Sensitivity Testing 
2. 6.1. MIC Determination 
Macro broth dilution determination of MIC was carried out using CWD or ISS broth; 
the inoculum suspension density was adjusted to be equal that of 0.5 McFarland 
standards (bioMerieux, Basingstoke, UK) (Andrew JM, 2001). This suspension of 
bacteria was equivalent to an absorbance at 600 nm of 0.025-0.035. Briefly, liquid 
media (10ml) was added to 14 universal tubes making the range of antibiotic 
concentrations of 0.032 to 128.0mg/L. One ml of media containing the antibiotic 
dilutions was transferred to test tubes with one ml of bacterial suspension. The 
inoculum suspension was further diluted to give an inoculum size of 105 CFU/ ml in 
the same media of antibiotics. Tubes were mixed thoroughly and incubated for 18-20 
h at 37ºC in air and then checked for visible growth. The MIC was determined as the 
lowest concentration of antibiotic at which there was no visible growth.  
 
 2. 6. 2. E-Tests 
E-tests were performed following the British Society of Antimicrobial 
Chemotherapy    (BSAC) method (Andrews, 2001) with modifications. Penicillin E-
test strips (AB Biodisk, Sweden) were used with ISS or CWD solid medium. The 
overnight culture of the strain to be tested was diluted with sterile MQ to 0.5 
McFarland standards and an aliquot of 100l spread three ways on the plate with a 
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sterile cotton wool bud. The plate was then air dried for 30 min, the strip added and 
the plate incubated at 37 ºC with the results read at 48h.  
 
2. 7. Selection for Penicillin Resistance by Successive Cycling Using 
Liquid Media 
Selection for penicillin-resistant mutants was performed in broth cultures by 
exposing bacteria to gradual increasing concentrations of penicillin G. Initially, a 
series of broths containing different concentrations of antibiotic were inoculated; 
following incubation, the broth culture with the highest concentration of penicillin G 
that could support growth was used to sub-culture into CWD liquid media containing 
further incremental increases in the antibiotic concentration. The whole cycling 
experiment was followed over a minimum of 10 cycles and repeated with 2 
independent isolates of S. aureus Oxford. Following each cycle, Gram staining was 
carried out for the cells growing in highest level of penicillin G. The percentage of 
Gram negative cells were calculated from the average of Gram negative cells in 5 
different microscopic fields.  
 
2. 8. Growth Curve 
A representative growth curve was established to determine the change in the 
absorbance readings over time for 3 strains of S. aureus (Wild type, RS1/19, T12). A 
single colony was inoculated into 5ml of the BHI broth media and incubated 
overnight at 37ºC; an aliquot of 1.0 ml was then transferred to a 100 ml of fresh 
liquid media of the same composition, to give a 1:100 dilution. The suspension was 
diluted so that the turbidity was similar to that of 0.5 McFarlands. Growth was 
monitored for each of three replicates for about 10h. One ml of the liquid culture was 
aseptically taken to read the absorbance at 600nm. Absorbance readings were 
determined every 30 min and the data then plotted to obtain a growth curve. The 
culture incubated overnight and the last reading was measured after 24h.   
 
2. 9. Analysis of Penicillin Binding Protein (PBPs) Profile 
2. 9. 1. Membrane Protein Preparation 
Membrane proteins were prepared according to the method of (Sieradzki et al., 1999) 
with some modifications. Cells grown to the late exponential stage in 1L of BHI 
44 
 
medium were collected by centrifugation at 12,000 × g for 10 min at 4˚C,  washed 
twice in 50mM Tris.  HCl, 150mM NaCl, 5mM MgCl2 buffer, (pH 7.5), 
resuspended in the same buffer, supplemented with 10µl/ml bacterial Protease 
Arrest™   (Biosciences)   (GE Health Care Life Sciences), and   10mM   β- 
mercaptoethanol. Lysostaphin, DNase, and RNase were added to the final 
concentration of 100, 20, 10 μg/μl,  respectively. The suspensions were incubated on 
ice for 30 min, followed by sonication for a total of 5 min, in 1 minute bursts with 2 
min intervals on ice water batch after each 1 min sonication cycle. The suspension 
were then centrifuged at (5000rpm) for 10 min at 4˚C   to   pellet   the   hole   cells.  
Partially lysed /broken cells were harvested by ultracentrifugation at 110,000 ×g 
(50000rpm) for 45 min at 4ºC, washed twice in 50mM  phosphate buffer (pH 7.0), 
and membranes were solubilized by 2% (v/v)Triton X-100, snap frozen and stored in 
freezer at -80ºC. 
2. 9. 2. Estimation of Protein Concentration 
 The Bradford assay was used for estimation of protein concentration, which is a 
dye-binding assay first developed by Bradford (Bradford 1976). It is based on the 
principal that, upon binding to protein, the maximum absorbance of an acidic 
solution of Coomassie Brilliant Blue G-250 shifts from 465nm to 595nm. The 
concentration of unknown samples can be estimated by comparison of their 
absorbance values to the absorbance values of a series of known protein 
concentrations.  
 
2. 9. 3. Bradford Assay 
Estimation of protein concentration was performed using Protein Assay Dye Reagent 
Concentrate (Bio-Rad Laboratories Ltd.). A series of BSA standards ranging from 0-
40μg  was  prepared   from  a  stock  solution  of  2mg/ml  BSA  in  2%Triton  X-100 (2% 
Triton X-100 in phosphate buffer pH 7.0) and each made up to a final volume of 
25μl  in  2% (v/v) Triton X-100. Aliquots of samples of unknown concentration were 
also  prepared  in  a  final  volume  of  25μl  of 2% (v/v) Triton X-100. To each of these 
samples,   75μl   ddH2O  was   then   added.   Finally,   900μl   of   25%   (v/v)   Protein  Assay  
Dye Reagent Concentrate was added to each solution, mixed and incubated at room 
temperature for 10 minutes. Absorbance was measured at 595nm and the protein 
concentration of each sample calculated from the plotted BSA standard data. 
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2. 9. 4. Mini-format 1-Dimensional SDS-PAGE 
SDS-PAGE analysis of protein samples was performed according to the 
discontinuous Trisglycine Tris-Glycine buffer system of Laemmli (Laemmli 1970), 
using Bio-Rad’s  Mini  Protean  II  vertical  gel  apparatus  (Bio-Rad Laboratories Ltd.).  
 
2. 9. 4. 1. Gel Casting 
SDS-PAGE mini gels were performed using 0.75mm thick gels composed of a 12% 
acrylamide resolving gel and a 5% acrylamide stacking gel. These were cast using 
the Mini-Protean II Cell (Bio-Rad Laboratories Ltd.) and clean glass casting plates. 
Resolving gel solutions were prepared containing 12% (w/v) acrylamide 
(acrylamide:bis-acrylamide 37: 5: 1) (Bio-Rad Laboratories Ltd.), 375mM Tris-HCl 
pH 8.8, 0.1% (w/v) SDS, 0.05% (w/v) ammonium persulphate (Bio-Rad 
Laboratories Ltd.), and 0.2% (v/v) TEMED (Bio-Rad Laboratories Ltd.). Stacking 
gels were similarly prepared containing 5% (w/v) acrylamide and 125mM Tris-HCl 
pH 6.8 as the buffer. The resolving gel was cast first and overlaid with water-
saturated butan-1-ol. Once this had set, the butan-1-ol was rinsed out and excess 
water removed by blotting. The stacking gel was then overlaid onto the level surface 
of the resolving gel and individual sample loading wells created by insertion of a 
Teflon comb. Wells were then rinsed free of any unpolymerised acrylamide.  
 
2. 9. 4. 2. Sample Preparation and Gel Loading 
Bocillin FL (Invitrogen, Molecular Probes) a derivative of penicillin V, was used to 
detect the penicillin binding proteins in membrane preparations. The method of Zhao 
et al., (1999) was followed. Protein samples 10-15µg/µl  in 2% Triton X-100 were 
solubilised in 5x SDS sample loading buffer (12% (w/v) SDS, 5% (w/v) DTT 
(Melford Laboratories Ltd., Ipswich, UK), 0.05% (w/v) bromophenol blue, 0.312 M 
Tris-HCl pH 6.8, 50% (v/v) glycerol) to give a 1x concentration in a volume of up to 
16.7μl.  To this protein mixture 3.3μl  of  Bocillin  FL 10mM (final concentration) was 
added to give a final volume of 20µl. The reaction mixture was incubated at 37ºC for 
30 min., then denatured at 100˚C  for  3  min  and  centrifuged  for  1  min to pellet cell 
debris and insoluble material. Amersham ECL plex fluorescent Rainbow marker 
(225, 150, 102, 76, 52, 38, 31, 24, 17, 12 kDa) was used to determine the protein 
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sizes,   2μl   Rainbow   markers   mixed   with   2μl   5X   SDS   and   6μl   of   water   and   the  
mixture loaded in the gel without heating this used along with labeled protein 
samples   that  have  been  prepared  previously.10μl  of  each  reaction  mixture  (approx.  
7.5-15ug of protein was subjected to SDS-PAGE analysis (12% polyacrylamide gel, 
Bio-Rad laboratories). The protein gels were rinsed with water immediately after 
electrophoresis, to visualize the labeled PBPs. The gels were directly scanned with 
The Typhoon 9400 Variable Mode Imager (Amersham Biosciences) was used in 
fluorescence acquisition mode at normal sensitivity, three channels were used (Cy2 
channel excitation at 488nm and emission at 530 nm, Cy3 channel excitation at 
532nm and emission at 580nm, and Cy5 channel excitation at 633nm and emission 
at 670nm.), then the images were overlaid to detect rainbow marker and PBPs 
together (Zhao et al., 1999). 
 
2. 9. 4. 3.  Electrophoresis 
Electrophoresis through the stacking gel was conducted at 100V, after which the 
voltage was increased to 200V until the dye front reached the bottom of the resolving 
gel. Gels were then carefully detached from the apparatus and proteins visualized 
immediately by Typhoon scanner. 
 
2. 10. Lysostaphin Susceptibility  
The method of Sieradzki et al. (1999) was used for lysostaphin susceptibility test. 
The overnight culture was used to inoculate 50 ml of liquid media at a 1 in 100 
dilution and further incubated until the exponential phase was reached, as judged by 
an absorbance reading and the previously established growth curves of the relevant 
strain. The culture was centrifuged at 13,000 rpm for 5 min and washed three times 
in 20 mM KPO4 buffer (pH 7.5), and after the final wash re-suspended in the same 
buffer. The absorbance reading at wavelength 620 nm, using disposable cuvettes and 
a visible spectrophotometer, was adjusted to approximately 0.25. The 
spectrophotometer was temperature controlled at 37 °C. One unit of lysostaphin was 
then added, the cuvette shaken and returned to the spectrophotometer for continuous 
reading. The data was plotted as a percentage of the initial wavelength 620 nm. 
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2. 11. Autolysis with Triton X-100 
 Autolysis with Triton X-100 followed the method by Fournier and Hooper (2000) 
with minor modifications. Cells were grown in CWD liquid media in triplicate to the 
exponential phase, OD600 of 0.6 to 0.8, using the same overnight culture as the 
inoculum. The cells were pelleted by centrifugation and resuspended in the same 
volume containing 50mM Tris (hydroxymethyl) aminomethane hydrochloride Tris-
HCl (pH 7.5) and 0.1% Triton X-100. The cells were then incubated at 30C with 
shaking, and the changes in OD580 were measured.  
 
2. 12. Quantitative Autolysis Assay Using Extracellular Autolysin  
Cell wall hydrolysis assays were examined as described by (Zhu et al., 2010). 
Extracellular peptidoglycan hydrolases of bacteria were isolated from 15 ml of a 16 
h culture by centrifugation at 6,000 x g for 15 min at 4C. The supernatant was filter-
sterilized and concentrated 100-fold using Vivaspin 6 Centrifugal Filter units 
(Milipore, 5 kDa) (Sartorius stedium biotech). The concentration of total proteins in 
each preparation was determined using the Bradford assay. Briefly, 100 µg of 
enzyme extract was added to a suspension of autoclaved and lyophilized S. aureus 
Oxford or RS1/19 cells (1 mg/ml) in 100 mM Tris-HCl (pH 8.0), and incubated at 
37C with shaking (150 rpm). Cell wall hydrolysis was measured as a decrease in 
turbidity at 600 nm every 30 min. 
 
2. 13. PBP Binding Reactions 
 To  determine  the  IC50  for  each  PBP  with  selected  β-lactam antibiotics (penicillin G, 
cefotaxime, cefoxitin, and cefsolodin), approximately 100 µg/ml of solubilized 
membrane   protein   was   incubated   with   different   concentrations   of   β-lactam 
antibiotics ranging from (0.064-64 µg/ml) for 10 min at 37°C.  Bocillin FL was then 
added, to final concentration of 10mM, and the incubations were continued for 
another 10 min. The proteins were then  denatured  at  100˚C  for  3  min  and  centrifuged  
for 1 min to pellet cell debris and insoluble material. 10μl  of  each  reaction  mixture  
(approx. 15µg of protein was subjected to SDS-PAGE analysis (10% polyacrylamide 
gel, Bio-Rad laboratories). The protein gels were rinsed with water immediately then 
subjected to fluorography. The 50% binding affinity (IC50) was calculated by 
measuring the density of each PBP band for different amount of each antibiotic used. 
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Subsequently, the data was represented as a graph of relative density versus 
concentration of antibiotic used.  
 
 
2. 14. Effect of Cefoxitin or Cefotaxime on Penicillin G Sensitivity of 
Oxford and RS1/19 Types of S. aureus 
Iso-sensitest plates were prepared and mixed with 25% of MICs of cefoxitin, 
cefotaxime, or cefsoludin. Antibiotics were added into agar media after they cooled 
to 50°C, then left for minimum period of time before inoculation.  
 
Bacteria were inoculated into BHI broth media and incubated at 37°C in an orbital 
shaker (set to 150 rpm) overnight. Standard inoculums were adjusted by diluting 
overnight cultures with the same used liquid medium to turbidity equal to the 0.5 
McFarland standards. Sterile cotton tipped swabs were dipped into the standard 
inoculum suspensions and excess fluid removed from the soaked swab prior to the 
entire dried agar surface of Iso-sensitest media being wiped by the swab in three 
directions to cover the plate by thin layer of inoculum. The plates were left for 10 
min to dry and E-test strips applied to the agar surface with sterile forceps. Agar 
plates were incubated at 37°C overnight (18-20 h) and MICs of penicillin G 
determined according to E-test reading guide of AB BIODISK.  
 
2. 15. Effect of Cefoxitin on Cefotaxime Sensitivity of Oxford and 
RS1/19 Types of S. aureus 
In this experiment the macro broth dilution method was used; 12 tubes containing 
(10 ml) of Iso-sensitest broth media were prepared and mixed with 25% of MICs of  
S. aureus variants of cefoxitin. The inoculum suspension densities of Oxford or 
RS1/19 were adjusted to be equal that of 0.5 McFarland standards (bioMerieux, 
Basingstoke, UK) (Andrew JM, 2001). Antibiotic dilutions (cefotaxime) were 
transferred to each tube making a range of antibiotic concentrations of 0.016 to 
64µg/ml. Subsequently, one ml of bacterial suspensions were added. Tubes were 
mixed thoroughly and incubated for 18-20 h at 37ºC in air and then checked for 
visible growth. The MIC was determined as the lowest concentration of antibiotic at 
which there was no visible growth 
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2. 16. Molecular Biology 
2. 16. 1. Preparation of Genomic DNA 
Total chromosomal DNA was prepared using the method by Palomares et al 
(Palomares, Torres et al. 2003) with some modifications. Cells were grown in 5 ml 
of LB liquid medium overnight and centrifuged. The pellet was resuspended in 1.8 
ml of TE buffer (Tris 10 mM, EDTA 1 mM, pH 8.0) containing lysostaphin(100 
g/l),  mutanolysin (250  μg/ml)  ,  and  incubated  at  37C for one hour. Then 300 l 
of  10%  sodium  dodecyl   sulphate   (SDS)  and  proteinase  K   (250  μg/ml)  were   added  
and the suspension incubated at 65C for one hour. Afterwards 500 l of 5 M 
sodium chloride (NaCl) and 500 l of 10% Cetyl Trimethyl Ammonium Bromide 
(CTAB)/0.7 M NaCl were added after being heated in a water bath at 65C for 10 
min to aid release of DNA due to increased solubility of the suspension. A 
chloroform-phenol extraction was then performed by adding equal volumes of 
Phenol/ Chloroform/ Isoamylalcohol 25: 24: 1 (V: V: V), the mixture were then 
centrifuged at 4000rpm/5minutes. The upper, aqueous phase was recovered and 
subjected to two further phenol/chloroform/ isoamylalcohol extractions. A final 
chloroform extraction was carried out to remove residual phenol. The DNA was 
precipitated with an equal volume of isopropranol and centrifuged at13, 000 rpm for 
10 min, and washed with 70% ethanol before being air dried and resuspended in 100 
µl  TE  buffer  and  stored  at  4˚C  overnight  and  -20˚C  for  longer term storage.  
  
2. 16. 2. Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) DNA amplifications were performed as described 
by (Sambrook et al., 1989).  Screening PCR and some cloning PCR reactions were 
carried in a total volume of 50µl and included  (2.0  ng/  μl  )  of  target  DNA,  1x  buffer  
(Bioline), 1.5mM of MgCl2 ,  200 nM  of dNTP,  400 nM of each primer  and 0.02 u/ 
µl of Taq DNA polymerase (Bioline). The PCR machine was set for one cycle of 
5min at 95ºC, 30 cycles of 45 sec at 50ºC and 5min at 72ºC, finishing with one cycle 
of 10 min at 72ºC, following the PCR reaction, the products were separated by 
agarose gel electrophoresis using a  HaeIII molecular weight marker. Gels, 
containing  ethidium  bromide  at  a  final  concentration  of  0.5μg/ml,  were made at the 
appropriate agarose concentration to separate the size of the DNA samples. DNA 
samples were prepared by adding DNA loading buffer (30% sucrose, 100mM 
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EDTA, pH 8; 0.05% bromophenol blue) to the sample prior to electrophoresis. DNA 
bands were viewed by illumination with UV light and images recorded by 
photography.   
 
PCR reactions for cloning and mutagenesis were  carried  out  in  50  μl  volumes  using  
1  U  of  Phusion™  High-Fidelity DNA polymerase (Finzymes supplied by NEB UK), 
1  x  HF  Buffer,  200μM dNTPs (Promega), 0.5-1  μM  of  each  primer,  1  pg  – 10 ng 
DNA template and sterilized distilled  water   to   the   final  volume  of  50  μl.  Reaction  
mixtures were heated to 98°C for 30 sec to denature template. Primers were annealed 
at 54- 60°C for 20s and the product extended at 72°C for 20 sec per 1 kb DNA to be 
amplified. Denaturation, annealing and extension cycles were repeated 25-35 times. 
A final extension time of 5 min at 72°C ensured completion of all strands. 
 
2. 16. 3. Purification of PCR Products 
PCR products were purified by either agarose gel electrophoresis or using GFX PCR 
DNA and gel band purification kit (Amersham Biosciences, UK). 1 x volume of 
PCR product was mixed with 5 x volume of capture buffer (supplied by 
manufacture), the mix were transferred to a spin column and spun at 14,000 rpm for 
30   sec   and   the   flow   though   discarded.   500   μl   of   wash   buffer   (supplied   by   the  
manufacture) were added to the column and it was spun for 30 sec at 14,000 rpm and 
the flow through discarded. The column was then spun for 1 min at 14,000 rpm to 
remove residues of the wash buffer and the dry column were inserted to a 1.5 ml 
microcentrifuge tube and 30 – 50  μl  of  sterile distilled water was added. The column 
was incubated at room temperature for 1 min and spun at 14,000 rpm for 1 min.  
Elute contains the purified PCR product. 
 
2. 16. 4. Purification of DNA From Agarose Gels 
DNA was extracted from agarose gels using GFX PCR DNA and gel purification kit 
(Amersham Biosciences, UK) as described by the manufacturer. Briefly, the desired 
bands were cut out of the agarose gel and put in a 1.5 ml micro centrifuge tube. To 
the gel slice   add   10   μl   of   capture   buffer   for   each   10   mg   of   gel   slice. The gel 
dissolved in a capture buffer by heating it to 60°C for 10 min. The dissolved gel was 
transferred to filter spin columns incubated at room temperature for 1 min and spun 
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at 13,000 rpm for 30   sec.  The   flow   through  was  discarded  and  700  μl  of  washing  
buffer and the columns were spun at 13.000 rpm for 30 sec and the flow through 
discarded. Columns were spun for 1 min to remove the last residues of the wash 
buffers and transferred to new labeled 1.5 ml microcentrifuge tubes. Subsequently, 
30 – 50   μl   of   sterile   destilled  water   was   added   directly   to   the  membrane   and   the  
columns were incubated at room temperature for 1 min and spun at 13,000 rpm for 1 
min. The eluted DNA was stores at 4°C. 
 
2. 16. 5. RNA Extraction 
RNA extraction was performed using RNeasy mini kit (Qiagen). Briefly cells were 
grown and centrifuged at 4000g for 15 minutes, pellets then resuspended in TE 1.8 
ml of TE buffer (Tris 10 mM, EDTA 1 mM, pH 8.0) containing 200 g/ ml of 
lysostaphin, 400 U/ml mutanolysin, and 40 g/ ml proteinase K (final concentrations) 
and incubated at 37 C for 1-2 hours with occasional gentle mixing. A volume of 350 
µl from lysed cells was used and proceeds to elution of RNA, followed 
manufacturer’s  instructions. DNase1 (Qiagen) was used by mixing 10 µl of enzyme 
with 70 µl of the DNase I supplied buffer and added to each RNA sample tubes 
according   to   the   manufacturer’s   instructions.   RNA   samples   were   eluted   50μl  
volumes, analyzed using a NanoDrop1000 spectrophotometer (Lab tech), and stored 
at -80°C for longer terms. 
 
2. 16. 6. RNA Agarose Gel Electrophoresis 
Electrophoresis tanks and gel combs were soaked in 0.1M NaOH for 15-30 min, and 
rinsed with RNease free water several times. Total RNA 500ng in 1x MOPS (3-N-
morpholino  propane  sulfonic  acid)  buffer,  1.0  μl  of  ethidium  bromide  and  1.0  μl  of  
RNA loading buffer (50% glycerol, 1mM EDTA and few grains of bromo phenol 
blue)  made  up  to  10.0μl  by  RNase  free  water  were  mixed  and  boiled  for  few  minutes  
and loaded on RNA agarose (1.2% in 1x MOPS buffer) mini gels. 
 
2. 16. 7.  cDNA Synthesis 
First strand of cDNA was generated using the Superscript III transcriptase 
(Invitrogen)  system.  For  this  one  μg  of  total  RNA  was  reverse  transcribed  in  a  total  
volume  of  20μl  containing  random  hexamer  primers  (150  ng/μl)  (Invitrogen),  made  
52 
 
up  to  11.0μl  with  sterilized  MQ  RNase  free  water,  the  mixture  was  heated  at  65ºC/  5  
minutes, put on ice for 5 minutes and spun briefly. Then 1 x RT buffer (Invitrogen), 
10nM DTT (Invitrogen), dNTP (0.5 mM) (Bioline), RNase inhibitor (Promega 2.0u/ 
μl),  and  Reverse  Transcriptase  (RT  III)  (10u/  μl,  Invitrogen)  as  final  concentrations,  
were  added.  The  suspension  of  20  μl  was  incubated  at  42ºC  for  90  minutes,  followed  
by 72ºC for 15 minutes. After confirming that cDNA synthesis was successful by 
normal PCR, samples were then stored at -20ºC. 
 
 
2. 16. 8. Real-Time Quantitative PCR (RT-qPCR) 
A cocktail of following components was made in 20µl reaction mixes. The cDNA 
synthesized from the total RNA was diluted in a 1:4 retio with sterile nuclease free 
water and was used as a template for the real-time reaction. 
 
Syto9 (5µM)      0.25µl 
Forward primer (10pmol/ µl)                0.25 µl 
Reverse primer (10pmol/ µl)          0.25 µl 
5x reaction Buffer                                2 µl 
MgCl2 (1.5mM)                                    0.6 µl 
dNTP mix (10mM of each dNTP)          0.4 µl 
Taq DNA polymerase (Bioline)             0.08 µl 
Sterile dH2O                                  15.67 µl                 
 
Total    19.5 µl                                                          
                                   
                                   
0.5 µl of template was added and mixed with the rest of the reaction mix in flat 
topped real-time PCR tubes, and spun briefly. Samples were then run in the 
RotorGene 3000 (Corbett Research) using the following parameters: 95ºC for 10min 
followed by 95ºC for 20sec, 54-56ºC (annealing tempreture) for 20sec, and at 72ºC 
for 20sec, with data collection in each cycle at 72ºC. 
Melt: 
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55ºC-99ºC, hold 30 seconds on the 1st step, and 5 seconds on subsequent steps. The 
data from the run were acquired the annealing tempreture using the multi channel, 
emission at 470nm and detection at 510 nm. 
 
 
2. 16. 9. Data Analysis Using (REST-2009)  
The assay relies on measuring the increase in fluorescent signal, which is 
proportional to the amount of DNA produced during each PCR cycle. Individual 
reaction are characterized by the PCR cycle at which fluorescence first rises above a 
defined or threshold background fluorescence, a parameter known at the threshold 
cycle (Ct) value. The more target there is in the starting material, the lower the Ct 
value. This correlation between fluorescence and amount of amplified product 
permits accurate quantification of target molecules over a wide dynamic range 
(Nolan et al., 2006). Ct values and reaction efficiency were produced in comparative 
quantification analysis generated by Rotorgen 3000 and used for data analysis using 
REST-2009 software (Corbett Research). The Relative Expression Software Tool 
(REST) was used (Pfaffl et al., 2006). REST software is used to determine changes 
in target gene expression standardised by non-regulated reference genes (Corbett 
Research 2006). The purpose of this software tool in this study was to verify the 
results of microarray data of RS1/19 with the wild-type Oxford strain. 
 
2. 16. 10. DNA Sequencing  
PCR products for the genes (or part of the genes) required for sequencing was 
purified using Amersham Biosciences GFX purification kit, and quantified using 
NanoDrop1000 spectrophotometer (Labtech). The PCR products were then 
sequenced (Durham sequencing service) with the same primers used for 
amplification, details of which are given in the appropriate chapter section. 
 
 
 
2. 16. 11. DNA Restriction Enzymes 
Restriction enzymes were obtained from Promega, UK. DNA restriction digest 
contained 0.5-1  μg  of  DNA,  1U  of  restriction  endonuclease  and  1  x  buffer (supplied 
54 
 
by manufacture) made up to a final volume of 30-40  μl  with  sterile distilled water. 
Digests were incubated for between 2 to 18 h at the appropriate temperature. 
Restriction enzymes and cut off ends from PCR products were removed from the 
reaction using GFX DNA purification kit as described in the   manufacturer’s  
instructions (Amersham Biosciences, UK). For digested plasmid desired fragment 
was isolated on a 0.7-1% wt/vol agarose gel and gel purified as described in section 
2. 16. 4. 
 
2. 16. 12. Dephosphorylating Vector 
If a single enzyme is used (nondirectional cloning), terminal 5'-phosphates must be 
removed with heat inactiveted alkaline phosphatase (Invitrogen) after the digestion 
to prevent self-ligation (recircularization) of the plasmid.1  μL  (5U)  of  enzyme  was 
added to the restriction digestion reaction, then incubated for 15 minutes at 37°C to 
remove 5' phosphates from vector. Heat inactivate for 15 minutes at 65°C.  
 
2. 16. 13. DNA Ligation 
Ligation of DNA was carried out using either T4 DNA ligase supplied by 
Promega UK. Purified DNA inserts were ligated to purified vector DNA in a ratio of 
3:1. The ligation reaction mix also contained 1 x T4 DNA ligase buffer (supplied by 
manufacture)   and   1   U   T4   DNA   ligase   in   a   final   volume   of   10   μl   made up with 
sterilized distilled water. Reactions were incubated overnight at 16°C. 
 
2. 17. Manipulation of Escherichia coli 
2. 17. 1. Electro-competent Cells 
Electro-competent E. coli XL-1 Blue cells were prepared as described by (Ausubel et 
al., 1988). Briefly, 1 L of LB broth was inoculated with 10 ml of an overnight E. coli 
culture. The culture was incubated at 37°C, shaking at 200 rpm until an OD600 of 0.5 
– 0.8 was reached. Following incubation on ice for 15 – 20 min, the cells were 
harvested by centrifugation at 5000 x g, 4°C for 10 min. Cells were then washed in 1 
L of ice-cold sterile distilled water, recentrifuged, washed with 500 ml ice-cold 
sterile distilled water, then resuspended in 20 ml ice-cold 10 % vol/vol glycerol. 
Cells were centrifuged once again prior to resuspension in a final volume of 1 ml of 
ice-cold 10 % vol/vol glycerol. Aliquots of   40   μl   were   transferred   to   cold  
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microcentrifuge tubes and flash frozen in liquid nitrogen before storage at -80°C. 
 
2. 17. 2. Heat Shock Transformation of E. coli Cells       
Cells were removed from the freezer and thawed at room temperature until just 
liquid, and placed back on ice. 40 μL  aliquots  were  mixed  with  1-10  μL  of  DNA and 
incubated on ice for 20 min. Cells were heat shocked by placing tubes in a 
42°C water bath for 90s, and then chilled by returning to ice immediately. 
Cells  were   recovered   by   adding   500  μL  of  LB   and   incubated   shaking   at   37°C   for 
approximately 1 h and plated on LB plates containing appropriate antibiotic. 
 
2. 18. Manipulation of S. aureus 
2. 18. 1. Preparation of Plasmid DNA 
For purification of plasmid DNA from S. aureus a Wizard®Plus SV Minipreps DNA 
Purification System (Promega UK) was used with modification to the protocol. 
Briefly, 2-3 ml of a S .aureus overnight culture was harvested in a by centrifugation 
14,000 rpm 1 min. The   pellets   was   resuspended   in   250   μl   of cell resuspension 
solution (supplied by the manufacturer) and  5  μl  of  a  5  mg/ml  Lysostaphin  (Sigma)  
was added, mixed and incubated at 37°C   for   30   min.   250   μl   cell lysis solution 
(supplied by the manufacturer) was added and mixed by gently inverting the tube 3-4 
times,  350  μl  neutralization solution was added and tube gently inverted 3-4 times to 
facilitate total mixing. Mixture was centrifuged for 10 min at 14,000 rpm to 
precipitate genomic DNA and cell debris. Supernatant was gently poured on to a spin 
column and spun at 14,000 rpm for 1 min and flow through  was  discarded.  750  μl  of  
wash solution (supplied by manufacturer, Ethanol added) was added and column 
centrifuged again for 1 min at 14,0000 rpm. Flow through discarded and the same 
step repeated again this time with 250 µl of wash solution. Flow through and the 
column spun again at 14,000 rpm for 1 min to get rid of wash buffer residues. Spin 
column was transferred to a new micro centrifuge tube and 30 – 50  μl  nuclease free 
water was added. Columns were incubated at room temperature for 1 min and 
plasmid DNA recovered by centrifugation at 14,000 rpm for 1 min. 
2. 18. 2. Preparation of Electro-competent S. aureus 
Electro-competent S.aureus RN4220, cells were prepared as described by (Schenk 
and Laddaga, 1992). Briefly, an overnight culture of the desired strain was grown in 
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30 ml of B2 broth for no more than 15 h. This overnight culture was used to 
inoculate 200 ml of pre-warmed BHI broth to an OD600 of approx. 0.25. The culture 
was incubated at 37°C, shaking at 200 rpm until an OD600 of 0.35 – 0.4 was reached 
(approx 1 – 1.5 h). All of the washes and incubations were done a room temperature 
unless otherwise stated. The cells were harvested by centrifugation at 10.000 x g for 
10 min. Cells were then washed in 30 ml of sterile distilled water, recentrifuged, 
washed with 30 ml sterile distilled water. Centrifuged again and resuspended in 10 
ml 10 % vol/vol glycerol. This step was repeated with resuspension in 5 ml of 10 % 
vol/vol glycerol and incubated at room temperature for 15 min. Cells were 
transferred to 1.5 ml microcentrifuge tubes and centrifuged once again at 10.000 x g 
prior to resuspension in a final volume of 1.5 ml of 10 % vol/vol glycerol. Aliquots 
of 80 μl  were stored at -80°C. 
 
2. 18. 3. Electroporation of S. aureus Cells 
Electrocompetent cells were removed from the freezer and thawed at room 
temperature prior to use. The cells were mixed with approx. 1  μg  of  plasmid  DNA 
was  added  to  70  μl  of  electrocompetent S. aureus cells and transferred to a 0.2 
mm electroporation cuvette (BioRad). A BioRad Gene Pulsar was used, according to 
manufacturer’s  instructions,  to  deliver  an  electric  pulse  of  2.3  kV  (25μF,  100Ω). 
The cuvette was immediately removed and 1 ml of SMMP broth was added. After 
incubation for approx. 2 h at 37°C (unless otherwise stated) 100 – 200   μl   of   the 
bacterial suspension was spread on to an appropriate selective plate, the rest of the 
cells were spun at 13.000 rpm for 1 min, supernatant discarded and resuspended in 
200  μl  SMMP broth and spread in an appropriate selective plate. 
 
2. 19. 80α Transduction 
Phage 80α for transduction of S. aureus was carried out as described by 
Lindisay, J. (2006) as follows:  
 
2. 19. 1. Phage Lysate Preparation 
To get a high titer of phage lysates, an overnight plate of the  S. aureus 8325-4 cells 
was inoculated into LK broth and incubated at 37ºC  with shaking for approximately 
3h. A 7 ml aliquot of bacterial cells were then spun down, and resuspended in 7ml 
phage buffer  plus  7ml  BHIB.  1  ml  of  phage  80α  stock  (kindly  supplied  by  Dr.  Jodi  
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Lindsay) was added, mixed gently and incubated at room temperature for 10min. 
The suspension was then incubated at 30 ºC with slow shaking (70rpm), mixed 
gently after 2h incubation, then checked and mixed again each hour. Phage 80α  
causes partial lyses and even after it has been left overnight on the bench the 
suspension remains clouldy. Lysates were spun down and filter sterilized using 
0.2µm pore size filter and stored at 4 ºC.  
 
 2. 19. 2. Determination of Phage Titres 
Titres of 80α  lysates  were determined as follows. An overnight plate of the recipient 
cells S. aureus 8325-4 was inoculated into LK broth and incubated at 37ºC for 
approximately 3h. Phage lysates were diluted in phage buffer to 10-8 and 100µl of 
each dilution mixed with 400 µl of recipient cells and 30 µl of 1M CaCl2, this 
mixture was left on bench for 15 min. Each dilution was mixed with 7 ml top agar 
(tempered  to  50˚C) and poured over phage bottom plates; the top agar was allowed 
to set and incubated at 30 ºC for 18-24h. 
 
2. 19. 3. Phage Transduction 
S. aureus (Oxford, 8325-4, RS1/19, and SH1000) cells were transduced as described 
by (Lidisay,J. 2006). An overnight culture of RN4220 (pGL485-pbp4) was grown in 
20 ml LK broth. The cells were harvested by centrifugation for 10 min at 10000 rpm 
and resuspended in 1 ml LK broth. Both a sample and a control were mixed; the 
sample  consisted  of  500  μl  cells, 1 ml LK with 10 mM CaCl2 and  500  μl phage 80α 
lysate. The control  consisted  of  500  μl cells and 1.5 ml LK with 10 mM CaCl2. Both 
sample and control was incubated first for 25 min stationary and 15 min, with 
shaking at 37°C. After incubation, the sample and control was transferred to an ice 
bucket and 1 ml of ice-cold 0.02 M sodium citrate was added. Both Sample and 
control was centrifuged for 10 min at 10,000 rpm at 4°C and resuspended in 1 ml ice 
cold 0.02 M sodium citrate and incubated on ice for 2-3  h.  Aliquots  of  100  μl  was  
spread  on  selective  LK  plate’s  containing 0.05% wt/vol sodium citrate. Plates were 
incubated at 37°C for 12-72 h and transduction of the desired DNA was verified by 
testing the expression of pbp4 by RTq-PCR and overproduction of PBP4 in 
membrane preparations. 
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The same method was used with to transduce (Oxford & RS1/19) cells with 
RN4220(pMAD-Δpbp4), expect that all the incubation were performed at 30°C 
instead of 37°C, because pMAD is a temperature sensitive vector. 
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CHAPTER THREE 
Characteristics of in vitro Generated 
Penicillin Resistant S. aureus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
3. 1. Introduction 
Cell wall deficient CWD bacteria can be obtained in vitro by growing cells on solid 
or liquid media, with increased osmolality, in the presence of penicillin (Fuller et al., 
2005). CWD bacteria have altered morphology and cultural characteristics due to 
damaged or absent cell wall structures (Onwuamaegbu et al., 2005). However, the 
loss of the cell wall may be permanent (stable L-forms) or temporary, as some may 
regain their wall and grow normally (unstable L-forms) (Yong, 2007). It has been 
reported that survival under conditions preventing normal cell wall formation 
promotes complex adaptations that acquire a fitness cost, (Hubscher et al., 
2007). The ability of bacteria to survive, grow and reproduce as CWD forms has 
been reported for a number of bacterial species like B. subtilus, E. coli and L. 
monocytogenes (Leaver et al., 2009, Siddiqui et al., 2005, and Dell Erra et al., 2009). 
CWD forms of S. aureus have been identified clinically in patients with recurrent 
skin lesions, and also in some cases of meningitis, endocarditis, arthritis and other 
diseases (Stoitsova et al., 2000). 
 
β-lactam antibiotics exhibit differential affinities for the four PBPs in S. aureus 
(Georgopapadakou et al., 1982).  For example, PBP4, has a remarkably low affinity 
and high deacylation rate for penicillin analogues compared to other PBPs; this 
results in only 10-46% of the protein being bound by penicillin at a given time, 
depending on the strain of S. aureus (Chambers et al., 1994), and also explains the 
early observation that PBP4 has penicillinase activity, turning over 25 penicillin 
molecules per minute in vitro (Navartna et al., 2010; Kozarich et al., 1978). 
However, PBP4 has a very high affinity and low deacylation   rate   for   the  β-lactam 
cefoxitin, resulting in effective PBP4 inhibition (Wyke et al., 1981; Sumita et al., 
1990). It has been observed that S. aureus strains with different genetic background 
have relatively different affinities for the same antibiotics used (Table 3. 1) 
(Kosowska-Shick et al., 2010).  
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Table  3.  1.  Binding  affinities  of  β-lactams for S. aureus PBPs 
 
                                                             IC50 (µg/ml)a 
PBP          Strain 
                                        ceftaroline      cefotaxime      ceftriaxone      penicillin G 
 
PBP1     ATCC 29213          0.5                   0.5                   0.25                   4 
              873                          8                      4                      2                        0.5 
              510                          0.5                   2                      0.5                     128 
              2149A                     1                      0.5                   4                        2 
              1287                        0.125               4                      1                        4 
              25                            0.5                   1                      16                      0.5 
 
PBP2     ATCC 29213          0.25                 1                      0.25                   8 
              873                         0.5                    0.5                   0.5                     0.5 
              510                         0.125                0.5                   0.25                   64 
              2149A                    1                       2                      1                     >128 
              1287                       4                       1                      1                        4 
              25                           0.25                  0.5                   2                        1 
 
PBP2a   ATCC 29213          NP                   NP                   NP                     NP 
              873                          0.5               >128                 >128                     64 
              510                          0.25             >128                   1                         64 
              2149A                     1                  >128                 >128                     2 
              1287                        1                    4                        2                        4 
              25                            0.01               0.5                     0.25                   4 
 
PBP3     ATCC 29213          0.125             1                        1                        1 
              873                          0.125             0.125                 0.25                   0.03 
              510                          0.125             0.25                   0.25                   4 
              2149A                     0.5                 4                        2                        2 
              1287                        0.1                 1                        1                        0.25 
              25                            0.25               0.25                   1                        0.5 
 
PBP4     ATCC 29213        >8                  >8                      >8                      >8 
              873                       >128              >128                  >128                  >128 
              510                       >128              >128                  >128                     64 
              2149A                  >128              >128                  >128                  >128 
              1287                       64                 >128                 >128                     4 
              25                           ND                  ND                   ND                     ND 
 
a NP not possible, ATCC 29213, as a MSSA strain, lacks PBP2a. ND, no 
demonstrable binding of Bocillin FL to PBP4 was observed. (Table taken from Kosowska-Shick et al., 2010). 
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Study of the CWD variants by transmission electron microscopy showed 
thickened and diffuse cell wall, whereas CWC strains had a cell wall which was 
microscopically indistinguishable from wild type cell wall (Fuller et al., 2005).  
 
The CWD cells were resistant to lysis by lysostaphin, which suggests that they are 
not dependent on the presence of the cell wall for their intactness or have altered 
lysostaphin targets. CWD cells were very sensitive to lysis by TritonX-100. This is 
likely due to more accessibility of the detergent to their membranes than the 
membranes of parental strains. On the other hand, CWC (RS1/19) cells show a slight 
increase in resistance to lysis by lysostaphin in comparison to the Oxford strain and a 
significant increase in lysostaphin sensitivity when compared to CWD cells. It has 
been previously reported that the five glycine cross-bridge on peptidoglycan is the 
target for lysostaphin (Kline and Blackburn, 1994). This may suggest that RS1/19 
cells have intact peptidoglycan structure which is essential for their integrity. In 
addition, RS1/19 cells were resistant to the action of Triton X-100, indicating that 
recovery of cell walls is important to prevent access of the detergent into the cell. 
Furthermore Fuller et al., also performed HPLC analysis that indicated that the 
muropeptide in the RS1/19 contains shorter glycan chain and a larger number of 
pentaglycine cross-bridges (Fuller et.al. 2005).  
 
In order to better understand how S. aureus responds to exposure to the cell wall 
active antibiotics, penicillin G, S. aureus Oxford (ATCC9144) was passaged in the 
presence of increasing concentrations of the antibiotic in liquid medium with a raised 
osmolality. The aims of this chapter are to determine the kinetics of acquisition of 
penicillin resistance and to investigate the relationship between loss of cell wall 
integrity and inheritance of high-level penicillin resistance. Additionally, 
experiments were designed to determine if the activity of PBP4 is important in the 
resistance mechanism by using antibiotics with different affinities for PBPs as 
selective inhibitors 
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3. 2. Results and Discussion 
3. 2. 1.  Selection for Penicillin Resistant Mutants by Successive 
Cycling in Liquid Media and its Correlation to a Gram Negative 
Phenotype 
The aim of this experiment was to generate CWD bacteria that exhibit resistance to 
penicillin G, study the characteristics of CWD cells and investigate the relation 
between acquisition of penicillin resistance and their Gram staining characteristics. 
 
Induction of CWD bacteria can be carried out using both solid and liquid media. 
Strain RS1/19 was generated by successive sub-cultures on solid media containing 
increasing concentrations of penicillin G (Fuller et al., 2005). Cells within colonies 
on agar plates are metabolically heterogeneous, whereas those in liquid cultures are 
all in the same metabolic state; additionally, liquid medium led to more equivalent 
penicillin G concentration.  It is likely therefore that penicillin resistant strain would 
be induced more quickly in liquid culture.  
 
In this experiment, a series of CWD variants of S. aureus ATCC 9144 (Oxford) were 
generated in liquid medium with elevated osmotic potential in the presence of sub-
lethal levels of penicillin G. Initially, a series of cultures with different, sub-lethal 
levels of penicillin G were grown and subsequently analyzed for their Gram reaction. 
The percentage of Gram negative cells in each transfer were determined by counting 
the number of Gram negative cells in five microscopic slides, and then the 
percentage of the average were calculated. The culture with the highest percentage of 
Gram negative cells was used to inoculate fresh cultures in CWD medium with a 
penicillin concentration range between 100% and 400% compared to which the cells 
were previously grown in. This process was repeated for a further 9 serial passages, 
during which time the MIC rose from 0.064 to 32µg/ml and near 100% of the cells in 
the culture stained Gram negative. At the end of the selection procedure 10 strains 
with different MIC to penicillin G concentrations ranging from (0.064 to 32µg/ml) 
were obtained and stored at -80˚C;;  each  strain  was  named  according  to  the  number  
of transfers for example CWD (AM1) refers to the CWD cells obtained from  1st  
transfer of the serial passage.  
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Growth of the cells on BHI agar, or in LB medium, or CWD medium without 
addition of penicillin caused them to revert to CWC forms for example T1 is the 
revertant from 1st transfer that stained 100% Gram positive.  
 
On incubation of the Oxford strain in high osmolality medium in the presence of 
penicillin, the majority of cells exhibited a cell wall defective phenotype, implied by 
Gram-negative staining of the cells (Figure 3. 1. C, D). Penicillin resistance rose 
gradually until the 6th and 7th transfer where it suddenly rose 2 fold from 0.5 to 
2µg/ml and then from 2 to 8µg/ml respectively. After this time it continued to rise 
steadily to reach 32µg/ml (Figure 3. 2). On first exposure to penicillin G 90% of the 
cells stained as Gram negative, however this dropped on further transfers in the same 
amount of penicillin, and even dropped when grown in medium containing 
significant increases of penicillin concentration. Throughout this experiment, the 
maximum production of CWD cells which was characterized by Gram negative 
staining in the 3rd, (AM3) and 10th (AM10) transfer (Figure 3. 3). Cells grown in 
CWD media with penicillin showed profuse Gram negative staining early in the 
experiment, with further transfers a mixture of Gram negative and Gram positive 
cells were seen which may indicate reversion of CWD variants to the CWC 
phenotype. This may suggest that CWD are unstable and will revert back to a cell 
wall competent state very easily even in the presence of penicillin G. Similar results 
were observed from CWD lines which has been generated in CWD liquid media 
(CL3/19) and on CWD solid media (CS1/19) (Fuller et al., 2005).  
 
Although CWD bacteria may be considered similar to the bacterial protoplast 
(Markova et al., 2008), when they are observed microscopically they show variable 
morphological characterization: pleomorphic cells with indistinct margins and loss 
of the typical cell arrangement characteristic of S. aureus. Interestingly, following 
growth of CWD forms for many generations in the absence of penicillin G, which 
led to reverting to CWC phenotype, the cells remain resistant to high concentrations 
of penicillin G. This might be achieved by these cells gaining stable resistance to 
penicillin G through either mutations in PBPs or alterations in gene regulation. CWC 
(T12) colonies also differ from the wild-type strain because they exhibit smaller 
colonies with less pigmentation as compared to the wild-type Oxford strain (Figure 
3. 1. A, and B).  
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Figure  3.  1.  Cultural  and  growth  characteristic  of  S.  aureus  variants.  Colonies of S. 
aureus grown on BHI agar plates, wild- type Oxford (A) and revertant strain T12 (B). 
Colonies of RS1/19 are smaller in size and less pigmented.  Gram  stain  of  the  S.  aureus  
strains   at   high   magnification   power   1,000X.   Typical   wild   type   S.   aureus   strain   (C),  
CWDB   in   the   presence   of   sub-inhibitory   concentration   of   penicillin  G   (D).  Wild-type  
cells   stains   uniformly  Gram   positive,  while   cell  wall   deficient   cells  AM3   shows   95%  
Gram  negative  cells  with  indistinct  margins. 
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From this experiment it is clear that acquisition of penicillin resistance is achieved in 
a small incremental steps and correlates with specific mutations occurred in the 
bacteria to allow the antibiotic-resistant, cell-wall deficient strain to be generated. 
The results suggest that loss of cell wall and antibiotic resistance are two separate 
processes; growth in sub-letahl levels of antibiotic causses loss of cell wall, but 
mutation is required for a resistance phenotype to be established.  On first exposure, 
90% of the cells exhibit a lose cell wall integrity without cell lysis occurring. On 
subsequent exposure to penicillin G part of the population revert to a Gram positive 
reaction and continue to grow even in the presence of high concentration of 
penicillin G. This suggests that these cells have adapted to grow in the presence of 
the antibiotic, perhaps due to peptidoglycan alteration. This may be an indication that 
Gram negative cells can participate in the development of antibiotic resistance, by 
giving time to develop gene mutations and cell adaptation.  
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Figure  3.  3.  Percentages  of  Gram-negative  cells  after  each  transfer.  In  each  
transfer  5  fields  on  the  microscopic  slid  were  counted,  and  then  the  percentage  of  
the  average  represented  in  each  bar.  Majority  of  S.  aureus  cells  become  Gram  
negative  when  challenged  with  penicillin. 
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Figure   3.   2.   Penicillin   G   MIC   of   S.   aureus   Oxford   after   each   serial  
passage   with   increasing   concentration   of   penicillin   G.   Penicillin  
resistance  increased  gradually  from  0.032  µg/ml  in  1st  transfer  to  32µg/ml  in  
the  10
th  
transfer.   
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3. 3. PBP Assays Reveal a Correlation Between Increased Binding of 
Labeled Penicillin to PBP4 and Reduced Antibiotic Susceptibility. 
 
It has been reported that overproduction  of  PBP4  is  responsible  for  intrinsic  β-lactam 
resistance in S. aureus strains exposed to high level of penicillin G (Henze and 
Berger-Bächi, 1996), and overproduction of PBP4 has been implicated in the 
resistance seen in cells generated on media with high osmolality (Fuller et al., 2005). 
In order to understand the kinetics of the development of high levels of PBP4 and 
see if there is a correlation to resistance acquisition, in CWD and CWC derivatives, 
PBPs profile of these strains were studied. 
 
3. 3. 1. Optimization of Membrane Protein Preparation 
S. aureus has four PBPs, ranging between 85 to 45 KDa in size, on the basis of 
migration of the labeled PBPs on SDS-PAGE. Initial analysis of PBPs in membrane 
preparations identified more than the four expected polypeptides. This was likely to 
have been caused by either proteolysis of membrane proteins during preparation or 
non-spesific binding of labeled penicillin to protein bands, resulting in many labeled 
proteins. It was therefore necessary to optimize the preparation of membranes from 
this particular strain of S. aureus.  
 
Initially the method of Nigel et al., (1980) was followed. Cells of S. aureus strains 
were lysed by Lysostaphin and incubated at 30°C for 30mins. Membrane proteins 
were then labeled with Bocillin FL, separated by SDS-PAGE and scanned using the 
Typhoon Imager (Figure 3. 4A). Only one band was clearly visible, which may be 
due to incomplete lysis of cells using lysostaphin alone.  Subsequently, cells were 
lysed using Lysostaphin as well as sonication, following the method of Zhao et al 
(1999). In this method in addition to incubation of cells with lysostaphin at 4°C for 
30mins, cells were sonicated to lyse the cells completely. The samples were then 
labeled with Bocillin FL and proteins separated by SDS-PAGE (Figure 3. 4B). 
Several extra bands, to those expected to represent the four PBPs in S. aureus, were 
present on the SDS gel, which could have resulted from proteolysis of PBPs. 
 
To test if these extra bands were due to non-specific binding to the Bocillin FL or 
were present because of proteolysis of the PBPs, two separate experiments were 
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performed. In the first experiment the method of DeLoney and Schiller (1999) was 
followed, 15g of membrane fractions were labeled with penicilloic acid with 
increasing concentration ranging from (0.5 – 50U).  Penicilloic acid is the product of 
the -lactamase reaction and does not bind to the active site of PBPs; therefore, pre-
treatment with this does not prevent Bocillin FL from binding to PBPs.  After 
incubation of the membrane preparations with penicilloic acid, at 37°C for 15 min., 
Bocillin FL was added and incubated for another 20 min prior to the membrane 
protein being analyzed using SDS gels (Figure 3. 4C). Since the intensity of protein 
bands did not decreased in the presence of penicilloic acid it is likely that additional 
bands are due to proteolysis of PBPs. This hypothesis was confirmed because the 
bands completely disappeared when membrane protein fractions were pre-incubated 
with high concentration of penicillin G., prior to addition of Bocillin FL. These data 
indicate that the additional bands present were probably proteolytic fragments of 
PBPs, which still contain the active- site serine residue of penicillin-binding proteins 
that interacts   covalently   with   β-lactam antibiotics (Dargis and Malouin, 1994) 
(Figure 3.4D).  Galleni et al., 1993 have also reported the detection of additional 
unidentified PBPs in electrophoresis profile of E. coli, but in contrast to our results,  
they suggested that these bands may be nonspecific since they did not completely 
disappeared in competition experiments with high concentrations of penicillin G. 
 
Several modifications of the membrane preparation method were made out in an 
attempt to prevent proteolysis. The serine protease inhibitor protease inhibitor PMSF 
(phenylmethylsulphonyl fluoride 0.5mM was added before addition of lysostaphin, 
to prevent proteolysis during cell lysis (Sieradzki et al., 1999). Samples were then 
run on SDS gels along with fluorescent rainbow markers (Amersham ECL Plex) 
(Figure 3. 4E). The rainbow fluorescent marker used was composed of proteins 
linked to two dyes, Cy3 and Cy5; therefore the gels were scanned via the Cy3 and 
Cy5 channel and then overlaid onto the labeled PBP scan which was detected using 
the Cy2 channel (Figure 3.4F). This experiment was useful because the molecular 
weight of each PBPs band was demonstrated by using the rainbow marker. From the 
results of this experiment it was obvious that there was overproduction of PBP4 
according to its molecular weight, but PMSF was not totally effective in preventing 
proteolysis.  
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Therefore, another approach to prevent proteolysis was to add bacterial Protease 
Arrest™   (Biosciences)   at   a   concentration   of   10µl/ml   of   membrane   suspension. 
Protease arrest contains both irreversible and reversible  protease inhibitors to inhibit 
serine, cysteine and other proteases, which is reported to inhibit over 90% of 
protease activities (GE Health Care Life Sciences). The protease-inhibitor was added 
before sonication of the cells and another 10µl was added during solubilization of 
membrane protein with 2% Triton-X100.  Then  the  membrane  proteins  (15μg)  from  
wild type and RS1/19 were labeled with Bocillin FL, the labeled PBPs were 
separated on SDS-PAGE and detected by a Typhoon scanning (Figure 3.4G). These 
results shows four clear bands with a minor band labeled with Bocillin FL positioned 
between PBP2 and PBP3 may be due a proteolysis product. 
 
Overproduction of PBP4 in RS1/19 compared to Oxford strain is clearly evident and 
confirms that the high levels of pbp4 mRNA, observed by DNA microarray (Chapter 
four), leads to high levels of PBP4 protein in membranes. 
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3. 3. 2. Relationship Between MICs, Gram Reaction and Penicillin 
Binding Profile of S. aureus after Each Transfer 
MIC of an antibiotic is defined as the lowest concentration (maximum dilution) of 
antimicrobial that will inhibit the visible growth of micro-organisms after overnight 
incubation (Andrews, 2001). MIC determination was carried out for penicillin G 
using the macro broth dilution method following the British Society for 
Antimicrobial Chemotherapy (BSAC) standard methods (Andrews, 2001). For PBP 
analysis membrane proteins were prepared from CWC derivatives of each transfer 
from T5 to T10 strains. CWD strains were not used because they are unstable and 
need special requirments (CWD media supplemented with penicillin G), for this 
resean CWC strains were used. PBPs binding capacity of CWC strains was 
visualized by fluorescent penicillin in order to compare their PBPs profiles and also 
to investigate the relationship between changes in PBP4 activity and retention of 
penicillin G resistance in CWC variants. 
 
In view of the fact that comparing penicillin-labeled bands of different strains can be 
affected by any changes in protein volumes loaded onto gels, PBPs ratios within a 
sample was considered to be a more sensitive and accurate assessment of PBP 
binding capacity. Assays of PBP ratios of CWC lines (Figure 3. 5), revealed great 
alteration in the penicillin binding capacity of PBPs. Scanning membrane proteins of 
T5, T6, T7, T8, T9, and T10 strains showed a gradual increase in PBP4 bands in 
comparison to the Oxford strains. This result is consistent with a gradual increase in 
the resistance to penicillin G. Interestingly, the increased PBP4 binding capacity and 
low PBP2/PBP4 ratio persisted in CWC derivatives when grown in antibiotic free 
media and was associated with stability of penicillin G resistance. These data may 
indicate that alteration in PBP4 activity plays an important role in obtaining high 
penicillin resistance stabilization in CWC derivatives.  It is likely that the cell walls 
in CWD cells were disrupted, as indicated by Gram-negative staining and electron 
microscopy (Fuller et al., 2005). Together these data strongly imply that in addition 
to overexpressed PBP4, an altered cell wall might be associates with obtaining this 
form of penicillin resistance. 
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                Oxford            T5                      T6                          T7                        T8                        T9                        T10 
PBP2/PBP4  ratio          53.8                        11.3                            8.2                          6.81                        6.72                            3.88                    2.3         
MIC      µg/l                                  0.064                      0.5                                2                                  8                                  16                                    32                          32 
 
Figure  3.  5.  Correlation  between  overexpression  of  PBP4  with  decreased  sensitivity  
to  penicillin  G.  Bocillin  FL  was  added   to  membrane  proteins  prepared  from  wild-type  
Oxford  and  CWC  (T5  to  T10)  cells.  PBPs  were  separated  by  SDS-PAGE  electrophoresis  
and  visualized  using  a  Typhoon  scanner.  The   intensity  of  PBP2  and  PBP4  bands  were  
measured,   in   each   lane,   and   the   ratios   show   increasing   penicillin   binding   capacity   of  
PBP4.  MICs  were  determined  by  E-test.   
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To summarize, it can be concluded, from these experiments, that the decrease in 
susceptibility to β-lactam antibiotics in T10 is developed gradually, and is correlated 
with a variety of changes happened in these cells. The first step in developing 
resistance is through disruption of the cell wall, which was indicated by a Gram 
negative staining reaction. Meanwhile the cells are able to develop cell adaptation 
changes (likely through the gene mutations) needed for stable resistance to penicillin 
G. One change identified is an increase in penicillin binding capacity of  PBP4 in 
membranes, which might indicate a role for this protein in resistance to penicillin G.  
Regarding RS1/19, the CWC strains which have been generated following each 
transfer in penicillin G was not available; consequently experiments were done only 
CWC strains (T5-T10). 
 
3. 4. Characterization of Penicillin Resistant Lines 
In  previous  experiments  it  was  shown  that  increases  in  β-lactam resistance correlated 
with overexpression of PBP4 in membranes. Importantly this confirms the data for 
RS1/19, reported of Fuller et al. (2005), with an independently isolated strains. To 
investigate other modifications that occurred in these cells relating to stable 
resistance, both RS1/19 (Fuller et al., 2005) and T12 (T10 after two extra passage in 
CWD media in the absence of penicillin) were compared to wild-type Oxford strain. 
The logic for using two independent strains is that characteristics relating to the 
penicillin resistance mechanism should be consistently recognized in them. 
 
3. 4. 1. Growth Rate Determination  
Modification or alteration of any cell wall components by either mutation or 
environmental factors could potentially affect the total chemical, physical, and 
structural integrity of the cell wall, which may result in alterations in colonial 
morphology and growth characteristics. Growth rates give a simple indication of 
whether the revertant strains (RS1/19 and T12) behave differently compared with the 
wild-type Oxford strains. 
 
The growth curve of the wild-type Oxford and the revertant strains RS1/19 and T12 
were determined by measuring the absorbance readings at 600nm. Figure 3. 6 shows 
a growth curve that was established for these strains using three biological 
replications. BHI broth media was inoculated with an overnight culture to an A600 
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of 0.03. The culture were incubated at 37 ºC with shaking (150 rpm); growth was 
monitored for each of the three replicates for about 18hrs by recording the absorbance 
every 30 min for 5 h, then the culture left overnight and the last absorbance reading 
recorded after 18hrs. The mean generation times for each strain was determined from 
the exponential growth phase and the lag phase were also determined. For the wild-
type the lag phase was 62 min and mean generation time was 40 min, in comparison 
the lag phases for RS1/19 and T/12 were 142 min and 135 min and the mean 
generation time were 64 min and 48 min respectively. The revertant strains feature 
much slower growth compared with the parental S. aureus cells, as the lag phase was 
over twice as long and the mean generation time was slower than the wild –type 
strain. Reduced growth rate, may be a further strategy to cope with the cell wall 
defects upon exposure to inhibitory concentrations of penicillin G. These cells might 
have a decreased metabolic rate due to the thicker cell wall, previously reported 
(Fuller et al., 2005). 
  
After 18h, the absorbance reading was 2.36 for the Oxford strain and 2.26 and 2.29 
for RS1/19 and T12, respectively, indicating that they grew to the same extent.  
Similar results have been reported for growth of cells with mutations in femA; after 
selection for lysostaphin resistance, the clones demonstrated a slow growth rate 
(Kusuma et al., 2007). Similarly, Hübscher et al., showed that inactivation of femAB 
resulted in a phenotypic adaptation (slow growth rate), which might be evidence for 
a common survival strategy in S. aureus (Hübscher et al., 2007). 
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Figure  3.  6.  Representative  growth  curve  of  wild  type  (Oxford)  and  
revertant  strains  (RS1/19  and  T12).  Growth  curves  of   the  wild-type  
Oxford   and   revertant   strains   grown   in   BHI   liquid   medium   at   37   °C  
showing  that  the  revertant  strains  has  a  longer  lag  phase,  slower  mean  
generation  time  in  comparison  to  the  wild-type  strain. 
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3.  4.  2.  Overexpression Of PBP4 Correlates With Resistance To 
Lysostaphin. 
Lysostaphin is an antimicrobial agent belonging to a major class of antimicrobial 
peptides and proteins known as the bacteriocins. It is an extracellular enzyme 
secreted by strains of Staphylococcus simulans  biovar staphylolyticus (Schindler et 
al., 1964). The target of lysostaphin is the pentaglycine cross-bridge of 
peptidoglycan, where it cleaves specifically between the third and the forth glycine 
residues of the pentaglycine (Figure 3. 7).  
 
PBP4 is a transpeptidase  and carboxypeptidase  which forms peptide bonds between 
adjacent stem peptide via a pentaglycine bridge; overexpression of PBP4 has been 
reported to lead to more pentaglycine cross-bridge of peptidoglycan in another strain 
(Pereira et al., 2007). Therefore lysostaphin susceptibility test were carried out to test 
whether this is also the case in RS1/19 and T12. According to this test cells with 
overexpressed PBP4 would be expected to lyse more slowly than cells with 
unchanged expression of PBP4 due to more pentaglycine bridge in the 
peptidoglycan. Lysostaphin susceptibility tests were carried out on cells grown to the 
exponential phase in BHI medium (Figure 3. 8). As anticipated, the revertant strains 
RS1/19 and T12 were more resistant to lysostaphin in comparison to the wild-type 
Oxford strain; 50% of cell lysis occurred after 6 min in wild-type cells and after 14.3 
min and 14 min for the revertant strain RS1/19 and T12 respectively. These results 
confirm that the increased levels of PBP4 protein in membranes corresponds to 
increased PBP4 activity, correlates with increased lysostaphin resistant. 
 
 
 
 
 
78 
 
 
 
Figure 3. 7. Peptidoglycan structure in S. aureus showing the primary site of 
lysostaphin hydrolysis. NAcGlu, N-acetylglucosamine; NAcM, N-
acetylmuramicacid; A, L-alanine; D-Q, D-glutamine; K, L-lysine; D-A, D-alanine; 
G, L-glycine.* indicates site of cleavage Adapted from (Bastos et al., 2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure   3.   8.   Lysostaphin   susceptibility   of   the   wild-type   (Oxford)   and  
revertant  strains  RS1/19  and  T12.  Cells  were  grown  to  exponential  phase  at  
37˚C   then   treated  with   lysostaphin   (1U/ml).   The   revertant   strains   are  more  
resistant  to  lysostaphin  compared  to  the  wild-type  strain.  Values  are  the  mean  
of  three  experiments  and  the  bars  represents  standard  error  of  the  mean.   
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3. 4. 3. Reduced Autolysis with Triton X-100 in Revertant Strains 
Non-ionic detergents, like Triton X-100, have been used commonly to extract 
membrane associated enzymes without loss of activity (Komatsuzawa et al., 1994). 
This reagent also induces the release of acylated Lipoteichoic acid (LTA) and 
bacterial autolysis (Koch 2001). To do this, Triton X-100 has to penetrate the cell 
wall and therefore if the cell walls are altered in the revertant strain a difference in 
the rate of autolysis might be expected. Triton X-100-induced autolysis assays were 
performed on whole cells of the wild-type Oxford and revertant RS1/19 and T12 
strains, following the method of Fournier and Hooper (2000) with minor 
modifications. Three biological replicates for each strain were tested. 
 
The results show that 50% lysis occurred at 32.0 min for the wild-type strain while 
the revertant strain RS1/19 and T12 were more resistant, as 50% lysis occurred after 
87 and 57 min respectively (Figure 3. 9),. This indicates an altered cell wall in the 
revertant lines, which is consistent with the earlier findings that suggest the cell walls 
of the revertant cells RS1/19 are thicker (Fuller et al., 2005) and this may explain the 
reduced autolysis in revertant strains. Abnormal wall thickness can be related to 
either lower rates of cell wall degradation or increased rates of cell wall biosynthesis. 
Increased thickness of the cell wall and slow growth rate has been shown to inhibit 
wall turnover and autolysis by blocking the access of murein hydrolases to their cell 
wall substrate (Sieradzki and Tomasz 1997). On the other hand, it has been reported 
that a similar substrate-arresting mechanism related to some quantitative or 
qualitative alterations in the wall teichoic acid led to reduced autolysis and thickened 
cell wall (Sieradzki and Tomasz 2003; McAleese et al., 2006). To conclude, these 
observations imply that reduction in the rate of autolysis is most probably related to 
an altered cell wall structure.  
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Figure  3.  9.  Autolysis  assay  of  Oxford  strain  and  revertant  strains  RS1/19  and  
T12   in   the  presence   of  Triton  X-100.  Bacterial   cells  were   collected   from   early  
exponential   phase   (OD₆₀₀=   0.7),   washed   twice   with   ice-cold   water   and   re-
suspended   in   an   equal   volume  of  Tris-HCl   (pH  7.2),   containing   0.05%   (vol/vol)  
Triton  X-100.  The  rate  of  autolysis  was  measured  as  the  decline  in  optical  density.  
Bars  represent  standard  error  of  the  mean. 
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3. 4. 4. Decreased Autolysis of Heat Killed Cells of RS1/19 
Compared to Oxford Cells. 
The atl gene encodes a bifunctional autolysin that can be purified from the culture 
supernatant as two extracellular peptidoglycan hydrolases (Liu et al., 2011)); the C-
terminal domain of the protein has glucosaminidase activity and the N-terminal 
domain with the amidase activity (Foster, 1995). Quantitative peptidoglycan 
hydrolase analysis was carried out for both Oxford and RS1/19 strains to determine 
any reduction or absence of autolysin activity. It is thought that most of the 
autolysins of S. aureus are the products of one gene (atl), which can be visualized as 
a multiple bands during gel electrophoresis due to preform processing (Bose et al., 
2012). 
 
The autolysins extracted from both Oxford and RS1/19 cells were tested for activity 
using both strains as substrate, to identify any differences between these cells (Figure 
3. 10). Firstly autolysins extracted from each type of cell (Oxford and RS1/19) were 
used to degrade the peptidoglycan from the heat-killed cells of the same line. After 
4h of incubation it was obvious that the autolysins extracted from the Oxford strain 
hydrolyzed the peptidoglycan of the Oxford strain more efficiently as 60% lysis 
occurred at the 5h of incubation compared with only 10% lysis after 6h incubation 
when RS1/19 cells were treated with autolysin from RS1/19. This could be because 
either RS1/19 expressed reduced whole-cell autolytic activity, which results in less 
degradation of the peptidoglycan of RS1/19 cells or the cell wall of RS1/19 is thicker 
and more complex due to the accumulation of mutations during selection of this 
strain, which led to reduced susceptibility to autolytic activity. 
 
To test whether the component of the cell wall in Oxford and RS1/19 has any effect 
on the autolysis activity, heat killed cells of Oxford strain used as a substrate for 
RS1/19 autolysins, and heat-killed cells of RS1/19 strains were used as substrate for 
Oxford strain (Figure 3. 10). The results showed that RS1/19 autolysins degrade 
peptidoglycan of the Oxford strain efficiently; however, Oxford autolysins do not 
have a significant effect on RS1/19 peptidoglycan. This means that the autolysins 
from both cells are highly active and the differences seen in rates of autolysis must 
therefore be related to the cell wall structures in the Oxford and RS1/19 strains. It is 
82 
 
possible that the thicker cell wall in RS1/19 leads to decreased autolytic activity, 
which is in agreement with the results reported by Utaida et al., 2006 who showed 
that reduced autolytic activity is a common phenotype to the glycopeptide-
intermediate S. aureus (GISA) as a result of thickened cell wall after growth in the 
presence of vancomycin. In conclusion, data show that both crude autolysin 
preparations are nearly equally active but activity against different cell types varies 
(presumably reflecting differences in call wall architecture). 
 
 
 
 
 
Figure 3.10. Whole cell autolysis activity profile of Oxford and RS1/19 Strains.  
100µg of extracellular autolysin were added to a suspension of heat-killed and 
lyophilized cells and the decreased turbidity were measured over time. Extracellular 
autolysin extracted from Oxford cells (  ). Extracellular autolysin extracted from 
RS1/19 cells (   ). Heat-killed cells prepared from Oxford strain (    ), Heat-killed 
cells prepared from RS1/19  (    ). Bars represents standard error of the mean. 
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3. 5. Analyzing the Role of PBP4 in Resistance Using ß-Lactam 
Antibiotics Which Have Different Affinities to PBPs. 
Analysis of PBPs in a previous experiment (Section 3. 3. 1. & 3. 3. 2) showed an 
increase in binding of Bocillin FL to PBP4 in RS1/19 and T12. As RS1/19 also 
shows increased expression of the pbp4 gene as indicated by microarray data 
(Appendix 1), the increased binding is likely due to an increase in the amount of 
PBP4 in the membranes of these strains.  
 
It is known that PBPs differ in their binding affinity according to the penicillin 
derivative used (Chamber et al., 1992). Therefore differences in binding affinities to 
a variety of penicillins can be used as probes for PBPs activity (Sieradzki et al., 
1997). For example, cefsoludin has a relatively high affinity for PBP1 and PBP3 
(Georgopapadakou et al., 1980; Farha et al., 2013), penicillin G and cefotaxime have a 
high affinity for PBP2 (Farha et al., 2013) and cefoxitin has a high affinity for PBP4 
(Farha et al., 2013). The antibiotic concentration required to block 50% of the binding of 
Bocillin FL to each PBP is defined as the IC50 (µg/ml) (Moison et al., 2010), which can 
be  tested by direct labelling of PBPs with Bocillin FL after being pre-treated with each 
β-lactam antibiotic.  
 
3. 5. 1. Comparison of the MIC of the Wild-Type and CWC Types of 
S. aureus to  Different  Β-Lactam Antibiotics.  
This experiment was designed to study the comparative susceptibilities of the wild- 
type and the revertant strain RS1/19 to different ß-lactam antibiotics. MIC 
determinations were carried out using both E-tests and macro broth dilution assays, 
following the British Society for Antimicrobial Chemotherapy (BSAC) standard 
methods (Andrew et al., 2001). E-test was performed to determine the MIC of S. 
aureus for penicillin G, while the macro broth dilution method was used for 
cefoxitin, cefotaxime and cefsoludin. All sensitivity tests used Iso-sensitest broth 
(Andrew et al., 2001).  
 
Analysis of the comparative susceptibility of the S. aureus variants to β-lactam 
antibiotics showed dramatic differences in penicillin G susceptibility of 0.064 µg/ml 
in the wild-type (Oxford strain), and 24 µg/ml in the CWC derivative RS1/19 (about 
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375 fold). Significant elevation in cefotaxime resistance from 2 µg/ml in the parental 
strain to 128 µg/ml in the generated CWC types (about 64 fold) was also measured. 
Compared to the parental strain, CWC S. aureus variants were only slightly affected 
by cefoxitin and cefsoludin with two fold reduced susceptibility from 2 µg/ml and 4 
µg/l to 4 µg/ml and 8 µg/ml, respectively (Table 3.2). 
  
The observed increase in penicillin G resistance in the revertant strain is consistent 
with the results obtained by Elmer et al., (2002) and Fuller et al., (2005) who also 
observed stable retention of increased penicillin G resistance in CWC variants of 
S.aureus after reversion from CWD forms. Interestingly, the increased cefotaxime 
resistance of CWC types of S. aureus compared to the wild-type is a similar picture 
to MIC analysis with penicillin G and both of these antibiotics have a high affinity 
for PBP2.  
 
 The most likely explanation for drastically reduced susceptibility to penicillin G and 
cefotaxime,   in   RS1/19,   is   the   low   affinity   of   these   β-lactam antibiotics to PBP4 
(Georgopapadakou et al.1982). Penicillin G and cefotaxime have high affinities for 
PBP2 (Farha et al., 2013), this means that the transpeptidase of PBP2, which is 
inhibited by penicillin G and cefotaxime in the Oxford strain makes them sensitive to 
low concentrations of these antibiotics. In the case of the RS1/19 strain, the 
transpeptidase activity of overexpressed PBP4 may compensate for the inhibited 
transpeptidase activity of the other PBPs. In another words, higher penicillin G or 
cefotaxime concentrations are needed to bind to PBP4 to inhibit CWC bacterial 
growth, due to overexpression of PBP4 in RS1/19. This possibility is supported 
further by sensitivity of the revertant cells to cefoxitin and cefsoludin, which have 
high affinities for PBP4 (Georgopapadakou et al.1982).  
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Table 3. 2. β-lactam antibiotic susceptibilities of wild-type and resistant CWC 
cells grown on Iso-sensitest media.  
Antibiotic   Oxford    RS1/19 
                                                         MIC (µg/ml) 
penicillin G  0.064 24 
cefoxitin  2    4 
Cefotaxime 2 128 
cefsoludine  4 8 
 
 
 
 
3. 6. Binding  of  Different  β-lactam Antibiotics to Penicillin Binding 
Proteins in Oxford and RS1/19 Cells.  
Fluorography of PBPs labeled with Bocillin FL has been the primary experimental 
method  used   to   assay   binding   of   β-lactam antibiotics. PBPs differ in their binding 
affinity among different species and according to the antibiotic used. Therefore,  the 
binding affinity of PBPs in the wild- type   and   revertant  RS1/19   strains   to   each  β-
lactam antibiotics were measured, in order to help understand the role of these 
proteins in the elevated resistance to penicillin G.  
 
The association between resistance and altered binding affinity has been based 
largely on quantitative differences in binding to Bocillin FL to PBPs for susceptible 
compared with resistant strains. Binding has been measured by determination of 
IC50 (Chamber, 1994). 
 
3. 6. 1. PBP Binding Studies: Competition Between Various -
Lactams and Bocillin FL.  
 
To   estimate   the   IC50   for   each   antibiotic,   different   amounts   of   β-lactam antibiotics 
(0.032 µg/ml to 64 µg/ml) were mixed with 100µg/ml of membrane proteins. This 
mixture was incubated for 30 min. prior to the addition of Bocillin FL.  
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Reduction of the detection of labeled PBPs with Bocillin FL by increasing antibiotic 
concentrations represents competition by that specific antibiotic.  
 
Figure 3. 11 represent the affinities of each antibiotic for the PBPs in the wild-type 
Oxford strain. The 50% binding affinity was calculated by measuring the density of 
each PBPs for different amount of each antibiotics used.  Figure 3. 12 exemplify the 
density measurements for penicillin G. Subsequently, the data was represented as a 
graph of relative density versus concentration of penicillin G used (Figure 3. 13). 
Similar analysis was carried out to calculate affinities of each antibiotic for the 
individual PBPs in the wild-type Oxford and RS1/19 isolates and is reported as 
IC50s (Figure 3. 14; Table 3. 3). 
 
Penicillin G has a high affinity to PBP1, PBP2, and PBP3 in the Oxford strain with 
IC50s of 0.064, 0.4, and 0.1 µg/ml respectively. However, it shows a low affinity to 
PBP4 with an IC50 of more than 4µg/ml (Figure 3. 11; Table 3. 3). A very low 
concentration of this antibiotic (MIC 0.064 g/ml) is sufficient to inhibit the growth 
of the Oxford strain. The same pattern was measured for cefotaxime, which 
possessed high binding affinity to PBPs 1, 2, and 3, while it has a low affinity to 
PBP4. In contrast cefoxitin and cefsoludin have high affinities for PBP4 with IC50s 
of 0.1 µg/ml; this means that in addition of inhibition of other PBPs, PBP4 is also 
inhibited in the presence of low concentration of these antibiotics. 
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  cefoxitin    µg/ml              C         0       0.1      0.25     0.5       1          2          4        16       64 
                           
cefotaxime    µg/ml           C     0       0.1     0.25     0.5        1          2         4         16      64 
cefsoludine  µg/ml              C         0        0.1     0.25     0.5       1          2        4       16       64 
Figure  3.  11.  Membrane  proteins  of  wild-type  Oxford  strain  pre-incubated  with  
increasing  concentrations  of  different  β-lactam  antibiotics  (µg/ml).  PBP  profiles  
were   detected   by   Bocillin   FL.   Antibiotic   concentrations   (µg/ml)   adjusted   in   all  
samples   to   a   standard   amount   of   loaded  proteins   (100µg).  First   lane   (C)   is   control  
sample  of  RS1/19  to  show  the  position  of  PBP. 
 
 
penicillin  G  µg/ml      C         0    0.032   0.064     0.1      0.2     0.5        1          2         4   
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Figure  3.  12.    Cell  membrane  of  wild-type  Oxford  strain.  The  intensity  of  each  
penicillin  binding  protein  band  (PBP1-4)  was  measured  within  each  square  and  for  
every  concentration  of  antibiotic  used  in  each  lane.   
Figure   3.   13.   Graphic   representation   to   determine   IC50   for   each   PBPs   for    
membrane   protein   of   wild-type   Oxford   strain   after   being   pre-treated   with  
penicillin  G.   the   50%   binding   affinity  was   calculated   by  measuring   the   density   of  
each  PBPs  to  determine  IC50. 
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penicillin G µg/ml  C        0.032    0.064        0.1         0.2        0.5           1            2           4 
    
             
cefoxitin µg/ml      C           0.1        0.25        0.5         1           2            4           16         64 
          
cefotaxime µg/ml  C          0.1        0.25       0.5            1            2          4            16          64 
 
cefsoludin µg/ml      C           0.1         0.25         0.5          1            2           4      16       64 
Figure   3.   14.   Cell   membranes   of   strain   RS1/19   pre-incubated   with   increasing  
concentrations  of  different  β-lactam  antibiotics  (µg/ml).  PBP  profiles  were  detected  
by  Bocillin  FL.  Antibiotic  concentrations  (µg/ml)  adjusted  in  all  samples  to  a  standard  
amount  of  loaded  proteins  (100µg).  First  lane  (C)  is  control  sample  of  RS1/19  to  show  
the  position  of  PBP.   
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Table 3. 3.  Binding  affinities  of  β-lactam antibiotics for S. aureus PBPs 
 
IC50(µg/ml) 
 
Antibiotic  
Oxford RS1/19 
 
PBP1 
 
 
PBP2 
 
PBP3 
 
PBP4 
 
PBP1 
 
PBP2 
 
PBP3 
 
PBP4 
penicillin   0.2 0.4 0.1 >4 0.2 0.5 0.1 >64 
Cefotaxime 0.1 <0.1 0.5 64 0.5 0.1 0.2 >64 
cefoxitin   0.5 0.2 <0.1 0.1 1.0 0.5 1.0 0.1 
Cefso-ludin 0.1 0.1 0.5 0.1 0.2 0.2 1.0 0.5 
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Binding assay for each individual PBP in RS1/19 demonstrated that penicillin G and 
cefotaxime have a low affinity to PBP4 compared to PBP2 (Figure 3. 14). Therefore, 
significant increases in the amount of these antibiotics were required for PBP4 
inhibition, with IC50s of  >64µg/ml (Table 3. 3). This result is in agreement with the 
results -obtained by Kosowska-shick et al., 2010 who showed that cefotaxime 
inhibits 50% of binding affinity of PBP4 at about 8 fold higher than it inhibits of 
PBP2 and those of Miller et al., 2005, who observed that the penicillin G IC50 value 
was 32µg/ml for PBP4 and 0.2 µg/ml for PBP2. Moreover, from results obtained in 
the present study, it is obvious that cefoxitin has a relatively high affinity to PBP4 
with an IC50 of 0.1 µg/ml (Table 3.3), which means that the over expressed PBP4 is 
inhibited in a very low concentration of cefoxitin. Likewise, cefsoludin inhibits 
PBP4 at a very low concentration, as it has an IC50s of 0.5µg/ml. 
 
In summary, RS1/19 cells have a moderately increased resistance to cefoxitin and 
cefsoludin, but a marked increase in resistance to cefotaxime and penicillin G. This 
supports the proposal that overproduction of PBP4 plays important role in reduced 
cefotaxime and penicillin G sensitivities. Therefore, it is likely that these cells can 
withstand inhibition of the transpeptidase activity of PBP2 because of the high 
activity of PBP4. This is confirmed by an increase in the IC50 of penicillin G and 
cefotaxime for PBP4 in revertant types with almost no change IC50 for PBP2. MIC 
values of antibiotics for the revertant cells correlated directly with increases in the 
IC50 for PBP4. 
 
3. 6. 2. Effect of Cefoxitin, Cefotaxime, and Cefsoludin on Penicillin 
G Sensitivity of Wild-Type Oxford and Revertant RS1/19 Strain. 
To test the hypothesis that PBP4 is an essential PBP, in RS1/19, the penicillin G 
MIC  was   determined  when   in   combination  with   β- lactam antibiotics that have 
different affinities for each PBP. The antibitoics used were cefoxitin, which 
preferentially binds PBP4 (Chambers et al., 1994), Cefotaxime, which 
preferentially binds PBP2 (Sieradzki et al., 1997), and Cefsoludin, which binds 
PBP1,  PBP2  and  PBP4  at  low  concentration  (IC50  0.1µg/ml)  (Table  3.  4).    These  β-
lactam antibiotics were used to inhibit selected PBPs and assess the effect of this 
interference on sensitivity to penicillin G.  
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 MICs of Penicillin G were determined for S. aureus strains grown in ISA media 
containing   25%   of   the   MIC   of   the   different   β-lactam antibiotics (cefoxitin, 
cefotaxime, and cefsoludin). Expression of penicillin G resistance of parental and 
CWC forms of S .aureus altered variably under these conditions. Cefoxitin was the 
most effective in reducing the MIC of penicillin G in RS1/19 (Table 3. 5); it also 
decreased penicillin G resistance of wild-type cells, but not as significantly as with 
RS1/19 cells (4 fold with 25% of MIC of cefoxitin).  
 
PBP4 seems to have an important role in mecA negative methicillin-resistant strains. 
Increased susceptibility to penicillin G in the presence of cefoxitin and reduced 
binding of Bocillin FL to PBP4 following pre-treatment with cefoxitin indicate that 
inhibition of PBP4 has an important role in penicillin G resistance of CWC types.  
However, if the reduction in penicillin G resistance is due to the synergistic activity 
of both cefoxitin and penicillin G only, reduction in resistance might be expected to 
be similar in both wild-type and revertant cells. The molecular and biochemical basis 
by which overexpressed PBP4 might confer resistance is not entirely clear though it 
may be that PBP4 overexpression in RS1/19 cells can replace an essential 
transpeptidase function of one or more high molecular mass PBPs. It has been shown 
that   β-lactam resistance might be changed by targeting PBP2 and PBP4 with 
combinations  of  β-lactam antibiotics that have different affinities for these PBPs. For 
instance, using a combination of antibiotics which have high affinity to PBP4 
(cefoxtin) and the PBP2-selective  β-lactams cefuroxime, ceftizoxime, oxacillin, and 
penicillin, decreased the MICs of these antibiotics between 32- to 128-fold. 
Conversely,  combining  cefoxitin  with  β-lactams having a low affinity for PBP2 led 
to only a 2- to 8-fold change in the MIC (Farha et al., 2013). 
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Table 3. 5. Analysis of penicillin G sensitivities of S.aureus variants grown in the 
presence of 25% of the MICs of cefoxitin, cefotaxime, and cefsoludin. 
  
 
 
Strains 
penicillin G(µg/ml) 
PG 
MIC 
25%MIC 
Fox 
fold 
decrease 
25%MIC 
cef 
Fold 
decrease 
25%MIC 
cso 
fold 
decrease 
Oxford 0.064        0.016         4 0.016             4 0.016    4 
RS1/19       24 0.094         255 6 4                  8 3 
*PG, penicillin G; fox, cefoxtin; cef, cefotaxime; and cso, cefsolodin. 
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Additionally, cefotaxime also caused an increase in penicillin G sensitivity of both 
the wild-type and revertant RS1/19 strains (4 fold with 25% of MIC of cefotaxime). 
Hence cefotaxime had similar effects on penicillin sensitivity of wild-type and CWC 
variants. Accordingly, reduction of MICs of penicillin G of S.aureus forms with 
cefotaxime could be due to synergistic activity of both antibiotics. However, other 
reasons for alteration of penicillin susceptibility of S. aureus variants by cefotaxime 
cannot be ruled out from results obtained in these experiments. Compared to 
cefoxitin, when cefotaxime was included in the ISA medium at a concentration 25% 
MIC, the MIC for penicillin G dropped from 24 to 6, because both of these 
antibiotics has a greater affinity for PBP2 than PBP4 and in combination did not 
dramatically alter the MIC.  Cefsoludin led to an increase in penicillin G sensitivity 
of both wild-type (4 fold with 25 % MIC of cefsoludin) and (3 fold with 25% MIC 
of cefsoludin) in the revertant RS1/19 strain (Table 3. 5).  
 
In summary, the reduced sensitivity to penicillin G in CWC cells is likely related to 
PBP4 overproduction, as antibiotics that selectively inhibit PBP4 activity cause the 
greatest reduction in penicillin G MIC, when used in combination.  This is evidenced 
by a remarkable rise of penicillin sensitivity of cells following treatment with the 
PBP4 selective antibiotic, (cefoxitin). 
 
3. 6. 3. Effect of sub-inhibitory concentrations of cefoxitin on 
cefotaxime MIC in the wild-type and revertant RS1/19 strains. 
 
Cefotaxime like penicillin G has a higher affinity for PBP2 than PBP4 (>200 fold 
and 1000 fold) respectively (Georgopapadakou et al., 1982). Like penicillin G, the MIC 
of cefotaxime rose dramatically in CWC cells (64 fold). Therefore, an experiment 
were carried out to investigate whether cefotaxime behave like penicillin G if it is 
used in combination with 25% MIC of cefoxitin. 
 
The cefotaxime MIC was tested for S. aureus wild-type and RS1/19 strains, grown in 
ISA media mixed with 25% MIC of cefoxitin (Table 3. 6); interestingly, the results 
were very similar to results with penicillin G. The RS1/19 strain exhibited a 32 fold 
reduction in MIC to cefotaxime while, the wild-type strain revealed only 4 fold 
reduction in their MIC to cefotaxime.  
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Table 3. 6. Cefoxitin increases Cefotaxime sensitivity of the wild-type Oxford and 
the revertant RS1/19 strains. 
 
Strains 
cefotaxime MIC(µg/ml) 
 
Cefotaxime 
MIC 
25% MIC 
Cefoxitin 
fold  
decrease 
Oxford   2 0.5                         4 
 
RS1/19   128 4 32 
 
 
 
 
These data again suggest that the increased activity of PBP4 is crucial for resistance 
in RS1/19, possibly because the transpeptidase activity it encodes is able to replace 
for cefotaxime inhibited PBP2 transpeptidase activity. 
 
To conclude, the data obtained in this chapter indicate that the reduction in 
susceptibility to penicillin G in CWC cells (RS1/19 and T12) is developed gradually. 
The resistant cells were growing slower than the wild-type Oxford strain and more 
resistant to lysostaphin and Triton X-100 induced autolysis. Moreover, Membrane 
protein prepared from the cells of each transfer showed a gradual increase in the 
PBP4 band in comparison to Oxford strain.  Interstingly, the reduced sensitivity to 
penicillin G in CWC cells is likely related to PBP4 overproduction, as antibiotics 
that selectively inhibit PBP4 activity cause the greatest reduction in penicillin G 
MIC, when used in combination. These data suggest a role for PBP4 overproduction 
in the penicillin resistance observed in RS1/19 and T12 strains, therefore it is 
necessary to overexpress pbp4 in S. aureus of different genetic background to check 
if PBP4 overproduction is necessary and sufficient for the observed resistance in 
RS1/19 and T12 strains.   
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CHAPTER FOUR 
Effect of Overexpression of PBP4 
on the Susceptibility of S. aureus to  β-
lactam Antibiotics 
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4. 1. Introduction  
It is well accepted that cell wall-active antibiotics inhibit bacterial growth by 
inhibiting peptidoglycan biosynthesis (Walsh, 2003).  S. aureus and other bacteria 
undergo an extensive program of gene and protein expression when treated with cell 
wall-active antibiotics (Singh et al., 2001) and cell wall stress stimulon is the term 
used to describe altered gene expression triggered by antibiotics that inhibit cell wall 
biosynthesis (Utaida et al., 2003).  
 
The effect of antibiotics on global bacterial gene expression is dose dependant. At 
low concentration, the number of transcripts regulated by the antibiotic is low, 
increasing until around 5% of total bacterial transcripts at concentrations close to 
those that inhibit growth. The number of regulated transcripts is reduced at higher 
concentration of antibiotics. This curve reflects the different effect of antibiotics on 
bacterial gene expression, at low concentration antibiotics might act a signalling 
molecules regulating specific gene expression. Upon increase in concentration stress 
responses sum up to the panel of regulated genes and at high inhibitory 
concentrations the observed changes mainly deal with the mechanism of action of 
antibiotic and cell growth inhibition (Fajardo et al., 2008). 
 
Increased microbial resistance to penicillin has been widely reported, and a number 
of resistance mechanisms have been observed. Amongst them is resistance that is 
mediated through a plasmid-encoded   β-lactamase (blaZ),   which   hydrolyses   the   β-
lactam ring of penicillin and many of its derivatives (Bondi and Dietz, 1945; Novick, 
1963). While, in some strains of S. aureus methicillin resistance is due to the 
production of a low affinity PBP2a, which is encoded by the mecA gene (Song et al., 
2004). Methicillin resistance relies upon a number of other genes, fem, for the 
expression of methicillin resistance; these housekeeping genes have a direct or 
indirect role in peptidoglycan synthesis or turnover and their correct function is 
essential for full expression of resistance (Berger-Bächi and Rohrer, 2002), because 
in mecA positive MRSA strains mutations in fem genes lead these strains to be 
oxacillin sensitive (Giannouli et al., 2010). Another class of borderline methicillin-
resistance is due to an alteration in the targets of these drugs, resulting in a decrease 
in  or   loss  of  affinity   for  β-lactams of crucial PBPs (Malouin and Bryan 1986). An 
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example of altered methicillin-binding affinities of PBP2 occurred as a result of a 
point mutation near the penicillin-binding motif of the transpeptidase active site 
(Hackbarth et al., 1995).  
 
In mecA and   β-lactamase negative S. aureus increased levels of PBP4 in the 
membrane following growth in increased concentration of penicillin, have been 
shown to be related to methicillin resistance (Fuller et al., 2005).  In another 
example, the methicillin-resistant mutant strain PV1 was selected in vitro with 
increasing concentrations of penicillin. The increase of resistance was correlated 
with changes in the amount of PBP4. The subsequent Tn551-mediated insertional 
inactivation of PV1 yielded a susceptible mutant strain, and no PBP4 was visible in 
membrane preparations. This was due to integration of the transposon into the pbp4 
gene itself or into a region controlling or interacting with its expression. The abcA-
pbp4-taqD sequences of wild-type S. aureus and of PV1 showed that the in vitro 
resistant strain PV1 had a single adenosine insertion and a 90 nucleotide deletion in 
the putative promoter region of abaA and pbp4 (Figure 4. 1. A) (Henze and Berger-
Bächi, 1995). The pbp4 gene is transcribed from a single promoter, the -10 region of 
which is reported to lay 264 base pairs upstream of the translational start site, 
resulting in a single transcript. The promoter region for pbp4 overlaps with the 
promoter for a divergently transcribed gene, abcA, by about 80 base pairs (Figure 4. 
1. B) (Domanski et al., 1997). The abcA gene encodes an ABC transporter, which is 
involved in the transport of antibiotics, heavy metals, hemolysins, and metabolites 
(Domanski and Bayles., 1995; Remy et al., 2012). Interestingly, a S. aureus strain 
with a deletion of abcA results in increased expression of pbp4 and increased 
peptidoglycan cross-linking, as well as increased resistance to PBP4-specific 
antibiotics such as imipenem and cefoxitin (Domanski et al., 1997). 
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Microarrays are one of the most powerful techniques that allow researchers to 
analyse expression of many genes in a single experiment quickly and efficiently. The 
simplest way to calculate the fold change is to divide the expression level of a gene 
in the sample by the expression level of the same gene in the control. A value of one 
indicates unchanged expression, less than one indicates a down-regulated gene, and 
more than one an up-regulated gene (Knudsen, 2004).  
The initial aim of the experiments described in this chapter is to verify the results of 
microarray data of RS1/19 cells, using qRT-PCR to examine the steady-state mRNA 
levels of selected genes. Another part is to study the effect of PBP4 over-expression 
on the sensitivity of S. aureus, with different genetic background, to penicillin.  T12 
was considered phenotypically similar to RS1/19, therefore only one strain RS1/19 
was taken forward. 
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4. 2. Results and Discussion  
4. 2. 1.  Microarray Data Revealed Overexpression of Genes Related 
to Cell Wall Biosynthesis. 
Comparison of the transcriptional profile of the Oxford parental strain and the in 
vitro selected penicillin resistant strain, RS1/19, was performed previously in our lab 
(T. Fawcett, unpublished) in order to identify genes that may be contributing to 
penicillin resistance. As many as 145 genes were found to be up-regulated and 91 
genes were down regulated in RS1/19 compared to the Oxford strain.  In RS1/19 
stable transcript reprograming of several cell wall related genes occurred following 
the challenge with penicillin; among them were pbp4, murA, murG, and lytM. These 
alterations in the cell wall are believed to prevent access of penicillin G (Fuller et al., 
2005).   
 
The gene encoding penicillin binding protein 4 (pbp4) displayed the highest relative 
expression level in RS1/19 (Appedix 1), of about 18.6 fold changes. However, the 
levels of the genes encoding the other PBPs (1-3) were unchanged. Other genes that 
encode enzymes involved in cell wall biosynthesis showed significant changes in 
expression in RS1/19; UDP-N- acetylglucosamine1-carboxyvinyltransferase (murA), 
which is the enzyme that catalyze the first step of peptidoglycan biosynthesis by the 
formation of UDP- Glc-NAc from fructose-6-phosphate (Barreteau et al., 2008) was 
up-regulated by 2.5 fold. Similarly, beta-N-acetylglucosaminyltransferase (murG), 
which is a transferase that adds GlcNAc from UDP-N- acetylglucosamine to lipid 
linked Mur-NAc pentapeptide to form undecaprenyl pyrophosphate linked 
disaccharide pentapeptide (lipid II) (Schneider and Sahl, 2010) was up-regulated 
2.31fold. Up-regulation of these enzymes may be a response by the cell wall to 
increase the rate of peptidoglycan synthesis.  murA appears to be the primary enzyme 
utilized in the staphylococcal cell for catalyzing the first step in peptidoglycan 
biosynthesis (Figure 4. 2); in murA inactivated cells the peptidoglycan content was 
reduced by approximately 26% and cells exhibited a  decreased growth rate and final 
culture density (Blake et al., 2009). The Overexpression of murA, murG, and pbp4, 
may be responsible for catalyzing more substrate needed for peptidoglycan 
biosynthesis in the cell wall. This may explain why the RS1/19 peptidoglycan is 
thicker than that in the Oxford strain (Fuller et al., 2005). Additionally, expression of 
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peptidoglycan hydrolase (lytM) mRNA increased 2.16 fold in RS1/19. LytM is 
suggested to be a lysostaphin-type endopeptidase with a glycyl-glycine target (Singh 
et al., 2010). This protein has been shown to have enzymatic activity that reduces 
muropeptide cross-linkage and glycan chain length (Pieper et al., 2006). However, 
overexpressed LytM is suggested to cause destruction of the cell wall and enhance 
cell lysis (Ingavale et al., 2003). LytM overexpression in RS1/19 may be required to 
promote septal peptidoglycan splitting and eventual daughter cell separation due to a 
thicker cell wall. On the other hand, reports indicated that overexpression of lytM in 
vancomycin resistant S. aureus (VRSA) plays some role in resistance to vancomycin 
and probably other cell wall inhibitor antibiotics (Pieper et al., 2006).  
 
To conclude, the pbp4 gene had the highest relative expression level in RS1/19 and 
reports from other studies indicate that high levels of PBP4 can have a role in 
penicillin resistance (Henze and Berger-Bächi, 1996, Fuller et al., 2005, and 
Banerjee et al., 2010). Therefore, experiments in this chapter were designed to study 
the effect of this protein on the sensitivity to penicillin in RS1/19. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pbp4 pbp2 
  Figure    4.  2.    Schematic  diagram  of  cell  wall  biosynthesis  in  S.  aureus  showing  genes  
up-regulated   during   treatment   with   penicillin   G.   The   synthesis   of   peptidoglycan  
precursors  is  initiated  in  the  cytoplasm,  where  6  ligases  (MurA-F)  catalyze  the  formation  
of   the   peptidoglycan      subunit,   lipid   II.   Interestingly,   the  murA   and  murG   genes,   which  
encode  two  of  these  ligases  have  been  up-regulated  according  to  microarray  data.  Lipid  II  
subunits  are  then  flipped  to  the  membrane-cell  wall  interface,  where  they  are  cross-linked  
by   the   penicillin-binding   proteins   (PBPs).   Bifunctional   protein   PBP2   mediates   both  
transglycosylation  and  transpeptidation,  while  other  PBPs,  especially  PBP2  and  PBP4,  can  
crosslink   the   lipid   II   pentapeptide   to   a   pentaglycine   cross-bridge   via   transpeptidation  
activity.  PBP4  was   also  up-regulated   according   to   the  microarray  data.  The  up-regulated  
genes  are  indicated  as  red  arrows.  (Images  adapted  from  Bugg  et  al.,  2011).   
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4. 2. 2. Validation of Microarray Assay by Real-Time RT-PCR 
Real-time quantitative RT-PCR (qRT-PCR) was performed to validate microarray 
data. As the original RNA used for the microarray analysis was not available, new 
RNA samples were extracted using the same conditions that were used for that 
experiment. Cells were grown in CWD medium until the early exponential phase 
then RNA was extracted, quantified by NanoDrop 1000 Spectrophotometry and 
cDNA synthesis carried out using 1µg of total RNA, using random hexanucleotide 
primers. PCR primers were designed for each gene to be quantified (Table 4.1) and 
the specificity of each primer was analysed by standard PCR and agarose gel 
electrophoresis, to establish that they gave PCR products of the expected sizes 
(Appendix 1). Additionally, three primer pairs, for gyrA, nuc and rho (DNA gyrase 
subunit A, Nuclease and Transcription termination factor respectively) were used to 
represent fragments of three internal control genes that had previously been used for 
a similar purpose (Theis et al., 2007). qRT-PCR experiments were used to test these 
internal gene primers and the stability of their expression in Oxford compared to 
RS1/19 strains. gyrA was found to be the most reliable primer as it showed stable 
expression in both strains; therefore this gene was chosen as a control reference gene 
to use in qRT-PCR experiments. PCR was carried out using a Rotor-Gene 3000 
(Corbett Research) machine using thermal cycling condition as follows: at 95ºC for 
10min followed by 95ºC for 20sec, 54-56ºC (according to the primers melting 
temperature) for 20sec, and at 72ºC for 20sec. The data were then subjected to 
analysis using the Relative Expression Software Tool (REST 2009) program, which 
is a software tool used to determine changes in the target gene expression 
standardized by non-regulated reference gene (Corbett Research 2006).  
 
A selected group of five genes showing up- or down- regulation was chosen to test 
the validity of the microarray data (Figure 4. 3). In general, there was a good 
correlation between microarray data and real-time RT-PCR data (Table 4. 2), as data 
using the two methods. Some variation between the two methods was seen for narG 
which was measured as having a 10-fold reduction in expression level in RS1/19 
using the microarray and only 2-fold reduction when measured by qRT-PCR. 
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Table 4. 1. Primers used for qRT-PCR experiments  
Gene Primer sequence forward (F) 
and reverse (R) 
Amplicon size          Reference 
Nuc F: tgtagtttcaagtctaagtagctcagcaa                                  96bp Alarcon et al.,  
2005     R: tgcactatatactgttggatcttcagaa                                                                       
Rho F: cgacgttcagacaatttacg                                           145bp Balaky, 2010            
R: gaaatattgaagcgggtgg 
gyrA F: gttgatggccaaggtaactttgg                                      210bp Balaky, 2010 
R: gatacctgatgcaccattgg 
pbp4 F:  aagtatggacaatcgcagacc    405 This study 
R: aaaccatctgtacccggcaaac    
murG F: tcctaagcttccacccataacg 210 This study 
 R: ctgacttaacaccaggattagcg 
lytM F: aacagcagcagcgattgaac     230 This study 
R: tcaggtgtgtgatgataatcccc 
narG F: tatcccagtctgaacgcgattc 207 This study 
R: acttcagaatgacggcaacacc   
tpi    F: atcaatatcagtttgtgcca                                            86 This study 
R: tggcacaaactgatattgatgg 
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Table 4. 2. Comparison of expression levels determined by microarray by real-
time RT-PCR analysis  
Gene Fold-change RT-PCR           Fold-change Microarray 
data     
 
pbp4 
 
17.832                                         
 
18.56 
murG          3.586 2.31                                          
LytM 2.608                                          2.16                          
narG   0.458                                          0.097                                
tpi     2.953                                          2.055               
Green downward arrows indicate significant reduction and red upward arrows 
indicate significant induction (p<0.05) 
 
 
Figure   4.   3.   Relative   expression   ratio   of   a   selection   of   genes   in   RS1/19  
compared   to  Oxford.     Genes   used   for  RT-PCR  analysis  were  pbp4,  murG,  
lytM,  narG,  and  tpi  each  with  three  replications.  gyrA  used  as  internal  control  
gene  (p  <  0.05).   
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This difference may be reflective of the greater dynamic range of the RT-PCR assay. 
In addition to that sometimes in microarray assay poor or absent hybridization 
signals were generated for one of the tested samples, and number of fold induction 
values can be under- or overestimated (Liu et al., 2005).   
 
4. 2. 3. Sequencing of pbp4 and its Intergenic Region Between pbp4 
and abcA Confirms no Mutations 
It has been reported that mutations in the promoter region (upstream of the pbp4 
gene, in the putative promoter region of abcA and pbp4) are responsible directly or 
indirectly for the overproduction of PBP4 and penicillin resistance (Henze and 
Berger-Bachi, 1996). Microarray data and real-time RT-PCR confirmed that pbp4 is 
the gene with highest expression level in RS1/19 compared to wild-type. 
Additionally strain T12, generated in this study, also has increased levels of PBP4 in 
membranes. The working hypothesis is that high PBP4 levels contribute to reduced 
antibiotic sensitivity in RS1/19 and T12 and experiments were designed to determine 
the reason for this over-expression. 
 
To check if there are any mutations in the intergenic region between abcA and pbp4, 
PCR was performed to amplify the promoter operator region of both genes (abcA 
and pbp4) from RS1/19, T12 and the parent Oxford strains using the primers DS1 
and DS2 (Table 4. 3). The PCR products were analyzed by agarose gel 
electrophoresis, purified using Amersham Biosciences GFX purification kit and 
directly sequenced using forward primer DS1. The data was then analyzed using 
multiple sequence aligment software (http://bioinfo. genotoul. fr/ 
multalin/multalin.html), which showed that the sequences of strains RS1/19 and T12 
are identical to the parent strain and no mutations were found (Appendix1). 
 
Recently, Banerjee at al., reported that methicillin resistance in an in vitro generated 
strain is due in part to an amino acid change at the entrance to the binding pocket of 
PBP4 (Banerjee et al., 2010). Therefore, it was important to establish whether the 
pbp4 gene has any mutations that could lead to reduced penicillin susceptibility, as 
seen in other systems. PCR was performed to amplify the structural gene of pbp4 
from RS1/19, T12 and the parent Oxford strain; four primer pairs, were designed to 
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cover the whole area of pbp4 (Table 4. 3). The PCR product was analyzed by 
agarose gel electrophoresis (Figure 4. 4). Then purified and sequenced using forward 
primers pbp4-p1, pbp4-p2, pbp4-p3, and pbp4-p4. No differences were found 
between the sequences of the parent Oxford and the revertant RS1/19 and T12 
strains (Appendix 1).  
 
To summarize, these experiments confirmed that the penicillin resistance observed in 
RS1/19 and T12 is not due to mutations in the promoter or the structural gene of 
pbp4. However, the data in chapter three showed correlation of PBP4 overexpression 
to resistance and therefore it remains likely that increased PBP4 is a contributory 
factor and therefore an important focus for further investigation. 
 
 
Table 4. 3. Primers used for sequencing of pbp4 gene. 
 
Primer name 
amplified 
Primer sequences forward primer 
(F)  reverse primer (R)                                      
Amplicon size (bp) 
region relative to 
pbp4start codon   
 
DS1 
 
F:gcaacgataagacccactgg     
 
 
597 
DS2 R: gccgacaaacctgcataacc         
pbp4-p1 F:agggaagattaacgctttatg     498 (-18 to 481)       
R:aaatcaacgaaatcgctcgtg   
pbp4-p2                       
 
R:aaatcaacgaaatcgctcgtg   402 (371to 773)       
F: aagtatggacaatcgcagacc    
pbp4-p3                       F: accaacaacgcatgcagttacg 405 (690 to1095) 
R: ttctcttggatagtccgcgtg 
pbp4-p4                       F: aaggtgagcaaaggataaatgg                                   384 (967 to1351) 
R: aaacggacaagtttcgcagcaa 
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4. 3. Over-expression of PBP4 is not Sufficient  for  β-lactam 
Resistance 
There  is  more  than  one  potential  explanation  for  the  reduced  sensitivity  to  β-lactam 
antibiotics observed in RS1/19, because there are many genes in this strain with 
changed expression levels, as confirmed by microarray data analysis. Notable 
amongst these data is that pbp4 has the highest relative expression. Testing the 
sensitivity  of  RS1/19  to  β- lactam antibiotics with different binding affinities for the 
four PBPs indicated that pbp4 is   necessary   for   the   observed   β- lactam antibiotic 
resistance (Chapter 3). Therefore a series of experiments were designed to test if 
over-expression of PBP4 alone  is  sufficient  for  β-lactam resistance. To test this, the 
pbp4 gene was cloned into the high copy number plasmid pGL485 and the 
recombinant plasmid transformed into a number of S. aureus strains. 
 
4. 3. 1. Cloning of the pbp4 Structural Gene  
 In order to overexpress the pbp4 gene in S. aureus, a high copy plasmid pGL485 
with a size of ~ 10kb was used. This plasmid is a shuttle vector containing two 
origins of replications, one is from pGB2 that allows replication in E. coli that are 
selected on spectinomycin (100µg/ml), and the second origin of replication is from 
pE194 that allows replication in S. aureus with a selection marker of 
chloramphenicol (10µg/ml) (Figure 4. 5) (Cooper 2009). Approximately 1.3 
kilobases (kb) of sequence, covering the pbp4 structural gene and including 18bp 
upstream of the ATG was amplified by PCR using forward and reverse primers FB1 
and FB2, then cloned downstream to the promoter region of pGL485 vector (Figure 
4. 6). The sequence of pbp4 in the wild-type Oxford and RS1/19 strains were 
previously shown to be identical, therefore the structural gene of pbp4 was amplified 
from S. aureus Oxford strain genomic DNA using the Phusion Hot Start II 
polymerase (High-Fidelity DNA Polymerase, Thermo Scientific). First the 
restriction site of ApaI and BamHI  were   incorporated   to   the  5’   end  of   the   forward  
and reverse primers respectively and three extra nucleotides were added at the end of 
the restriction site to increase the efficiency of restriction enzyme cutting (New 
England Biolabs).  
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Figure  4.  5.  Schematic  diagram  of  the     pGL485  vector.  This  shuttle  vector  have  
two  origins  of  replication  pGB2  in  E.coli    and    pE194  in  S.  aureus. 
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Vector  and  PCR  product  digested  and  ligated 
pbp4 
p1 
p2 
Chromosome  
template 
PCR    product    
of    pbp4 
Apa  I BamHI 
Transform  to  E.  coli 
Figure   4.   6   .   Diagramatic   scheme   for   cloning   the   pbp4   gene   into   high   copy  
plasmid      pGL485.   A   DNA   fragment   containing   the   structural   gene   of   pbp4,  
generated   by   PCR   amplification   using   primers   FB1   and   FB2,   was   restricted   with  
ApaI  and  BamHI.    pGL485  vector  was  restricted  with  the  same  restriction  enzymes,  
followed  by  ligation  of  these  fragments,  pbp4    and  pGL485.  The  constructed  vector  
pGL485-pbp4   was   transformed   to   E.   coli   competent   cells   using   electroporation.  
Transformed  cells  then  identified  by  colony  PCR  using  FB1  and  FB2  primers.       
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The primers were as follows: Forward ApaI primer (FB1) with the sequence 
acgggcccagggaagattaacgctttatg, and the reverse BamHI primer (FB2) with the 
sequence caaggatccctttataatgtgcaacttgtcc (restriction site underlined). The PCR 
machine was set for one cycle of 3min at 98ºC, 30 cycles of 30 sec at 98 ºC, 30 sec 
at 57ºC and 30 sec at 72ºC, finishing with one cycle of 5 min at 72ºC. Following the 
PCR reaction, the products were resolved by agarose gel electrophoresis and a band 
of 1.3 kb was obtained (Figure 4. 7). The PCR product was purified with the Roche 
High Pure PCR kit. The pbp4 fragment and pGL485 were both digested with BamHI 
for   4h   at   37C˚and   then   purified  with  Roche  High Pure PCR kit. The product was 
suspended in 30µl dH2O. A second digestion was carried out with ApaI  at  37C˚  for  
4h, and then it was cleaned again with PCR cleaning kit and suspended in 30µl of 
dH2O. Following overnight ligation of the digested pbp4 gene  and  pGL485  at  4˚C  
the construct pGL485-pbp4 was transformed into competent E .coli cells (XL1-Blue) 
and selected on LB plates containing spectinomycin (100µg/ml). Colonies 
containing recombinant plasmids were identified by PCR. The sequence of the pbp4 
gene was confirmed by sequencing with four forward primers pbp4-p1, pbp4-p2, 
pbp4-p3 and pbp4-p4 which was used earlier for pbp4 sequencing (Table 4. 3). The 
DNA sequence analysis confirmed that no mutations had been introduced into the 
pbp4 sequence during the cloning into pGL485-pbp4. 
 
Both the empty vector and the construct pGL485-pbp4 were transformed into 
competent S. aureus RN4220 cells by electroporation and selected on BHI agar with 
chloramphenicol (10µg/ml).  A negative control of RN4220 without vector was also 
incubated overnight  at  37˚C.    As  expected  the  control  RN4220  did  not  grow  because  
of the absence of selectable marker, but both RN4220 that contained the empty 
vector and the recombinant vector grew on the plates supplemented with 
chloramphenicol (10 µg/ml).  
 
Plasmids were extracted from RN4220(pGL485-pbp4) (plasmid encoded pbp4) and 
RN4220(pGL485) (empty vector) then digested with the restriction enzyme BamHI, 
and ApaI to compare the size of the empty and constructed vector Figure 4. 8  shows 
that the recombinant plasmid has a band of 1.3kb in size, corresponding to the 
expected size fragment of the pbp4 gene, while in the empty vector there is not a 
band of this size. 
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1315 1353 
1078 
872 
Figure 4. 7. Amplification of pbp4 from genomic DNA of the wild-type. Agarose gel 
electrophoresis of PCR amplicon for pbp4. DNA molecular weight marker (M) øX Hae III 
indicated on the left. The size of pbp4 product in bp is indicated on the right. 
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4. 3. 2. Expression of pbp4 in RN4220(pGL485-pbp4) is Higher 
Relative to Wild-Type Strain RN4220  
The pbp4 gene was successfully cloned into a high copy plasmid vector and 
transformed into RN4220. Before the hypothesis that increased levels of PBP4 
protein are sufficient for decreased sensitivity to penicillin G could be tested, it was 
necessary to determine the expression level of pbp4 in RN4220(pGL485-pbp4) 
relative to the wild-type RN4220 and whether there is an increase in PBP4 in 
membranes of the recombinant line. The results indicated that the steady-state 
mRNA levels of the target gene pbp4 in RN4220(pGL485-pbp4) was 228 fold 
higher that in RN4220, indicating a very high expression level from the plasmid 
encoded copy (Figure 4. 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 9. Relative expression ratio of pbp4 RN4220(pbp4) relative to the wild-
type RN4220 strain. It is clear that the pbp4 is up-regulated in RN4220(pbp4) 
compared to the wild-type,  gyrA  used as a reference gene. p value <0.05%. Three 
replication of the tested gene were used. 
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4. 3. 3. Membrane Protein Profile Confirms Increased PBP4 
Production in RN4220(pGL485-pbp4) Strain  
This experiment was carried out to test whether the high level of pbp4 mRNA in the 
recombinant strain results in an increase in the level of PBP4 protein in cell 
membranes.  Membrane proteins were prepared following the method of (Zhao et al., 
1999). Membrane  proteins  (15μg)  from  RN4220 and RN4220 (pGL485-pbp4) were 
labeled with Bocillin FL. The labeled PBPs were then separated on SDS-PAGE and 
detected by Typhoon scanning (Figure 4.10). PBP profile showed a detectable PBP4 
band in RN4220 (pGL485-pbp4) but not in the wild-type RN4220 membrane 
fractions.  This result clearly shows an increase in PBP4 protein in RN4220 
(pGL485-pbp4), indicating that the increase in expression of pbp4 mRNA resulted in 
increased PBP4 protein in the membrane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure   4.   10.   Bocillin   FL   binding   capacity   of   membrane   proteins.  
Fluorescently   labelled  Bocillin  FL  was   added   to  membrane  preparations   and   the  
proteins   separated   by   SDS-PAGE   electrophoresis   and   visualized   using  Typhoon  
scanner.   The   first   lane   shows   the   binding   capacity   of   the   membrane   proteins  
prepared   from   the   wild-type   RN4220,   while   the   second   lane   from   RN4220  
containing  the  constructed  vector  pGL485(pbp4).  Arrows  indicate  the  positions  of  
the  single  PBPs. 
            RN4220                  RN4220(pbp4) 
PBPs 
4 
2 
1 
3 
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4. 3. 4. RN4220(pGL485-pbp4)  Contains More Pentaglycine Cross-
Links Than the Parent Strain, RN4220 
Experiments, this far, clearly showed that the high level of pbp4 mRNA in the 
recombinant strain results in an increase in the level of protein in cell membrane. 
PBP4 is a transpeptidase, which forms peptide bonds between one stem peptide and 
the pentaglycine cross bridge of an adjacent stem peptide (Navratna et al., 2010). 
Overexpression of functional PBP4 would be predicted to lead to more pentaglycine 
cross-bridge in the peptidoglycan (Pereira et al., 2007). The enzyme lysostaphin is a 
peptidase that targets the pentaglycine cross bridge and so can be used to compare 
the extent of cross-linking in cell wall preparations (Sieradzki et al., 1999; Memmi et 
al., 2008 and Bastos et al., 2010). Therefore lysostaphin susceptibility tests were 
carried out determine the extent of cross-linking.  
 
 Lysostaphin susceptibility of the wild-type and RN4220 (pGL485-pbp4) were tested 
during the exponential phase of growth in BHI medium. RN4220 cells were grown 
in BHI medium, while BHI medium containing chloramphenicol 10µg/ml used to 
maintain the plasmid in RN4220(pGL485-pbp4).  The collected bacterial pellets 
were washed three times in 20 mM KPO4 buffer (pH 7.5), and after the final wash 
re-suspended in the same buffer. The absorbance reading at wavelength 620 nm was 
adjusted to approximately 0.25. The spectrophotometer was temperature controlled 
at 37 °C and the experiment started by the adding one unit of lysostaphin the cuvette 
shaken and returned to the spectrophotometer for continuous reading. The data was 
plotted as a percentage of the initial A620 nm. 
 
The results show that RN4220(pGL485-pbp4) cells are more resistant to lysostaphin 
compared to the wild-type (Figure 4. 11), as 50% of lysis occurred after 8 min in 
wild-type and after 13.8 min in RN4220 (pGL485-pbp4), which is a 1.7 fold 
difference and suggests that the there is a greater level of cross-linking in the 
recombinant strain, likely due to an increase in functional PBP4 protein in the 
membranes of RN4220 (pGL485-pbp4).   
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Figure  4.  11.  Lysostaphin  susceptibility  of  the  wild-type  (RN4220)  and  
recombinant   RN4220(pGL485-pbp4)   strains.   Cells   were   grown   to  
exponential   phase   at   37˚C   then   treated   with   lysostaphin,   The   RN4220  
(pGL485-pbp4)  strain  is  more  resistant  to  lysostaphin  in  comparison  to  the  
wild-type   strain.   Bars   represent   standard   error   of   the   mean   of   three  
independent  experiments. 
120 
 
It is possible that more cross-linking results in delayed peptidoglycan hydrolysis, or 
may be the increased in cross–linking prevented lysostaphin access to all 
pentaglycine target.  Therefore, It can be concluded that PBP4 overexpression is one 
of the most important causes of resistance to lysostaphin, probably as a result of 
more cross-linking in the RN4220 (pGL485-pbp4). 
 
4. 3. 5. Effect of PBP4 Expression on Autolysis Rate 
 RS1/19 was resistant to lysis by Triton X-100, which is an agent that removes 
inhibitors of endogenous autolysins (Boyle-Vavra et al., 2001). To assess whether 
increased pentaglycine bridge in the transduced strain RN4220 (pGL485-pbp4)) has 
any effect on peptidoglycan hydrolase activity, Susceptibility to Triton X-100 was 
performed. 
 
Autolysis of the wild-type RN4220 and the transformant cell RN4220 (pGL485-
pbp4) were tested during the exponential phase of growth in BHI medium. RN4220 
cells were grown in BHI medium until early exponential phase, while BHI medium 
containing chloramphenicol 10µg/ml used to  maintain the plasmid pGL48(pbp4) in 
RN4220(pGL485-pbp4). Cells were collected by centrifugation and the pellets 
washed twice in ice cold water, and resuspended in 0.05M Tris -HCl buffer (pH 7.2) 
containing 0.05% (vol/vol) Triton X-100. The cell suspensions were incubated with 
shaking and150rpm and 30°C. Cell lysis was measured as a decrease in A580 nm over 
a period of 3h and was expressed as a percentage of the initial A580 nm (Xiong et al., 
1999). This analysis revealed that there was no difference in the observed rate of 
autolysis between RN4220 and RN4220(pGL485-pbp4) strains (Figure  4.  12). Both 
strains exhibited a high autolysis rate, with about a 50% reduction in absorbance 
readings in approximately 30 min. This data suggests that PBP4 over-expression has 
no effect on the autolysis rate.  
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Figure  4.  12.  Autolysis  assay  of  RN4220  and  RN4220(pGL485-  pbp4)  in  the  
presence   of   Triton   X-100.   Bacterial   cells   were   collected   from   early  
exponential   phase   (A580 nm   of  0.7),  washed   twice  with   ice-cold  water   and   re-
suspended   in   an   equal   volume   of   Tris-HCl   (pH   7.2)   containing   0.05%  
(vol/vol)Triton  X-100.   The   rate   of   autolysis   was  measured   as   the   decline   in  
optical   density   A580 nm.   Bars   represent   standard   error   of   the   mean   for   three  
independent  experiments.   
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4. 3. 6. Over-expression of PBP4 is not Sufficient for the Reduced 
Penicillin G Sensitivity 
Previous experiments have clearly established that RN4220(pGL485-pbp4) has 
increased levels of functional PBP4 protein. To determine if the change in the level 
of PBP4 alone is sufficient to cause reduced susceptibility to -lactam antibiotics, 
antibiotic sensitivity tests were carried out using penicillin G, oxacillin and 
vancomycin, which is a glycopeptid (Table 4. 4). S. aureus (Oxford) was used as the 
control for RS1/19 and RN4220 was used as the control for RN4220(pGL485-pbp4).  
 
The Oxford strain was highly sensitive to both penicillin G and oxacillin while 
RS1/19 showed much decreased susceptibility to both antibiotics, with MICs of 32 
and 64µg/ml respectively. Conversely, the Oxford strain was less sensitive to 
vancomycin compared to RS1/19 with MIC values of 2 µg/ml and 1µg/ml 
respectively. These data show that RS1/19 has altered susceptibilities to all three 
antibiotics tested (Table 4. 4). Interstingly, It has been noted that the component of 
the media has an effect on the MIC determination of peniciilin G. The MIC for 
Oxford and RS1/19 was 0.064 and 64 µg/ml respectively when CWD media was 
used (Table 3. 2), while the sensivity of cells increased to 0.016 and 32 µg/ml for 
Oxford and RS1/19 when ISS was used (Table 4. 4).  
 
Altered vancomycin susceptibility in RS1/19, and RN4220 (pGL485-pbp4), could be 
explained by a higher percentage of completed cross bridges in their peptidoglycan, 
as a result of overproduction of PBP4. Vancomycin can bind to two types of targets 
in S. aureus cells; binding to free D-Ala-D-Ala dipeptides in the completed 
peptidoglycan layers interferes with cross bridge formation mediated by PBPs, but 
does not inhibit peptidoglycan synthesis in the nascent peptidoglycan (Cui et al., 
2006). The second target is on the nascent peptidoglycan chain, therefore the 
monomer that is located in the cytoplasmic membrane serves as the main target for 
vancomycin (Finan et al., 2001). PBP4 has been shown to be involved in secondary 
cell wall remodeling (Wyke et al., 1981). It has transpeptidase activity and appears 
also to act as a D, D-carboxypeptidase, by cleaving terminal D-alanine residues from 
un-cross linked muropeptides (Kozarich and Strominger 1978, and Navratna, V. 
2010). An increase in PBP4 activity would decrease the number of surrogate 
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vancomycin targets by decreasing the total cell wall content of D-Ala-D-Ala 
containing muropeptide as a result of increasing D, D-carboxypeptidase activity. 
 
 It has been estimated that in wild-type strains of S. aureus about 20% of D-Ala-D-
Ala residues remain unprocessed by PBPs (Hiramatsu, 2001and Boyle-Vavra et al., 
2001). While in cells overproducing PBP4 cross-linking there could be more than 
90% processing of the cross-links, causing the diffusion rate of vancomycin to its 
target (lipidII) to be increased (Pereira et al., 2007), because it passes through about 
20 layers of peptidoglycan without being trapped by the first target (Hiramatsu, 
2001). This may explain the increased sensitivity of RS1/19 and RN4220 (pGL485-
pbp4) to vancomycin, because more pentaglycine bridge are present in these strains, 
leading to increased diffusion rates of vancomycin without being blocked by the first 
target.     
 
The antibiotic sensitivity profiles of RN4220 and the recombinant strain RN4220 
(pGL485-pbp4), showed no differences in the MIC of penicillin G. However, the 
MIC for vancomycin was reduced from 4 µg/ml to 1 µg/ml in the recombinant 
strain, supporting the contention that there is additional PBP4 activity in 
RN4224(pGL485-pbp4). It is therefore clear that, PBP4 over-expression alone is 
insufficient   to   cause   the   β-lactam resistance phenotype observed in RS1/19. This 
leads to two possible conclusions; the first is that additional PBP4 activity is not 
required for the reduced susceptibility phenotype and the second is that it is 
necessary, but is in itself not sufficient. The antibiotic sensitivity data, presented in 
chapter three, indicates a role for PBP4 and therefore it is more likely that PBP4 
plays a role in the resistance phenotype, but is not solely responsible for it, meaning 
that modification of additional, unknown, host factor(s) is required for full 
expression of resistance to penicillin.     
 
Furthermore, reduction in vancomycin sensitivity in RN4220 (pGL485-pbp4) 
confirms that more pentaglycine cross-bridges, due to PBP4 over-expression, leads 
to increased sensitivity in the recombinant strain. Therefore it is clear that factors, 
other than PBP4 overexpression, may be involved in resistance   to   β-lactam 
resistance in RS1/19, whilst over-expression of pbp4 alone is enough to alter 
vancomycin sensitivity in the recombinant, RN4220 (pGL485-pbp4), strain. 
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Table 4. 4. MIC determinations for cell wall antibiotics, against wild-type cells 
and strains with increased PBP4 activity. 
 
Antibiotic 
MIC (µg/ml) 
Oxford RS1/19 RN4220 RN4220(pGL485- pbp4)              
penicillin  G 0.016             32 0.016                  0.016            
oxacillin   0.25               64   0.25                    0.25                                                                                                                  
vancomycin    2 1 4 1 
MICs  determined  by  E-test  for  penicillin  G,  and  by  broth  microdilution  for  oxacillin  
and  vancomycin. 
 
 
4. 4. Testing PBP4 Expression in Other S. aureus Strains 
S. aureus, RN4220 is a cloning intermediate in widespread use because it is the only 
S. aureus strain that can be efficiently transformed with foreign DNA (Atilano et al., 
2010). However, it has been recently shown, by whole genome sequencing, that it 
contains a number of genetic polymorphisms that affect virulence and general fitness 
(Nair et al., 2011) and therefore results obtained in this strain should be verified in a 
variety of other well characterized strains. For this purpose the recombinant vector 
was   transduced,   using   bacteriophage   80α,   to   a   number   of   genetic   backgrounds   S. 
aureus strains (Oxford, 8325-4, and SH1000), which were then tested for their PBP 
profile and antibiotic sensitivities.  
 
4. 4.  1.  Generalized  Transduction  Using  Phage  80α 
This experiment was carried out to transfer the vector pGL485 (pbp4) from RN4220 
(pGL485-pbp4) to other strains of S. aureus. Initially phage lysates were made on 
recombinant strain RN4220 (pGL485-pbp4), grown in LK broth containing 
chloramphenicol 10µg/ml, to select for strains that contain the vector pGL485(pbp4). 
Following incubation of the phage lysate (titre of 107 /ml) with the recipient strains, 
at a multiplicity of infection (MOI) of 10, plates were incubated for 12-72 h at 37ºC 
and the resulting colonies used to calculate the number of transductants per ml of 
culture (Table 4. 5).  
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Transduction frequency was calculated as the ratio of the number of transductants 
(CFU) obtained to the number of plaque-forming units (PFU) (Varga et al., 2012). 
Data showed that S. aureus strains, 8325-4 and SH1000, transduced more efficiently 
at frequencies of 2×10-4 and 7×10-5 respectively ompared to Oxford (Table 4. 
5).Transductants from each strain were selected and re- streaked on BHI plates 
containing chloramphenicol (10µg/ml) to use in the following experiments.  
 
Table 4. 5. Transduction Frequencies of   pGL485 (pbp4) into different S. 
aureus genetic backgrounds. 
 
Recipient Plasmid Selection MOI Transduced 
cells  
CFU/ml                 
Transduction 
Frequency 
(CFU/PFU)  
8325-4           pGL485(pbp4)   CmR 10 220 2×10-4   
SH1000 pGL485(pbp4)        CmR 10    72   7×10-5   
Oxford   pGL485(pbp4)        CmR 10 5 1×10-12 * 
* This relates to 2 attempts before any transductants were obtained. 
 
4. 4. 2. Over-expression of pbp4 in Three Different Genetic 
Backgrounds of S. aureus Results in Increased PBP4 Protein in 
Membrane Fractions 
To confirm the transfer of the constructed vector pGL485 (pbp4) to the different S. 
aureus strains, membrane proteins were prepared from wild-type strains Oxford, 
8325-4, and SH1000 and transduction strains, Oxford (pGL485-pbp4), 8325-4 
(pGL485-pbp4), and SH1000 (pGL485-pbp4). Analysis of membrane protein 
fractions showed increased binding of Bocillin FL to PBP4 in cells where the 
plasmid was successfully transferred compared to the wild-type. Additionally, 
investigation into the comparative PBP2/PBP4 ratios of wild-type and transduced 
cells showed a significant reduction in PBP2/PBP4 ratios in transduced cells due to 
PBP4 overexpression in these cells (Figure 4. 13). This result, in addition to altered 
vancomycin susceptibility in the transduced cells (Table 4. 6), indicate that this 
vector pGL485 (pbp4) has been successfully transduced to different S. aureus 
background strains.  
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Figure  4.  13.  penicillin  binding  capacity  of  membrane  proteins.  Bocillin  FL  was  
added   to   membrane   preparations   and   the   proteins   separated   by   SDS-PAGE  
electrophoresis.   Membrane   proteins   visualized   using   Typhoon   scanner.   Lane   (1,  
3,and   5)   shows   the   binding   capacity   of   the  membrane   proteins   prepared   from   the  
wild-type   Oxford,   8325-4,   and   SH1000   no   PBP4   can   be   detected.   While  
transductant   strains   in   lane   (2,   4,   and   6)   shows   increased   binding   capacity.  
PBP2:PBP4   ratio   indicated   under   each   lane.The   positions   of   the   single   PBPs   are  
indicated  by  arrows. 
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4. 4. 3. Overproduction of PBP4 is Not Sufficient for the Observed 
Reduced Antibiotic Sensitivity 
A previous experiment (section 4. 3. 6) showed that RN4220 (pGL485-pbp4) 
exhibits the same sensitivity to  β-lactam antibiotics (penicillin G and oxacillin) but 
show increased susceptibility to vancomycin as the parent, RN4220 cells. It was 
important to determine the effect of overexpression of PBP4 on cell wall inhibitor 
antibiotics in different genetic backgrounds of S. aureus. Therefore strains 8325-4 
(pGL485-pbp4), SH1000 (pGL485-pbp4), and Oxford (pGL485-pbp4) were tested 
(Table 4. 6). The MICs of each strain with and without the pbp4 expression plasmid 
remained the same for penicillin G and oxacillin, confirming that overproduction of 
PBP4   alone   is   insufficient   to   cause   a   change   in   the   sensitivity   to   to   β-lactam 
antibiotics, irrespective of the genetic background of the S. aureus strain. 
 
In each genetic background tested, the MIC for vancomycin in the transductants was 
lower than for the corresponding parental strain (Table 4. 6). In each case the change 
was small, but consistent. This means that increased vancomycin susceptibility was 
uniformly associated with increased peptidoglycan cross-linking in transductants. 
Therefore it indicates a possible relationship between the degree of cross-linking and 
vancomycin susceptibility.   
 
 
Table 4. 6.  MIC determinations for cell wall antibiotics, against wild-type and  
transductant strains with increased pbp4 activity. 
 
 
Antibiotic 
MIC (µg/ml) 
8325-4         8325-4 
(pGL485-pbp4) 
SH1000 SH1000 
(pGL485-pbp4) 
Oxford Oxford 
(pGL485-pbp4) 
Penicillin 0.064 0.064 0.064 0. 064 0.016 0.016 
Oxacillin 0.25 0.25 0.25 0.25 0.25 0.25 
vancomycin   4 2 4 2 2 1 
MICs determined by E-test for penicillin G, and by broth microdilution for oxacillin and vancomycin. 
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To conclude, the results demonstrated in this chapter showed that RS1/19 cells do 
not contain any mutations in pbp4 gene or in the region upstream of the pbp4 gene 
which might interfere with the resistance to penicillin G. Furthermore the data 
presented in this chapter do not support the hypothesis that expression of pbp4 alone 
is sufficient for the observed penicillin resistance in RS1/19. This is because 
overproduction   of   PBP4   in   transductant   strains   had   no   effect   on   the   sensitivity   to  
penicillin   G   or   oxacillin.   To test the necessity of this gene in the resistance 
mechanism, we aim to inactivate pbp4 gene using allelic replacement experiment in 
the background of RS1/19 cells.  
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CHAPTER FIVE 
The  Role  of  PBP4  in  β-lactam Resistance   
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5. 1. Introduction 
In vitro selection for resistance to cell wall inhibitor antibiotics in S. aureus has been 
associated with a variety of gene mutations, in particular genes related to cell wall 
biosynthesis (Utaida et al., 2003). It has been reported both in laboratory 
investigations and clinical studies that a major role of PBP4 over-expression (Henze 
and Berger-Bachi, 1996; and Fuller et al., 2005) or mutations in the pbp4 structural 
gene (Banerjee et al., 2010) is involved in methicillin resistance. On the other hand, 
studies   in   some   methicillin   resistant   strains   COL,   N315,   and   Mu50,   β-lactam 
susceptibility is unaffected by the deletion of pbp4 (Katamaya et al., 2003; Memmi 
et al., 2008). However, in some other strains MW2 and USA300 the loss of PBP4 
resulted in 16 fold reduction in oxacillin and nafcillin MICs, and dramatically 
decreased the expression of pbp2 (Memmi et al., 2008). These data appear to be 
conflicting and indicate that the full expression of methicillin resistance varies in 
different strains. 
 
There are different ways in which bacteria can naturally undergo mutagenesis; it may 
happen spontaneously (Beale, G., 1993), or be due to exposure to mutagens such as 
chemicals (Odete et al., 2011). Mutations can also be obtained experimentally in the 
laboratory by using transposons, signature-tagged mutagenesis, and allelic 
replacement experiments (Lindsay, 2008).  
 
The most commonly used technique to alter the S. aureus genome is allelic  
replacement  using  homologous  recombination  experiments.  O  ̓  Reilly  et  al.,  were  the  
first to use allelic replacement to generate a mutation in a structural gene in the 
chromosome of S. aureus   (O  ̓  Reilly   et   al.,   1986).  Allelic   replacement  mutants   are  
normally generated by cloning the gene of interest and then inserting an antibiotic 
selectable marker into the gene, prior to introducing the interrupted allele into the 
genome by homologous recombination. Practically, 1kb of the mutated gene is 
required for gene replacement, however longer pieces of DNA seem to increase the 
efficiency of the allelic replacement (Lindasy, 2008).  
 
The allelic replacement vector pMAD, which is a thermo-sensitive E.coli/S. aureus 
shuttle vector (Arnaud et al., 2004) was used in this study.  In this method, the vector 
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containing the mutated gene is introduced into S. aureus by electroporation, and the 
bacteria are then grown at the permissive temperature to allow replication of the 
plasmid. Following introduction of the vector the cultivation temperature is 
increased to the non-permissive temperature to block autonomous replication of the 
vector. Loss of the vector sequence from S. aureus can be carried out using a unique 
system.  The pMAD vector encodes a constitutively expressed thermo-stable   β-
galactosidase. This can be used in combination with the chromogenic substrate 5-
bromo 4-chloro-3-indolyle-β-D-galactopyranoside (X-gal) to identify bacterial 
colonies in which the plasmid has been excised. In addition, inserting a selectable 
marker (gene disrupting marker) into the target gene to be deleted makes the 
screening easier.  The use of this vector enables screening for bacteria that have lost 
the vector instead of selecting the allelic replacement mutants. The ability to screen 
for bacteria that have lost the plasmid increases the efficiency of mutant isolation 
compared to the classical method of allelic replacement (Arnaud et al., 2004). 
 
The experiments in Chapter Four proved that overexpressed PBP4 alone is not 
sufficient for the  β-lactam resistance, as over-expression of PBP4 in S. aureus with 
different  genetic  backgrounds  did  not  alter  the  antibiotic  sensitivity  to  a  range  of  β-
lactam antibiotics tested. To study the necessity of this gene for decreased sensitivity 
to penicillin G in RS1/19, it is important to knock-out this gene in RS1/19. For this 
purpose, mutants of S. aureus were constructed using the chromosomal integration-
excision approach described by Arnaud et al., 2004. This method was used to create 
allelic replacement mutants by cloning pbp4 gene and inserting a selectable 
spectinomycin resistant marker (spc) into the gene.  
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5. 2. Results and Discussion   
5.  2.  1.  Construction  of  Δpbp4 
Construction  of  ∆pbp4 was carried out utilizing chromosomal DNA from the Oxford 
strain as a template, DNA primers were designed with flanking restriction sites 
(Table 5. 1). The restriction site of EcoRI and BamHI were incorporated to the 5' end 
of the forward and reverse primers of the first pbp4 fragment respectively. Similarly, 
the restriction site of HindIII and BglII were incorporated to the 5' end of the forward 
and reverse primers of the second pbp4 fragment. Three extra nucleotides were 
added at the end of all restriction sites to increase the efficiency of restriction 
enzyme cutting (New England Biolabs).   
 
The first fragment consisted of 490bp from the upstream part of the gene (including 
the start codon and 5' part of the coding sequence) and the second fragment was 
644bp  (including  the  3’  part  of  the  gene  and  the  stop  codon).  These  two  fragments  
flank a 213bp deletion from the coding sequence of pbp4; DNA fragments (5' pbp4 
and 3' pbp4) were amplified by PCR. At the same time, primers were designed to 
amplify a 1.54 kb DNA fragment of a PCR product containing the entire 
spectinomycin resistance gene spc was used as a template.  The forward primer spc1 
F contained the BamHI restriction site while the reverse primer spc1 R contained the 
HindIII restriction site. Following PCR and purification of the amplicons. These 
three fragments (5' pbp4,   3’ pbp4, and spc) were digested with the corresponding 
restriction enzymes then purified.  
 
The amount of DNA in each fragment was quantified by NanoDrop 1000 
Spectrophotometry. These purified PCR DNA fragments were mixed in equal 
amounts (molar ratio 1:1:1) and ligated. The ligation mixture was used as templates 
to amplify the final fusion product, using the outside primers of (pbp4P1 F and 
pbp4P2 R). A single band of 2.7 kb was expected when run on agarose gel, but 
extraneous products were produced (Figure 5. 1. A). To reduce non-specific bands 
step wise PCR was used (IPGRI and Cornell University, 2003), with a raised 
annealing temperature to reduce the non-specific bands. The PCR reaction was set as 
follows: one cycle of 3min at 98ºC. Then three steps of cycling were used. First step 
was, 5 cycles of 30 sec at 98 ºC, 30 sec at 65ºC and 40 sec at 72ºC. Second step was 
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5 cycles of 30 sec at 98 ºC, 30 sec at 60ºC and 40 sec at 72ºC. Third step was 25 
cycles of 30 sec at 98 ºC, 30 sec at 56ºC and 40 sec at 72ºC, finishing with one cycle 
of 5 min at 72ºC. However, the non-specific bands were still detected. Subsequently, 
a band of a 2.7 kb was purified by loading the PCR reaction and excising the correct 
size band from an agarose gel and re-PCR. This time a smear of PCR product 
appeared on the agarose gel (Figure 5. 1. B). In order to clone the mutated pbp4 
fragment, the purified band of 2.7 kb, which was expected to be the right band, was 
used to insert into the PCR-Blunt II-TOPO vector. The constructed vector was 
transformed into competent E.coli cells, selected on LB media with kanamycin 
(50µg/ml) and colony PCR performed using vector specific primers M13 forward 
primer 5´gtaaaacgacggccag and M13 reverse primer 3´ caggaaacagctatgac. The 
vector was present, but no recombinant plasmids containing the correct insert were 
isolated. 
 
Table 5. 1. Sequences of primers used for pbp4 deletion, restriction sites are 
bold and Italic.                   
Primer 
name    
Primer  Sequence  (5’- 3’)                                           Restriction 
site        
Amplicon 
size in bp 
 
pbp4P1 F: caggaattccagggaagattaacgctttatg               EcoRI   490 
R: caaggatccaaatcaacgaaatcgctcgtg  BamHI  
pbp4P2 F: caaaagcttcaacgcatgcagttacg                        HindIII    644      
R: cacagatctgctttataatgtgcaacttgtcc               BglII 
spc1    F: ggatcccaggctgggtgccaagctctcg                    BamHI   1548 
R: aagcttgtgcttagtgcatctaacgc                         HindIII   
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Figure    5.  1.  Agarose  gel  of    ligation  mixture  to  construct  Δpbp4.  (A  )  these  5´  pbp4  ,3
´   pbp4,   and   spc      fragments   were   mixed   in   equal   amounts   and   ligated.   The   ligation  
mixture   was   used   as   templates   to   amplify   the   final   fusion   product,   using   the   outside  
primers  of  (5´  pbp4  P1  and  3´pbp4P2  ).  A  single  band  of  2.7  kb  was  expected  when  run  
on   agarose   gel,   M   is   a   DNA   molecular   marker   Hyperladder   I.   (B)  Amplification   of  
purified  2.7  kb,  after  being  excised  from  the  agarose  gel  but  a  smear  obtained  when  run  
the  PCR  product  on  the  agarose  gel.  M  is  Lambda  DNA/  HindIII  marker.     
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The initial strategy was to use PCR of the ligation mixture directly to clone into the 
pMAD vector, but this method was unsuccessful. As all the primers were already 
designed, a cloning strategy was developed to be able to utilize these, and the 
pGEM-3Zf (+) (Promega) plasmid as an intermediate vector for sub-cloning (Figure 
5. 2). This vector contains all of the same restriction sites as the primers in the 
correct orientation for the cloning strategy proposed except one primer, the pbp4P2 
reverse primer (Table 5. 1). Therefore an additional primer with a HindIII  restriction 
site in addition to the BglII restriction site was synthesized, for cloning into  pGEM-
3Zf (+) as follows: cacaagcttagatctgctttataatgtgcaacttgtcc.The first fragment of 
pbp4 (490bp) and pGEM-3Zf (+) were restricted with EcoRI and BamHI then 
ligated. This was transformed into competent E. coli cells that have been 
supplemented with ampicillin (150µg/ml) and X-gal (40 µg/ml), for easy screening 
for white/blue colonies. Usually vectors containing PCR products produce white 
colonies   as   a   result   of   insertional   inactivation  of   the  α-peptide   coding   region  of  β-
galactosidase. Colony PCR was used to screen the white colonies for the presence of 
the first insert and all the colonies tested were confirmed to contain the insert (Figure 
5. 3. A). This recombinant plasmid (pGEM-3Zf (+) (5   ′pbp4)) and the amplified 
spectinomycin resistance cassette (spc) were then restricted with BamHI and HindIII 
and ligated together. This was transformed to E.coli cells on LB plates supplemented 
with ampicillin (150µg/ml). Colony PCR for the growing colonies confirmed the 
presence of the second insert in three clones (Figure 5. 3. B). Recombinant pGEM-
3Zf + (5  ′pbp4+spc) was then extracted from E. coli cells. 
 
Since both the recombinant vector (pGEM-3Zf + (5   ′pbp4+spc)) and the second 
fragment of pbp4 (644bp) needed to be restricted with the same restriction enzyme 
HindIII, the vector was treated with alkaline phosphatase to prevent self-ligation, 
greatly facilitating ligation of the insert fragment into the vector. Colony PCR was 
used to search for positive clones. Since the third fragment had the same restriction 
site (HindIII) on both ends, insertion of the fragment in the right orientation was 
checked either by PCR using the 5´ primer of the third fragment (insert specific 
primer) and 3´ priming site of the pGEM-3Zf (+) vector (vector specific primer), or 
by extracting the vector from the positive colonies and restriction with EcoRI and 
BglII.  
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Figure  5.  2.    A.  Schematic  diagram  of  pGEM-3Zf(+)    vector  promoter  and  multiple  
cloning  region  sequence.  This  vector  serves  as  a  standard  cloning  vector.  Images  taken  
from  Promega.  B.  Map  of  the  pMAD  plasmid.  Unique  restriction  sites  are  indicated.  Images  
taken  from  (Arnaud  et  al.,  2004).   
A 
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Figure  5.  3.  Colony  PCR  for  screening  the  presence  of  the  insert  in  E.coli  
cells.  A.   First   fragment   of  pbp4   in   recombinant   plasmid   pGEM   3Zf   (+)(5  
′pbp4)  vector.  All  colonies  screened  contained  the  insert.  M  is      Hyperladdar  
I  DNA  marker,  1  is  a  control  PCR  product  the  other  lanes  are  colony  PCR.  
B.   Amplification   of   the   second   fragment   corresponding   spectinomycin  
cassette  gene  (spc)  from  E.coli  strains  using  colony  PCR.    M  is  Hyperladder  
I  DNA  marker,  2,  5,  and  6  lanes  are  desired  inserts. 
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EcoRI 
5 ′ pbp4  spc 
HindIII BamHI 
3 ′ pbp4 
BglII  HindIII HindIII 
EcoRI 
5 ′ pbp4  spc 
HindIII BamHI 
3 ′ pbp4 
BglII  HindIII 
 Right orientation 2.7 kb 
when restricted  
with EcoRI and BglII                          
EcoRI 
5 ′ pbp4  spc 
BamHI 
3 ′ pbp4 
HindIII  BglII HindIII 
 
In pGEM-
3Zf (+) 
vector 
Restricted  with  EcoRI  and  BglII  for  
cloning  in  pMAD  vector 
Figure      5.   4.   Diagram   of   sub-cloning   ∆   pbp4   into   intermediate   vector  
pGEM(+).  Only  the  insert  with  the  right  orientation  (when  restricted  with  EcoRI  
and  BglII)  would  give  the  band  of  2.7  kb.   
Wrong orientation 2.1 kb 
when restricted  
with EcoRI and BglII                           
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Figure   5.   5.      Restriction   enzyme   digestion   of   recombinant   pGEM-3zf   (+)  
(Δpbp4).  The         constructed   plasmid   pGEM-3zf   (+)   (Δpbp4)  were   digested  with  
EcoRI  and  BglII   then  resolved  on  1%  agarose  gel.  The  marker  is  Hyperladder  I,  
lane  1  is  an  empty  vector  and  lane  2  and  3  are  recombinant  vector  that  contain  the  
insert  in  the  wrong  orientation  of  the  size  of  2.1kb.           
3000 
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                    M                                  1                          2                              3   bp 
2.1	  kb 
140 
 
The right orientation of the final fragment would give a band of 2.7 kb, while the 
wrong orientations would give a band of 2.1 kb. Unfortunately, all the positive 
clones tested were with the wrong orientation (Figure 5. 4; Figure 5. 5). 
 
Another approach to ligate these fragments in the right orientation was by cutting out 
the insert (pbp4 and spectinomycin (5   ′pbp4+spc)) from the constructed vector 
pGEM-3Zf+(5   ′pbp4+spc)  using the restriction enzymes EcoRI and HindIII. The 
correct sized fragment was excised from an agarose gel and purified, whilst the third 
fragment was simultaneously restricted with HindIII and BglII. These fragments 
were mixed in equal amounts in a molar ratio of 3:1 to the corresponding restricted 
pMAD vector and ligated. The constructed vector was transformed to E.coli XL1-
Blue cells on LB plates selected with ampicillin (150µg/ml), spectinomycin (100 
µg/ml) and X-gal (40 µg/ml). Colonies of E. coli that contain pMAD vector were 
blue. Colony PCR was performed on ten blue colonies using outside primers 
(pbp4P1F and pbp4P2R).  Four positive colonies were isolated with the size band 2.7 
kb (Figure 5. 6).  
 
The   recombinant   pMAD∆pbp4 vector was extracted from E. coli cells and 
transformed into competent S. aureus RN4220 cells by electroporation.  Cells were 
grown on BHI plates with erythromycin (5µg/ml) as a selectable marker and X-gal 
(150µg/ml).  A negative control of RN4220 without vector was also incubated at 30 
C˚  for  48h.  Blue  colonies  were  only  seen  on  plates  containing  recombinant  vector.  
Plasmids  were  extracted  from  RN4220  (pMAD∆pbp4) and a PCR was performed to 
check the size of the insert; this was found to be 2.7 kb confirming the presence of 
the insert. Besides, when  pMAD∆pbp4 was restricted with EcoRI and BglII, a band 
of 2.7 kb was visualized on agarose gel. 
 
5.  2.  3.  Generalized  Transduction  Using  Phage  80α  
This   experiment   was   carried   out   to   transduce   the   plasmid   pMAD∆pbp4 from the 
restriction deficient strain, RN4220 to Oxford and RS1/19 so that pbp4 allelic 
replacement could be carried out in these strains. Initially phage lysates were made 
on recombinant strain RN4220(pbp4). Cells were grown in LK broth containing 
erythromycin (5µg/ml) and the phage lysates were used to transduce wild-type 
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Oxford strain using The Double-Layer Agar (DLA) technique (Santos et al., 2009).  
The plates were supplemented with erythromycin 5µg/ml and X-gal 150 µg/ml to 
select   for   Oxford   strains   that   contain   the   vector   pMAD∆pbp4.   Successful  
transduction and presence of the vector was confirmed by the presence of blue 
colonies and resistance to erythromycin after 12-72 h incubation at 30ºC.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure   5.   6.   Restriction   enzyme   digestion   of      pMAD   ∆pbp4.   The  
constructed  plasmid  vector  pMAD  ∆pbp4,  isolated  from  E.coli  ,  was  digested  
with   EcoRI   and   BglII      then   resolved   on   1%   agarose   gel.   The   marker   is  
Hyperladder  I.  Lane  2  is  recombinant  vector  that  contained  the  insert  ∆pbp4  of  
the  size  of  2.7  kb.   
3000 
10000 pMAD 
∆pbp4 
            M                 1               
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The frequency of transduction reduced dramatically in the Oxford strain in this 
experiment to 1×10-18. The same experiment was repeated to transduce pMAD 
∆pbp4 into RS1/19, but the efficiency of transduction was even lower in methicillin 
resistant RS1/19, being 1×10-30. Several modifications of the transduction method 
were used in an attempt to increase the efficiency. For this, the calcium chloride 
concentration was increased first from 5mM to 10 mM during transduction to 
increase the absorbance of the phage to receptors (Jodi Lindsay, personal 
communication) on the RS1/19 cells.  These experiments were repeated with all the 
steps and incubation temperature was changed from 37 ̊C to 30 ̊C. None of the 
modifications of the basic transduction protocol produced any transductants.  
 
It   has   been   reported   that   some   antibiotics,   like   β-lactams, stimulate bacteria to 
produce phage (Santos et al., 2009), which has been shown to result in replication 
and high frequency transfer of staphylococcal pathogenicity islands (Maiques et al., 
2006). Therefore, in an attempt to improve the transduction efficiency, a sub-
inhibitory concentration of penicillin G (final concentration of 0.5µg/ml) was added 
to LK plates in addition to erythromycin and X-gal. This method resulted in 
successful   transduction,   but   only   two   colonies   of   RS1/19   pMAD   ∆pbp4 were 
obtained; this shows that this strain can be transduced, but very inefficiently (1×10-
30).  
 
One of the main reasons that it has been difficult to genetically manipulate S. aureus, 
in this study, is that RS1/19 used does not belong to the same lineage as RN4220, 
which is derived from 8325-4 and belongs to lineage ST 8 (Lindsay and Holden, 
2004). RS1/19 which was generated from the Oxford strain belongs to lineage ST 30 
(Kearns et al., 2006). The major known barrier to transduction in S. aureus is the 
type 1 Restriction Modification (R-M) system, encoded by the sau1hsdR genes, and 
it is lineage specific. The R-M system serves to strictly control the mechanisms of 
uptake of foreign DNA. Moreover, RN4220 has a mutation in the sau1hsdR that 
allows it to accept foreign DNA (Waldron and Lindsay, 2006). It has been reported 
that the ten main lineages of S. aureus carry unique combinations of sau1hsdR genes 
that control the sequence specificity of the system. Thus, DNA from a different 
lineage is regarded as foreign DNA and destroyed. Therefore mobile genetic element 
(MGE) present in one strain will transfer horizontally to other strains of the same 
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lineage at a higher frequency than to strains of other lineages. In another words the 
R-M model suggests that genetic exchange of any kind may be more efficient 
between isolates with the same sau1hsdR profile than between those with different 
profiles (Waldron and Lindsay, 2006).  This explains the difficulties experienced 
during  transducing  pMAD∆pbp4 to both wild-type Oxford and RS1/19 strains.  
 
5. 2. 4. Allelic Replacement of pbp4 Gene  to  Create  RS1/19∆pbp4 
Mutants 
The   recombinant   pMAD∆pbp4 was successfully introduced into RS1/19 strain by 
transduction. Thus, to obtain cells with a chromosomally integrated copy of 
pMAD∆pbp4 via  a  single  crossover  event  (SCE),  a  single  blue  colony  was  streaked  
onto  BHI  agar.  Plates  were  incubated  at  30̊  C  for  24h  and  a  single blue colony, from 
this plate, was inoculated into BHI medium without antibiotic and incubated with 
shaking for 2h at 30°C, before transfer to 42°C for 6h to increase the frequency of a 
single cross over event. Serial dilutions of this culture were plated on BHI agar 
plates, containing erythromycin (5µg/ml) and X-gal (150µg/ml) and incubated at 
42°C for 24-48h. One light blue colony was selected which represent cells that have 
a SCE due to the fact that the vector integrated as a single copy in the chromosome 
produces less -galactosidase than several plasmids in the cytoplasm (Arnaud et al., 
2004). The recombinant pMAD∆pbp4 did not integrate to RN4220 (pMAD∆pbp4) 
chromosome as a single crossover event, because for this process to happen cells 
need to be cultivated at non-permissive tempreture to block autonomous replication 
of the vector. 
 
To subsequently obtain cells that had excised pMAD vector sequences and the 
chromosomal copy of pbp4 from the chromosome (double cross over events), light 
blue colonies were  used  for  alternative  cultures   in  BHI  medium  at  30˚C  and  42˚C.  
For this purpose, one colony inoculated in BHI medium without antibiotic was 
incubated with shaking at 30°C for 6h then a 1000-fold dilution of the culture was 
made in fresh BHI medium and incubated overnight with shaking at 42°C. This 
procedure was repeated over 6 days, and then serial dilutions were made from the 
culture and plated on BHI plates supplemented with X-gal and spectinomycin 
(100µg/ml). White colonies that are resistant to spectinomycin are potential mutant 
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strains due to plasmid excision. Following 48h of incubation, no growth was 
detected, indicating that either no correct excision events had taken place or that the 
spectinomycin gene disrupting marker was not functional in S. aureus. To determine 
if the spectinomycin gene was functionally expressed in these cells, the MIC of 
spectinomycin  was   tested   for   both  RS1/19   and  RS1/19(pMADΔpbp4). The values 
obtained showed no difference, with both strains having an MIC of 8µg/ml, 
regardless  of  the  pMADΔpbp4 construct. This suggests that the spectinomycin gene 
was not functional in RS1/19 cells and an alternative selection strategy was required.  
Therefore blue/ white colony screening was performed on BHI plates supplemented 
with X-gal, as erythromycin-sensitive white colonies would represent candidate 
clones resulting from a double crossover event and loss of the erythromycin 
resistance and -galactosidase genes, encoded on the vector (Figure 5. 7).  
 
To confirm the gene deletion and integration   of   the   Δpbp4 into the chromosome, 
genomic DNA was prepared from each of the candidate colonies. PCR was 
performed using flanking primers approximately 100bp upstream and downstream of 
pbp4 gene. The sequence of the forward primer was pbp4F1 F (acacctttagctacacacg) 
and the sequence of the reverse primer was pbp4F2 R (acgtacagaaggcatttcgac); the 
size of PCR product for the wild-type parent strain would be 1.6 kb, while the size of 
PCR  product   for   the  mutant  RS1/19  ∆pbp4 was expected to be 2.9 kb. To further 
confirm the deletion and the presence of spc gene in the chromosome, PCR was 
performed using flanked forward primer of pbp4 F1 and reverse primer of spc which 
gave the size of 2298 bp and another PCR with forward primer of spc and reverse 
primer of pbp4 F2 with a size of 2335 bp  (Figure 5. 8). From approximately 100 
colonies tested only one clone contained a deleted pbp4, whilst the remainder of the 
colonies all had the original genomic DNA configuration of the pbp4 gene. 
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Figure  5.  7.  RS1/19  colonies  following  transformation  with  the  pAMD∆pbp4  vector.  
Cells   were   cultivated   at   30ᵒ   C   for   2h   then   transferred   to   42ᵒ   C   for   6h;;   dilutions   were  
plated  on  BHI  agar  containing  X-gal  in  the  absence  of  the  antibiotic.  Then  one  single  blue  
colony  was  used   for   alternative  sub-cultures  at  30ᵒ  C  and  42ᵒ  C   for  6  continuous  days;;  
dilutions  were   then  plated  on  BHI  containing  X-gal  without  antibiotics.  White  colonies  
have  undergone  the  excision  and  loss  of  the  vector;;  whereas  blue  colonies  retain  a  copy  
of  the  plasmid  integrated  in  the  chromosome.   
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When   a   suicide   pMADΔpbp4 vector inserts in the upstream region of pbp4 as a 
single event, the entire plasmid is inserted into the chromosome (SCE). Two copies 
of the downstream region will be present on the chromosome until a second 
homologous recombination event has taken place between the two downstream 
regions. This second recombination event excises the pMAD vector. The resulting 
products are either the original pbp4 allele  or  a  strain  that  now  has  the  mutant  Δpbp4 
allele, within the chromosome and the wild-type allele on the plasmid. This is 
determined by the location of the recombination events; if the second crossover 
occurs  on  the  opposite  side  of  the  Δpbp4, the chromosome of the resulting bacteria 
will contain the mutant allele of the pbp4 gene (Figure 5. 9). 
 
To further confirm allelic replacement, the PCR product of the flanking region and 
the regions that had undergone recombination were sequenced (Figure 5. 10). The 
sequencing confirmed the insertion-deletion event.  This analysis showed the 
presence of some point mutation in the sequence of the first fragment of pbp4 (5′  
pbp4); four point mutations at positions 32, 70, 297, and 302 were present. In the 
same manner, three point mutations occurred in the second cloned pbp4 fragment  (3′  
pbp4) in the position 1068, 1334 and 1366. There is no effect of these mutations 
because pbp4 is already none-functional  in  the  RS1/19∆pbp4. These mutations may 
have occurred during amplification of PCR fragments, or during exposure to UV 
light to cut out fragments from the sub-cloning vector pGEM-3Zf (+) to clone it to 
pMAD vector.   
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pMAD∆pbp4 
Spc 
 5’pbp4  3’ pbp4 ∆pbp4 
5’pbp4 Spc  3’pbp4  pMAD∆pbp4  5’ pbp4 ∆pbp4  3’pbp4 
 5’pbp4 Spc  3’pbp4 
              1-  Cointegrate 
              2-  Excision 
Figure   5.      9.   Schematic   representation   of   the   two   step   allelic   exchange  
procedure.  Areas  labelled  5’pbp4  and  3’pbp4  represent  DNA  sequences  of  two  
fragments  of  pbp4  flanking  a  213  bp  deletion  of  the  pbp4  gene.  The  crossed  lines  
lines   indicate   crossover   events.   The   integration   of   pMAD   via   homologous  
sequences   can   take   place   in   5’pbp4   or   3’pbp4.   The   co-integrate   undergoes   a  
second  recombination  event,  such  that  the  spectinomycin  resistance  marker  will  
either   remain   in   the   chromosome   3’pbp4   area   or   be   excised   along   with   the  
plasmid  5’pbp4  area.  Gene  replacement  occurs  only  if  the  second  recombination  
event  occurs  in  3’pbp4  area. 
149 
 
Figure  5.  10.  Schematic  diagram   for   the  nucleotide   sequence   in  RS1/19Δpbp4. 
Nucleotide sequence of the pbp4 region is indicated by its corresponding ATG 
starting codon which is underlined. Nucleotides of recombinant regions of the 
RS1/19Δpbp4 (pbp4) allele that differ from the presented RS1/19 sequence are 
indicated above the corresponding nucleotide position in lowercase letters. The 213 
nucleotides   deleted   from   strain   RS1/19Δpbp4 which has been substituted by spc 
gene are highlighted. The flanking primers used for sequencing are indicated by 
arrows, while the primers used for amplification of pbp4 gene for homologous 
recombination are indicated as dashed arrows.  
ACACCTTTAGCTACACACGTAATATATTTGCATTATTTTTCAAATTAACTGCAGAAAACTTT
ATTTTCAACAATTTAATTAAGGTGAAGTGAATTAGCAATGATTTCCGTAAGTAGGAATAACC
ATTG 
                                 
CTTTTAGGGAATATTTAAGAATTGGAAAAGGGAAGATTAACGCTTTATGAAAAATTTAATAT
CT 
                t                                     g                     
ATTATCATCATTTTATGTTTAACATTAAGTATTATGACACCATATGCACAAGCTACTAACAG
TGACGTAACCCCTGTACAAGCAGCAAATCAATATGGTTATGCAGGTTTGTCGGCTGCATACG
AACCGACGAGTGCTGTTAATGTAAGTCAAACTGGACAATTACTGTATCAATACAATATCGAT
ACTAAGTGGAATCCAGCGTCTATGACTAAATTAATGACAATGTACTTAACATTGGAAGCTGT
AAATAAGG 
                      t    g       
GGCAGCTTTCACTTGATGACACAGTCACAATGACGAACAAAGAATATATTATGTCTACACTA
CCTGAGTTGAGTAATACGAAACTATATCCTGGACAAGTATGGACAATCGCAGACCTATTACA
AATTACAGTATCTAATTCTAGTAATGCCGCGGCATTAATTTTAGCTAAGAAGGTTTCAAAAA
A 
  
CACCAGCGATTTCGTTGATTTAATGAATAACAAAGCTAAAGCTATCGGAATGAAAAATACAC
ATTTCGTCAATCCAACGGGTGCTGAAAATTCAAGATTACGTACATTTGCACCAACAAAGTAT
AAAGACCAAGAACGTACTGTAACGACTGCTAGAGACTATGCCATTTTAGATTTACACGTGAT
TAAAGA 
                                       
GACACCTAAAATATTAGACTTTACAAAGCAGTTAGCACCAACAACGCATGCAGTTACGTATT
ACACATTCAACTTTTCATTGGAAGGTGCAAAAATGAGTTTGCCGGGTACAGATGGTTTAAAA
ACTGGATCAAGTGATACAGCAAATTACAACCATACGATTACTACCAAACGAGGTAAATTTAG
AATTAATCAAGTTATCATGGGTGCAGGAGACTATAAAAACCTTGGTGGCGAGAAGCAACGTA
ATATGATG 
                    t   
GGGAATGCATTAATGGAACGCTCATTTGATCAGTATAAATATGTAAAAATATTGTCTAAAGG
TGAGCAAAGGATAAATGGTAAGAAATATTATGTTGAAAATGATCTTTACGATGTTTTACCAA
GTGATTTTAGTAAAAAAGATTATAAACTTGTAGTCGAAGATGGTAAAGTACACGCGGACTAT
CCAAGAGAATTTATTAATAAAGATTATGGACCTCCAACTGTAGAAGTTCATCAGCCAATTAT
TCAAAAGG 
                           c                               g            
CAAATACTGTTGCTAAAAGTATGTGGGAAGAACATCCATTATTCACTATCATTGGTGGTACA
TGCCTTGTCGCTGGATTAGCACTTATTGTTCATATGATAATCAATCGTTTATTTAGAAAAAG
AAAATAAAA 
              
CATACTAAAAACGGACAAGTTGCACATTATAAAGCTGCGAAACTTGTCCGTTTTATATTTAT
TTTATAATAACCTAAGTTAATTTATCGTTTAGTATCGATAGTTCTATATAATTTATTTAGCA
TCTT 
                             
TACCATATAATTCTTGTTTGATTTTAGTCGTCGAAATGCCTTCTGTACGT 
150 
 
5. 3. Characteristic of RS1/19∆pbp4 Strain 
Experiments in this section were carried out to study the effect of the pbp4 gene 
deletion on RS1/19, testing whether PBP4 over-expression is necessary for the 
reduced  sensitivity  to  β-lactam antibiotics, the effect on the degree of cross-linking 
indirectly using lysostaphin susceptibility and the rate of autolysis.  
  
5. 3. 1. Characterization of PBP Profile in the Membrane of 
RS1/19∆pbp4.  
This experiment was carried out to confirm the deletion of the pbp4 gene by 
homologous recombination via double crossover event   from  RS1/19∆pbp4 resulted 
in an absence of PBP4 in membranes, as detected by binding of fluorescently labeled 
penicillin. Single colonies from overnight plate cultures of RS1/19 and 
RS1/19∆pbp4 were grown in BHI medium and the pellets were used for membrane 
preparation. Membrane proteins were analyzed by SDS-PAGE, where PBPs were 
identified by their ability to bind to Bocillin FL. Figure 5. 11 shows a detectable 
PBP4 band in RS1/19, but no evidence of binding to a protein of the size of PBP4 in 
RS1/19∆pbp4. This result clearly shows disrupting of the pbp4 gene resulted in no 
PBP4 production in the membrane fractions. This is another substantial indication 
for pbp4 deletion  in  RS1/19∆pbp4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
151 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure   5.   11.      Bocillin   FL   binding   capacity   of   membrane  
proteins.  Bocillin  FL  was  added  to  membrane  preparations  and  
the   proteins   separated   by   SDS-PAGE   electrophoresis   and  
visualized   using   Typhoon   scanner   indicating   the   absence   of  
PBP4   from   RS1/19∆pbp4   strain.   The   positions   of   the   single  
PBPs  are  indicated  by  arrows. 
              RS1/19                                              RS1/19∆pbp4   
4 
3 
2 
1 
PBP4 
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5. 3. 2. Antibiotic Sensitivity Tests show that PBP4 is Necessary for 
the Reduced Sensitivity to ß-lactam Antibiotics in RS1/19 
It has been confirmed previously that overproduction of PBP4 alone is not sufficient 
for reducing the sensitivity of RS1/19 to penicillin G (section 4. 4. 3). Therefore 
macro-dilution antibiotic sensitivity tests were performed, with a number of -lactam 
antibiotics and vancomycin, to determine if deletion of pbp4 had any effect on 
antibiotic sensitivity in RS1/19 (Table 5. 2).  Penicillin G, oxacillin, and cefotaxime 
all bind relatively poorly (higher dissociation constants) to PBP4, while cefoxitin 
and cefsoludin have high affinities (lower dissociation constants) for PBP4 
(Georgopapadakou et al., 1982). 
 
Deletion of pbp4 led to a significant increase in sensitivity to penicillin G in 
RS1/19∆   pbp4, compared to RS1/19 (Table 5. 2). The MIC reduced dramatically 
from 32µg/ml to 0.008µg/ml - a 4000 fold reduction), which is lower than in the 
Oxford strain. This clearly confirms that pbp4 is a key element in the network of 
genes associated with the resistance to penicillin G in RS1/19. The same affect was 
noted with oxacillin and cefotaxime, as the MICs for these antibiotics reduced from 
64µg/ml and 128µg/ml, in RS1/19, to 4µg/ml and 0.5µg/ml,   in   RS1/19∆   pbp4, 
respectively. The MIC for cefoxitin and cefsoludin were changed only slightly 
because PBP4 is inhibited at very low concentrations of cefoxitin and cefsoludin in 
RS1/19. Since cefoxitin and cefsoludin have high affinities for PBP4, deletion of 
PBP4 has little effect on the MIC for these antibiotics. The increased Bocillin FL 
binding capacity in RS1/19 is due to over-production of PBP4 and deletion of this in 
RS1/19∆  pbp4 results in a reduction in the concentration of antibiotic required for 
inhibition of growth. Therefore, it can be concluded that pbp4 is vital for the 
expression of -lactam resistance in RS1/19, but it is not sufficient on it is own.  
 
Vancomycin susceptibility testing demonstrated a reduction in vancomycin 
susceptibility, from (1 µg/ml) in RS1/19 to (16 µg/ml) in RS1/19∆  pbp4 following 
pbp4 inactivation. This result is in agreement with the results obtained by (Finan et 
al., 2001) who showed that loss of PBP4 led to increased vancomycin resistance in 
VSSA. In another report, inactivation of overproduced PBP4 was shown to decrease 
the MIC for vancomycin resistant isolates (Sieradzki et al., 1999). Inactivation of 
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pbp4 is associated with a lower degree of cross-linking of the peptidoglycan 
network, which can be measured using HPLC (Finan et al., 2001) and leads to an 
increase of free D-Ala-D-Ala residues in the cell wall (Sieradzki and Tomasz 2003). 
The lethal targets for vancomycin molecules are located at the sites of cell wall 
synthesis on the plasma membrane (Sieradzki et al., 1999). The free D-Ala-D-Ala 
residues in the mature peptidoglycan strands constitute a potential non-lethal target 
for vancomycin (Sieradzki and Tomasz, 1997). Binding of large vancomycin 
molecules to non-lethal targets blocks the movement of the vancomycin molecules to 
their lethal target, D-Ala-D-Ala residue of the lipid linked peptidoglycan precursor 
(Hiramatsue., 2001). This explains the reduction in vancomycin sensitivity in 
RS1/19Δpbp4 as reduction in secondary transpeptidase in this strain would lead to 
less cross-linking and additional non-lethal targets in the mature peptidoglycan 
structure. 
   
In summary, RS1/19∆ pbp4 tested in this study has a moderately increased 
sensitivity to cefoxitin and cefsoludin, but a marked increase in sensitivity to 
cefotaxime, oxacillin, and penicillin G compared to RS1/19. The data presented in 
this chapter lead to the conclusion that inactivation of pbp4 played an important role 
in increased cefotaxime and penicillin G sensitivities in RS1/19∆ pbp4 and is 
therefore necessary for the penicillin and methicillin resistance phenotype of RS1/19.  
 
Table 5. 2. Antibiotic sensitivity test declare that PBP4 is necessary for the 
reduced  sensitivity  to  β-lactam antibiotics. 
 
Antibiotic MIC (µg/ml) 
Oxford RS1/19                  RS1/19Δpbp4              
penicillin G                             0.064                      24 0.008                          
oxacillin   0.25                         64   1 
Cefotaxime 2 128   0.5 
cefoxitin    2 4 2 
cefsoludin   4 8   4   
vancomycin    2 1 16   
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5. 3. 3. Inactivation of PBP4 Affects the Level of Peptidoglycan 
Cross-linking 
 PBP4 is a transpeptidase, which forms peptide bonds between adjacent stem peptide 
via a pentaglycine bridge. Previous reports related loss of PBP4 to a reduction in 
peptidoglycan cross-linking in methicillin sensitive S. aureus, MRSA COL, MW2 
and glycopeptide resistant S. aureus (Memmi et al., 2008 and Sieradzki et al 1999). 
It seems likely, therefore, that inactivation of PBP4 would lead to less cross-linking 
in   RS1/19Δpbp4. Lysostaphin is a protease that targets pentaglycine bridges and 
lysostaphin susceptibility has been used as an indirect way to detect decreased cross-
linking observed in GISA strains (Koehl et al., 2004). For this reason, lysostaphin 
susceptibility tests were performed for the wild-type, RS1/19, and RS1/19Δpbp4 
cells  (Figure  5.  12).  These  results  show  that  the  RS1/19Δpbp4 was more sensitive to 
lysostaphin compared to RS1/19, with 50% of cells lysing after 14 min in RS1/19, 
and  only  4  minutes  in  RS1/19Δpbp4. 
 
From the results obtained in this experiment it is clear that lysostaphin resistance 
correlates with overexpression of PBP4. In RS1/19 PBP4 overexpression correlates 
with reduced sensitivity to lysostaphin and inactivation of the pbp4 gene, in RS1/19 
Δpbp4, correlates to increased sensitivity to lysostaphin. This is likely due to 
variations in cross-linking, because PBP4 acts as a secondary transpeptdase in the 
mature peptidoglycan.  
 
To summarize, the data presented support the contention that overexpression of 
pbp4, leading to an increase in functional PBP4 protein in membranes, was the main 
cause of resistance to lysostaphin in RS1/19. Inactivation of this gene in 
RS1/19Δpbp4 caused it to be more sensitive to lysostaphin, likely due to a decrease 
in the degree of peptidoglycan cross-linking.   
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Figure  5.  12.  Lysostaphin  susceptibility  of  the  wild-type  (Oxford),  RS1/19  and  
RS1/19Δpbp4.  Cells  were  grown  to  exponential  phase  at  37˚C  then  treated  with  
lysostaphin  (1U/ml);;  RS1/19  is  more  resistant  to  lysostaphin  in  comparison  to  the  wild-
type  and  RS1/19Δpbp4  strain.  Values  are  the  mean  of  three  experiments  and  the  bars  
represents  standard  error.   
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5. 3. 4. Autolysis with Triton X-100 
  To assess whether the reduction of cross-linking in RS1/19Δ  pbp4 had any effect 
on murein hydrolase activity, induction of autolysis with non-ionic detergent Triton 
X-100 was analysed. However, no differences in ODs were observed between the 
RS1/19 and RS1/19Δ  pbp4 strains exposed to 0.05% Triton X-100 at 30˚C  with  
shaking  (Figure  5.  13).  
 
 In  common  with  RS1/19,  RS1/19Δpbp4 exhibited a low autolysis rate, with 50% 
lysis taking approximately 95min for each strain, which is significantly longer than 
the Oxford strain (50% lysis in approximately 30 minutes), suggesting that pbp4 
inactivation has no effect on the autolysis rate. This and the previous data showing 
that PBP4 overexpression in Oxford did not change the autolysis rate in 
Oxford(pbp4) (section 4. 3. 5) indicates that autolysis is independent of PBP4 
activity. Therefore, other factors must be responsible for the reduced autolysis in 
RS1/19  and  RS1/19Δpbp4, such as a thickened cell wall, which may be a by-product 
of the antibiotic resistance (Fuller et al., 2005). This result is consistent with the 
results reported by Memmi et al. (2008) who observed no differences in the autolysis 
rate between methicillin resistance S. aureus MW2 and pbp4 mutated MW2 strain. 
On the other hand, Utaida et al., 2006 showed that reduced autolytic activity is a 
common phenotype to the glycopeptide-intermediate S. aureus (GISA) as a result of 
thickened cell wall after growth in the presence of vancomycin (Utaida et al., 2006). 
In addition, alterations in the teichoic acid component of the cell wall have also been 
reported to be responsible for reduced autolytic activity in GISA (McAleese et al., 
2006). Therefore it can be concluded that inactivation of pbp4 has no effect on 
autolysis rate in RS1/19Δpbp4. 
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Figure  5.  13.  Autolysis  assay  of  Oxford  strain,  RS1/19  and  RS1/19  ∆pbp4  
with  0.05%  Triton  X-100.    After  adding  Triton  X-100  (0.05%),  the  autolysis  of  
mid-exponential  phase  cultures  were  determined  at  30˚C  with  shaking  by  serial  
OD580  measurments.  Bars  represent  standard  error  of  the  mean  for  three  
independent  experiments.   
0
20
40
60
80
100
120
0 50 100 150 200
%
 In
iti
al 
Ab
so
rb
an
ce
 
Time (min) 
Oxford
RS1/19
RS1/19∆PBP4 
158 
 
Taken together, the results presented in this chapter shows that RS1/19∆pbp4  is  
more sensitive to lysostaphin, likely due to a decrease in the degree of peptidoglycan 
cross-linking, also inactivation of pbp4 gene contributes with reduced sensitivity to 
vancomycin as a result of reduction in the cross-linking and increase in the degree of 
non-lethal targets in the mature peptidoglycan structure. Interestingly, RS1/19∆pbp4 
has a moderately increased sensitivity to cefoxitin and cefsoludin, but a marked 
increase in sensitivity to cefotaxime, oxacillin, and penicillin G compared to RS1/19. 
This suggests that PBP4 is not solely responsible for the resistance and other factors 
must also play a role. We aim to identify these changes in resistant cells. Therefore a 
number of genes that participate in cell wall biosynthesis were selected to be 
inactivated using allelic replacement experiments to test their association with the 
resistance mechanism in RS1/19 cells.  
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CHAPTER SIX 
The  Role  of  MGT  in  β-lactam Resistance   
 
 
 
 
 
 
 
 
 
 
 
 
160 
 
6. 1. Introduction 
S. aureus produces four native PBPs, designated PBP1-4, which differ in their 
peptidoglycan  biosynthetic  functions  and  affinity  to  β-lactam antibiotics (Chambers 
et al., 1994). In addition two monofunctional transglycosylases, namely MGT and 
SgtA, have been shown to be involved in peptidoglycan synthesis (Reed et al., 
2011).  It is clear that the functions of PBPs are critical for cell morphology (Paul et 
al., 1995) and also for the development and maintenance of antibiotic resistance 
(Leski and Tomasz, 2005). PBP1 has been shown to be essential in several studies, 
because its function cannot be replaced by the other PBPs. Inactivation of this 
protein cause a loss of septum formation, a dramatic increase in cell mass, and a 
block of cell division leading to rapid lysis (Pereira et al., 2007).  Penicillin 
analogous and the carbapenem antibiotics have a very high affinity to PBP1, and it is 
over-expressed by the S. aureus when exposed to these antibiotics (Dumitrescu et al., 
2011).  PBP2 is the only bifunctional (traspeptidase and trasglycosylation activities) 
HMM protein. In MRSA strains the essential function of PBP2 (transpeptidase 
acivity) can be replaced by PBP2a; however point mutations made in the active site 
of the TGase domain caused a dramatic increase in methicillin sensitivity  as well as 
the presence of very short peptidoglycan chain. On the other hand it has been shown 
that TPase activity of PBP2 is essential for growth of MSSA lacking the mecA gene 
(Pinho et al., 2001).  
 
PBP3 has a monofunctional TPase activity, however deletion of the pbp3 gene 
results in no gross phenotypic change, though it does cause a considerably reduced 
autolysis rate (Pinho et al., 2000). However, in some strains of S. aureus which 
developed a spontaneous resistance to methicillin a loss of pbp3 expression is 
observed due to a premature stop codon in the gene (Pinho et al., 2003). The acyl-
enzyme intermediate between penicillin and PBP3 is very stable, with a half-life of 
up to 115 minutes (Chambers et al., 1994), that is why long exposure to penicillin 
can  result  either  in  PBP3  with  considerably  reduced  affinity  for  β-lactam antibiotics 
or totally loss of PBP3 expression (Georgopapadakou et al., 1982). Additionally, 
some membrane bound enzymes, MGT and SgtA which catalyzes the elongation of 
peptidoglycan chains in a metal-ion dependent manner, were found to be correlated 
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to transglycosylase activity in vitro and to antibiotic resistance in S. aureus (Heaslet 
et al., 2009; Reed et al., 2011). 
 
The initial aim of this part of the project was to inactivate the other native PBPs  
(1-3), in addition to the monofunctional transglycosylases MGT and SgtA in RS1/19 
to test whether these genes have a role in reduced penicillin sensitivity. This 
approach could highlight any involvement of these genes, alongside with 
overexpressed PBP4 in developing the novel mechanism of resistance in RS1/19. 
Furthermore, as PBP2 transpeptidase activity has been reported to be essential for 
viability of S. aureus strains lacking mecA (Pinho et al., 2001), if it proved possible 
to   isolate  a  deletion  of  Δpbp2 in RS1/19 that would suggests an important role for 
overexpressed PBP4 in this strain. This would mean that the transpeptidase activity 
of overexpressed PBP4 in RS1/19 had the ability to replace the transpeptidase 
activity of PBP2, with the TGase activity perhaps being provided by MGTand/or 
SgtA. For these experiments allelic replacement, using homologous recombination, 
was chosen to delete the selected genes in RS1/19. 
 
6. 2. Results and Discussion 
6. 2. 1. Role of Monofunctional Transglycosylase mgt in ß-lactam 
Resistant Strain RS1/19 
Inactivation of PBP4 in RS1/19 showed an important role of PBP4 overproduction in 
the  observed  β-lactam resistance in RS1/19. On the other hand it also proved that it 
is not the sole determinant of decreased sensitivity to penicillin G. Therefore other 
genes along with pbp4 must  participate  in  the  β-lactam resistance.  
 
The final stage in peptidoglycan polymerization involves the synthesis of glycan 
strands catalyzed by transglycosylase enzymes of PBP2, MGT, and SgtA (Terrak 
and Nguyen- Distĕche, 2006). Although microarray data shows no change in the 
relative transcript level of mgt in RS1/19, to date there are few data regarding the 
relation of MGT to antibiotic resistance in S. aureus. Therefore experiments in this 
section were carried out to delete mgt in wild-type Oxford and RS1/19 strain and 
determine whether it plays a role in -lactam resistance in RS1/19.  
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6. 2. 2. Inactivation of mgt in RS1/19 Strain  
mgt was deleted in RS1/19 strain using the same strategy used to delete the pbp4 
gene in RS1/19, except that the gene used to interrupt the mgt structural gene 
encoded chloramphenicol resistance. External fragments of mgt were amplified from 
genomic DNA of RS1/19 flanking a 780bp deletion in the coding sequence of the 
gene. A chloramphenicol resistance gene was amplified from the vector pGL485, 
using PCR primers (Table 6. 1) and cloned into pMAD with the mgt gene fragments 
flanking it on either side. An intermediate cloning vector pBlue-script (SK+) was 
used for sub-cloning these fragments (Figure 6. 1). The mutated mgt fragment was 
cloned to the final pMAD vector, using DNA ligase.  pMAD∆mgt was transformed to 
E. coli  XL-1 Blue and colonies selected on LB plates containing Ampicillin (150 
µg/ml) and X-gal (40 µg/ml). Colony PCR was performed for ten blue colonies 
using outside primers (mgtP1F and mgtP2R) and four positive colonies were 
identified  with  a  band  of  2.5  kb.  The  recombinant  pMAD∆mgt vector was extracted 
from E. coli cells transformed by electroporation to S. aureus RN4220 competent 
cells, which were selected on BHI agar plates supplemented with chroramphenicol 
(10µg/ml) and X-gal (150µg/ml). Plasmids were extracted from RN4220 
pMAD∆mgt and  PCR  was  performed  to  check  the  size  of  ∆mgt 2.5 kb to confirm the 
presence  of   the   insert.  pMAD∆mgt were transduced to Oxford and RS1/19 strains. 
Allelic replacement was then carried out via double a cross over event to delete the 
chromosomal copy of the mgt gene, Screenings for the required clones was depended 
on the counter selection of chloramphenicol. Five white colonies that were resistant 
to chloramphenicol and sensitive to erythromycin were selected. To confirm allelic 
replacement and integration of the mutated mgt into the chromosome, PCR was 
performed on the genomic DNA using flanking forward and reverse primers mgtF1 
(Table 6. 1), the size 2.55 kb were obtained, while the size of wild-type mgt gene is 
2.63 kb (Figure 6. 2). 
 
 
 
 
 
 
163 
 
 
 
 
 
Table 6. 1. Sequences of primers used for mgt deletion, restriction sites are bold 
and Italic 
Primer 
name     
Primer  Sequence  (5’- 3’)                         Restriction 
site     
Amplicon size 
in bp 
 
mgtP1 
 
F: caagtcgacaggtgatttgcaatgac                 
 
SalI 
 
896    
 R: caaggatccagtttgagtacctatcgcttc          BamHI  
mgtP2 F: caatctagaaagtaacggggtgatccag            XbaI   722 
 R: aagagctcagatcttgttgcgtgtacttctttcg   SacI BglII    
cm1   F: caaggatccaataatggtttcttagacg                BamHI   866 
 R: caatctagaagtcggcattatctc                       XbaI    
mgtF1 F: tgccacataagatgtgttagg                                 - 2637 
 R: ctcataaggccttcgatag                                  -  
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Figure 6. 1  Schematic diagram of sequential cloning of the target gene fragments into 
pBlue-script (SK+)  cloning vector. First  DNA  fragment  (5’mgt) amplified by PCR flanked 
by Sall and BamHI.      Both   5’mgt   fragment with pBlue-script were restricted by Sall and 
BamHI. The restricted DNA fragments were ligated and transformed to E. coli cells.  
Subsequently,   the   recombinant   vector   pBlue   (5’mgt) was extracted. The second 
chloramphenicol gene (cm)  with  the  pBlue  (5’mgt) were restricted with BamHI and XbaI and 
ligated, followed by transformation to E. coli cells. The recombinant vector 
pBlue(5’mgt+cm) was extracted from E. coli cells,  then  ligated  with  the  third  fragment  3’mgt 
restricted with XbaI and SacI. The recombinant vector which contains the mutated mgt 
pBlue(Δmgt)) was transformed to E. coli cells and the then extracted. Finally the 
recombinant  vector  pBlue(Δmgt) were restricted with Sall and Bglll and sub-cloned to the 
final vector pMAD for allelic replacement experiments. 
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Size  (bp)                              2637        2552        1013              758 
      M                      1              2                  3                    4 
2300
0 
4361 
2322 
Size  (bp) 
Figure   6.   2.   PCR   to   confirm   the   allelic   replacement   of  mgt   in  
RS1/19.   PCR   products   using   flanking   primers   upstream   and  
downstream   region   of  mgt   in  RS1/19   lane   1.   PCR   products   using  
flanking   primers   upstream   and   downstream   region   of   mgt   in  
RS1/19∆mgt  lane  2.  PCR  products  using  flanked  forward  primer  of  
mgt  F1  and  reverse  primer  of  cm1  in  RS1/19∆mgt  lane  3,  while  lane  
4  with   forward  primer  of  cm1  and   reverse  primer  of  mgt  F1.  M  is  
Lambda/HindIII   DNA   marker.   The   size   of   each   PCR   product   is  
indicated.               
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6. 2. 2. Inactivation of Monofunctional TGase mgt has no Effect on 
Resistance to Cell Wall Targeting Antibiotics 
Antibiotic sensitivity tests were performed, using a number of -lactam antibiotics 
and the glycopeptide antibiotic vancomycin, to show if deletion of mgt has any effect 
on antibiotic sensitivity in RS1/19∆mgt (Table 6. 2). MGT mutant strains in Oxford 
and   RS1/19   showed   no   reduction   in   sensitivity   to   β-lactam antibiotics or 
vancomycin. The results obtained in this experiment is in agreement with those 
reported for the COL strain, which showed that inactivation of TGase activity of 
PBP2 caused a 16-fold increase in sensitivity to oxacillin, but no change was 
measured for the MGT deleted mutant (Reed et al., 2011). Accordingly, the authors 
indicated that even though MGT can replace the TGase activity of PBP2 in terms of 
cell viability, it cannot do so in terms of antibiotic resistance (Reed et al., 2011). It 
can be concluded from the data obtained in this experiment that although MGT 
activity may be important for peptidoglycan biosynthesis, it is not critical for cell 
viability  because  RS1/19Δmgt continued to grow normally. This is likely because the 
TGase domain of PBP2 and SgtA can replace the absence of TGase activity of MGT. 
In addition, it is not essential for the expression of resistance in RS1/19 or Oxford, as 
the MICs for -lactam   antibiotics   remain   the   same   in   RS1/19Δmgt as in RS1/19 
cells. 
 
Table 6. 2. Antibiotic sensitivity test show that inactivation of mgt has no effect 
on reduced  sensitivity  to  β-lactam and vancomycin antibiotics. 
 
 
Antibiotic 
MIC (mg/l) 
Oxford OxfordΔmgt RS1/19         RS1/19Δmgt              
penicillin G                 0.064                0.064                   24    24      
oxacillin 0.25                   0.25                    64 64    
cefotaxime 2 2 128 128 
cefoxitin 2 2 4 4     
cefsoludin 4 4    8   8 
vancomycin   2     2 1 1 
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6. 3. Attempted Deletion of Other Penicillin Binding Proteins (pbp1, 
pbp2, pbp3) and Monofunctional TGase SgtA 
In order to understand the role of other cell wall synthesis enzymes, PBPs and SgtA, 
in   expression   of   β-lactam resistance in the background of RS1/19 cells, it is 
necessary to knock-out these genes. Furthermore, in S. aureus the transpeptidase of 
PBP2 is essential  for  viability  in  MSSA  and  MRSA  exposed  to  β-lactam antibiotics 
(Pinho et al., 2001).  Therefore the aim was to inactivate PBP2 in the background of 
RS1/19 to test if the transpeptidase domain of overexpressed PBP4 can replace the 
transpeptidase of pbp2 at the same time that the TGase activity of Mgt and/or SgtA 
replaces  the  TGase  activity  of  PBP2.  If  transductants  with  Δpbp2 could be obtained 
it would mean that PBP2 is not essential for survival of RS1/19 and would show that 
the transpeptidase activity of overexpressed PBP4 with the TGase activity of MGT 
and SgtA would be sufficient for the survival in the pbp2 mutated background. 
 
The same strategy that was used to generate the mgt deletion was also used to delete 
the sgtA gene, except that the selectable marker was spc instead of chloramphenicol. 
For the other pbp genes (1, 2, and 3), minor modifications in sub-cloning fragments 
in the intermediate vector, pBlue-script (SK+), were used (Figure 6. 3). Genes with 
approximately a 1kb flanking region of the coding sequence were amplified using 
genomic DNA from RS1/19 and the primers shown in Table 6. 3. These were then 
restricted with SalI and BglII and sub-cloned to the intermediate vector pBlue-script 
(SK+). Constructs were transformed to E. coli competent cells and selected on LB 
plates supplemented with ampicillin (150 µg/ml) and X-gal (40µg/ml). The presence 
of the insert was confirmed in white colonies by colony PCR and plasmids were 
extracted from positive clones. One or more restriction sites for HindIII were found 
in each pbp gene, which is not present in pBlue-script (SK+); therefore recombinant 
vectors containing the pbp genes were restricted with HindIII to cut-out fragments of 
around 366bp and 316bp from pbp1 and pbp3 respectively. The pbp2 gene contained 
only one HindIII site, so no deletion took place in this case.  The selectable marker 
(gene-disrupting marker, spc) was restricted with HindIII and ligated into each of 
these genes prior to transformation into competent E. coli cells, which were selected 
with spectinomycin (100 µg/ml). Colony PCR reactions were carried out with spc2 
primers to screen for positive clones. Plasmid DNA was extracted from these cells, 
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restricted with SalI and BglII and cloned to the final vector pMAD. The four 
constructed  vectors:   pMAD(∆pbp1),   pMAD   (∆pbp2),   pMAD   (∆pbp3), and pMAD 
(∆sgtA) were transformed into E.coli The recombinant pMAD vectors was extracted 
from E. coli cells and transformed by electroporation into S. aureus RN4220 
competent cells and selected on BHI agar plates supplemented with erythromycin 
(5µg/ml) as a selectable marker and X-gal (150 µg/ml). Recombinant plasmids were 
extracted   from   RN4220;;   pMAD(∆pbp1),   pMAD   (∆pbp2),   pMAD   (∆pbp3), and 
pMAD  (∆sgtA) were restricted with SalI and BglII and run on agarose gels to check 
the size of the inserts (Figure 6. 4). Each vector was transduced to wild-type Oxford 
and RS1/19; this took several repeated attempts with the difficulty of transduction 
once again being more pronounced in RS1/19. Allelic replacement by homologous 
recombination was attempted for each of the target genes. Unfortunately, it was very 
difficult to screen for the allelic replacement mutants as the gene-disrupting marker 
(spc) was not functional in S. aureus. Therefore blue/white colony selection using X-
gal in the media to screen for the absence of the vector in the mutant strains was the 
only available option. White colonies were selected following the second 
recombination event; these could contain a chromosomal copy of either a mutant or 
wild-type allele of the target gene. Counter selection (spectinomycin) will only allow 
the mutant cells (single cross over and double cross over event) to grow on plates 
containing (100µg/ml) spectinomycin, but spc gene was not functional in these cells, 
therefore the only option was to isolate genomic DNA from all white colonies to 
screen for the mutated cells by PCR.  Despite considerable efforts, the frequency of 
allelic replacement was too low to identify a mutated target allele using this 
approach and all of the white colonies tested contained the wild-type allele of the 
target gene and therefore must have had excised the vector during the attempted 
second cross over procedure.  
 
In conclusion, it was not possible to isolate deletion mutants of the pbp1, pbp2, pbp3 
or sgtA genes due the time constraints. Spectinomycin selection did not work as 
expected in RS1/19 or Oxford and despite considerable effort; it was not possible to 
identify the required strains using the PCR analysis method. However, all of the 
tools needed to continue this part of the project are available and by swapping the 
spc gene with another antibiotic resistance selectable marker e.g. chloramphenicol it 
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should be possible to obtain deletions in the target genes and determine whether they 
are necessary for full expression of -lactam resistance in RS1/19.  
 
 
 
 
 
Table 6. 3. Sequences of primers used for pbp1, pbp2, pbp3, and sgtA deletion.  
Restriction sites are bold and Italic 
 
Primer 
name      
Primer  Sequence  (5’- 3’)                                   Restriction 
site 
Amplicon 
size in bp 
pbp1P1   F: caagtcgactacgcgaggaaagattgc                 SalI   1726 
R: cacggatccacttgtgctgtaccagtc                    BamHI 
pbp2P1 F: caagtcgacacaaaggatcttctcagcc                  SalI 2087 
R: cacggatcctgctgatgtgtcactacc                     BamHI   
pbp3P1 F: caagtcgacacaaatcgcacaaggctcac BamHI 1880 
R: cacggatcctacctaagtctccacctg                     XbaI    
spc2 F: aaaagcttcaggctgggtgccaagctctcg             HindIII 1548 
R: caaaagcttgtgcttagtgcatctaacgc                   HindIII   
sgtAP1 F: caagtcgacacaaaggatcttctcagcc                    SalI    901 
R: caaggatcccgatagcaacgatggcaatg                  BamHI 
sgtAP2  F: caatctagaatggctatacaccctacg   XbaI 777 
R:caagagctcagatctagcgttggtatgtcatc               SacI BglII     
spc3 F: ggatcccaggctgggtgccaagctctcg                    BamHI 866 
 R: caatctagagtgcttagtgcatctaacgc XbaI 
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Figure 6. 3.  Schematic diagram of sequential cloning of the target gene fragments into 
pBluE-script (SK+)  cloning vector. First DNA fragment pbp1 amplified by PCR flanked 
by SalI and BamHI.  Both pbp1 and pBlue-script were restricted by SalI and BamHI. The 
restricted DNA fragments were ligated and transformed to E. coli cells.  Subsequently, the 
recombinant vector pBlue (pbp1) were extracted, and restricted with HindIII. Digested 
pBlue(pbp1) and spc gene which is restricted with the same enzyme were ligated. The 
recombinant   vector   pBlue(Δpbp1) transformed to E. coli cells   and   then   extracted.   Δpbp1 
were amplified and along with pMAD vector restricted with SalI and BamHI, then ligated 
and transformed to E. coli.  
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Figure    6.  4.    Restriction  enzyme  digestion  of  recombinant  pMAD  vector.  
The  recombinant  vector  (isolated  from  E.coli  were  digested  with  SalI  and  BglII  
to  cut-out  the  insert.  The  digestion  product  resolved  on  1%  agarose  gel.  M  is  a  
DNA  marker  Hyperladder  I.  The  size  of  each  insert  is  indicated  in  bp. 
4361 
2322 
23,000 
Size(bp)                        M              pMAD         pMAD      pMAD       pMAD      pMAD  
                                                                               (pbp1)       (pbp2 )       (pbp3)        (sgtA) 
Size(bp)                                                                  9,666              2908        3635                3112              3226   
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7. 1. Kinetics of Acquisition of Penicillin Resistance 
In the present study CWD bacteria from Oxford strain were generated by passaging 
in liquid medium, with a high osmolality, that contained increasing concentration of 
penicillin G. Following 10 serial passages, the MIC rose from 0.064 to 32 µg/ml. 
The cells were then reverted to CWC forms by sub-culturing them in antibiotic free 
media several times. Of special interest was the observation that revertant CWC 
(T12) cells exhibited stable tolerance to penicillin G with an MIC of 24 µg/mL.  
Acquisition of penicillin resistance was achieved in a small incremental step and 
correlated with changes in the Gram staining characteristics of a large proportion of 
the cells in the population. These data are contrary to a previous report showing step-
wise acquisition of resistance to penicillin G on the fifth passage of an in vitro 
selection procedure (Henze and Berger- Bächi., 1995). The major difference in these 
two cases was the osmolality of the medium used. In this study a media with a high 
osmotic potential CWD was used which support the formation of CWD bacteria, 
while Henze and Berger- Bächi selected out methicillin resistance mutant PV1 by 
growth on increasing concentrations of penicillin in standard LB medium which did 
not allow the formation of CWD bacteria. Therefore it is likely that the composition 
of the media has a crucial role on the development of resistance mechanism. 
 
On the first exposure to penicillin G, Gram staining showed that about 90% of the 
cells gave a Gram-negative reaction and the cells had a diffuse edge. On continued 
exposure to the antibiotic, part of the population showed a Gram-positive reaction 
and continued to grow even in the presence of high concentration of the antibiotic. 
As the CWD medium, used for generating resistant strains, had a high osmolality, it 
is likely that bacteria with disrupted cell walls were protected from lysis. CWD 
bacteria  and L-forms are osmotically fragile, requiring electrolytes, sucrose, or other 
osmotic stabilizers to survive in the medium, (Onoda and Oshima, 1988) which is 
one of the factors that increased the chance of the surviving cells while introducing 
the mutations needed for developing increased penicillin resistance. Fuller et al. 
(2005) used the same method using both LB medium instead and high osmolality 
(CWD) medium. The  results showed that even though increasing penicillin 
concentrations in LB media caused an increase in penicillin resistance, it was much 
less than the level of resistance seen in CWD medium and was also quickly lost 
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when the penicillin pressure was removed. Besides, in the presence of penicillin, 
cells did not exhibit any Gram negative staining, which means that the content of the 
media had a very important role in induction and survival of CWD bacteria (Fuller et 
al., 2005). 
 
Reports in the literature suggest that the antibiotic sensitivity profile of revertant 
cells depends on the way that the L-form was induced (e.g. depending on the 
presence of stabilizer in the medium, period of incubation, and concentration of the 
antibiotic). Consequently, some revertant cells have susceptibility profiles similar to 
their parent cells, while others remain resistant to cell wall active antibiotics 
(Bertolani et al., 1975; Fuller et al., 2005).  
 
S. aureus Oxford, which is mecA-negative, was previously used to generate a 
methicillin resistant strain (RS1/19), on media with a high osmolality and was one of 
the strains used in this study. RS1/19 has small colonies, which are paler in 
appearance and has a slower growth rate compared to the wild type (Fuller, 2005). 
Like RS1/19, T12 cells small in size, lack the golden pigmentation, typical of S. 
aureus Oxford, and has a slow growth rate. RS1/19 cells have undergone extensive 
transcript reprogramming, resulting in different gene expression patterns, as 
confirmed   by  microarray   data   (Appendix   1).   The   ability   to   form   “variants”   under  
stress, both in vivo and in vitro, is one obvious character of S. aureus. Although S. 
aureus is non-motile and cannot form spores, it can adapt to environmental changes 
including changes to cell architecture. This includes L-forms, lack of pigmentation, 
small colony variants (SCVs), and slow growth rate (Marcova et al., 2008).     
  
The formation of variants also occurs in other bacterial strains. For example, 
Dell’Erra   et   al.   (2009) reported that stable L-forms of Listeria monocytogenes 
generally feature much slower growth rates compared to parental cells. They 
suggested that multiple phenotypic abnormalities could be as a result of alterations in 
global gene expression and /or cell signaling pathways in the mutant strains. Array-
based transcriptomics of parent and L-form cells revealed differences in expression 
of genes associated with morphological and physiological functions, leading to the 
conclusion that the L-forms featured down-regulated metabolic functions correlating 
with the dramatic shift in surface to volume ratio, whereas up-regulation of stress 
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genes reflects the difficulties in adapting to this unusual, cell wall-deficient lifestyle 
(Dell’Erra  et  al.,  2009). 
 
The colonies of the Oxford strain produce yellow pigmentation, while both RS1/19 
and T12 were paler in colour. The cell membrane contains a carotenoid pigment, 
Staphyloxanthin responsible for yellow or orange pigmentation. The gene for 
Staphyloxanthin biosynthesis (crtM, and crtN) are under the control of SigB, which 
is expressed as a general stress response (Wieland et al., 1994).  However microarray 
data shows no change in the expression of SigB, therefore other factors might be 
responsible for this phenomenon in T12 and RS1/19. Another possibility for the lack 
of pigmentation is due to mutation of the crt gene (Bornstein et al., 2010), but no 
data is available for the gene sequence in resistant cells. 
 
T12 and RS1/19 also exhibit small sized colonies, which look like SCVs and have 
slower growth rates compared to the wild type. In has been reported that SCVs are 
deficient in the electron transport system, such as the pathways for hemin, 
menadione and thiamine and thereby exhibit slow growth rate. Indeed, the disruption 
of genes involved in hemin or menadione biosynthesis generates SCVs (Morikawa et 
al., 2010). Similar results were obtained when other areas of S. aureus were affected; 
for example, cold shock caused slower growth of S. aureus due to activation of stress 
responses that decrease membrane fluidity and reduce enzymatic activity within the 
cell (Ooi et al., 2009). S. aureus and other bacteria grow more slowly in biofilms and 
diminished growth rates are an important factor in the increased resistance of 
bacteria within biofilms to many antibiotics (Fux et al., 2005). 
   
A common feature of alteration of peptidoglycan metabolism in RS1/19 and T12 is 
decreased sensitivity to lysis by both lysostaphin and Triton X-100. RS1/19 cells 
have a thicker cell wall (Fuller et al., 2005); thickening of the cell wall could be due 
to either a lower rate of peptidoglycan degradation or an increased rate of 
peptidoglycan biosynthesis. In other systems, increased thicknesses of the cell wall 
and slow growth rate have been shown to inhibit wall turnover and autolysis by 
blocking the access of murein hydrolases to their cell wall substrate (Sieradzki and 
Tomasz 1997).  
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The regulation of autolytic activity is generally complex and can occur at a number 
of different levels including autolysin enzymatic activity, post-translational 
processing of autolysins, and autolysin gene transcription. Alteration in these 
characteristics would contribute to a thicker cell wall, and in turn, decrease the 
susceptibility to lysostaphin and Triton X-100. As atl plays a crucial role in cell 
division and separation, lowered expression may produce build-up of peptidoglycan 
layers contributing to a thickened cell wall (Wootton et al., 2005). In RS1/19, the 
gene appears to be expressed normally as confirmed by Microarray data (Appendix 
1) and activity assays show autolysins from RS1/19 can effectively lyse wild-type 
cells, but that autolyins from either Oxford or RS1/19 do not readily lyse the altered 
walls of RS1/19 cells. 
 
 Another possible reason for altered autolysis could be related to some quantitative 
or qualitative alterations in the wall teichoic acid, as this has been reported to lead to 
reduced autolysis and thickened cell wall (Sieradzki and Tomasz 2003; McAleese et 
al., 2006).  AtlA has its optimal activity at neutral pH and this reduced dramatically 
at pH values below 6.5. WTA phosphate groups retain protons in the cell wall, which 
develops an acidic environment keeping the activity of the major autolysin AtlA low, 
therefore the activity of AtlA is affected by the presence or absence of WTA (Biswas 
et al., 2012).  Additionally, mutations within the S aureus virulence factor regulatory 
gene agr results in reduced autolysis rate (Fujimoto et al., 1998). Interestingly, 
microarray data (Appendix 1) shows down regulation of the agr regulatory factor in 
RS1/19, which might participate in the reduced autolysis rate.   
 
 Another abnormality of peptidoglycan metabolism in RS1/19 was detected in vitro 
by quantitative autolysis rate of whole cell using extracellular autolysin. Results 
indicated that the peptidoglycan component of RS1/19 is more resistant to 
extracellular autolysin extracted from both RS1/19 and Oxford strain. This result 
confirms that the autolysins in Oxford and RS1/19 cells are functionally active and 
reduced autolysis rate might be due to an altered cell wall in RS1/19. 
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 Assays of PBPs, during acquisition of penicillin resistance, revealed a gradual 
increase in the amount of PBP4 in membrane proteins, which altered the PBP2/PBP4 
ratio from 53.8 to 2.3 in Oxford and T12 respectively. The decrease in susceptibility 
to   β-lactam antibiotics also developed gradually, suggesting a causal link between 
the level of PBP4 and antibiotic sensitivity. In RS1/19, there are a variety of changes 
in gene expression, but prominent amongst these was pbp4, which was the gene with 
the highest expression level change. PBP4 is the only LMW PBP present in S. 
aureus (Wyke et al., 1981) and laboratory studies have shown that it has DD-
carboxypeptidase,  transpeptidase,  and  β-lactamase activities (Navratna et al., 2010). 
However the main function of LMW PBP4 in S. aureus is transpeptidase with little 
DD-carboxypetidase activity, which is evidenced by the presence of highly cross-
linked peptidoglycan in the cell wall of these bacteria. High DD-carboxypeptidase 
activity would decreases cross-linking, by removing the terminal alanine residue and 
so decreasing the amount of free D-Ala-D-Ala in the peptidoglycan, which is 
essential for transpeptidation. This is supported by studies that have show that PBP4 
inactivation leads to a lower degree of cross-linking (Sieradzki et al., 1999) and 
overproduction of PBP4 increases the percentage of cross-linking (Henze and 
Berger-Bächi, 1996).  
 
7. 2. The Use of Penicillin Analogues to Understand the Resistance 
Mechanism 
RS1/19 cells have a moderately increased resistance to cefoxitin and cefsoludin, 
(which readily inhibit PBP4 activity) but a marked increase in resistance to 
cefotaxime and penicillin G (which effectively inhibit the TPase activity of PBP2). 
These cells can likely withstand inhibition of the transpeptidase activity of PBP2, by 
cefotaxime and penicillin G, because of the high activity of PBP4. This contention is 
supported by data showing that in the presence of 25% of the MIC of cefoxitin, the 
MIC  of  penicillin  G  and  cefotaxime,  went  down  from  24  μg/ml  to  0.094  μg/ml  and  
128  μg/ml  to  4  μg/ml  respectively.  This  means  that  reduced  sensitivity  to  penicillin  
G and cefotaxime in CWC cells is likely related to PBP4 overproduction, as 
antibiotics that selectively inhibit PBP4 activity cause the greatest reduction in 
penicillin G MIC, when used in combination.  This is evidenced by a remarkable rise 
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of penicillin and cefotaxime sensitivity of RS1/19 following treatment with selective 
PBP4 inhibitory antibiotic (cefoxitin). Farha et al. (2013) reported   that   β-lactam 
resistance might be reversed by targeting PBP2 and PBP4 with combinations of 
existing  β-lactams. This was tested by using the PBP4-selective  β-lactam cefoxitin. 
When cefoxtin was combined with PBP2-selective   β-lactams cefuroxime, 
ceftizoxime, oxacillin, and penicillin, the MICs of these antibiotics decreased 32- to 
128-fold.  Conversely,  combining  cefoxitin  with  β-lactams having a low affinity for 
PBP2 led to only a 2- to 8-fold change in the MIC. They showed that in the absence 
of wall teichoic acid leads to mislocalization of PBP4 away from division septum, 
for that it is unable to perform its role of cross-linking in peptidoglycan. When these 
MRSA   cells   treated  with   β-lactams which binds PBP2 selectively sensitizes these 
cells. This shows the importance cooperation between PBP2 and PBP4 in mediating 
resistance  to  β-lactams antibiotics (Farha et al., 2013). This supports our conclusion 
that PBP4 overproduction has an important role in the observed resistance. 
 
Others have demonstrated that cefoxitin, which binds PBP4 irreversibly, was found 
to be synergistic with oxacillin at killing CA-MRSA strains compared to oxacillin 
alone. In the presence of one-fourth the MIC of cefoxitin, the MIC of oxacillin went 
down 64-fold (Memmi et al., 2008). Data produced in this study supports a role for 
PBP4   overexpression   in   β-lactam resistance, via molecular function as a 
transpeptidase that is necessary for highly cross-linked peptidoglycan. This 
hypothesis is based on a number of key observations, relating to high relative 
expression of pbp4 in RS1/19 strains; increasing the amount of PBP4 in CWC lines 
gradually  is  consistent  with  the  rise  in  MICs  and  the  synergistic  effect  of  β-lactams. 
Which selectively inhibit PBP2 and PBP4, indicates an important role for PBP4 in 
the observed resistance. 
7. 3. The Role of PBP4 in Penicillin and Methicillin Resistance 
To   test   the   role   of   PBP4   in   mediating   β-lactam resistance in RS1/19, PBP4 was 
overexpressed in S. aureus. Surprisingly, PBP4 overproduction in S. aureus, with 
different genetic backgrounds,   did   not   alter   the   MIC   to   β-lactam antibiotics. 
However, it produced a twofold decrease in the vancomycin MIC. The antibiotic 
sensitivity data presented in (Chapter Three) implicates the involvement of PBP4 
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overproduction in the resistance mechanism, leading to the conclusion that PBP4 
overproduction, alone, is not sufficient for full expression of resistance. In a previous 
report, high-level expression of pbp4 in mecA negative isolates, caused by a deletion 
in the region upstream of this gene, resulted in an increase in the amount of PBP4 in 
cell membranes and a reduction in susceptibility to penicillin and methicillin (Henze 
and Berger-Bächi, 1996).  Recently, Banerjee at al., reported that methicillin 
resistance in an in vitro generated strain is due in part to an amino acid change at the 
entrance to the binding pocket of PBP4 (Banerjee et al., 2010). Therefore, methicillin 
resistance in strains lacking mecA have different underlying bases, indicating that the 
genome is able to respond in different ways to subtly different selection pressures.  
 
mecA-mediated meticillin-resistance in S. aureus requires the concerted action of 
several host factors for full expression. In addition to factors essential for methicillin 
resistance (femAB). mecA positive strains have hetero-resistance to methicillin, with 
the majority of cells expressing low resistance to methicillin and a minority of cells 
express resistance to much higher concentrations. It has been demonstrated that this 
high level resistance is due to chromosomal mutations outside of the mecA, gene, 
and is also not related to the femAB operon. When the highly resistant cells were 
cured of the vector containing the mecA gene, the result was a methicillin sensitive 
strain and when the vector was introduced to these cells again it became highly 
resistant to methicillin. On the other hand transduced cells, derived from the original 
parents, showed a lower level of resistance to methicillin which was heterogeneous 
resistance (Ryffel et al., 1994). Arbeloa et al., demonstrated that expression of the 
mecA of S. aureus in E. faecalis and E. faecium can confer the resistance phenotypes 
in subpopulations of the bacteria, therefore, there are be other factors required for 
full expression of resistance (Arbeloa et al., 2004).  
 
PBP4 over-expression slightly decreased the vancomycin MIC; this was evident in 
strains with different genetic backgrounds and, although small, this effect was 
consistent. This means that increased susceptibility was uniformly correlated with 
increased peptidoglycan cross-linking in transductants. Therefore it indicates a 
relationship between the degree of cross-linking and vancomycin susceptibility. 
Increased PBP4 activity leads to a concomitant reduction in the number of free D-
Ala-D-Ala motifs in the mature peptidoglycan which serves as a first target for 
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vancomycin molecules, leading to increased diffusion rates of vancomycin to its 
second target on lipid II. Similarly, Finan et al. reported that PBP4 overproduction 
produces two-three folds decrease in the sensitivity to vancomycin in the VISA 
isolates (Finan et al., 2001).    
 
Allelic replacement via a double cross-over event was used to delete pbp4 in RS1/19. 
The   constructed   vector   pMAD(Δpbp4) was transduced from RN4220 
pMAD(Δpbp4) into the RS1/19 strain. Interestingly deletion of pbp4 led to a 
dramatic decrease in the MIC to penicillin G 4000 fold, oxacillin 64 fold, and 
cefotaxime 256 fold. It has been proposed that the transpeptidase activity of 
overproduced PBP4 correlates with the resistance mechanism in RS1/19 and 
therefore depletion of PBP4 would sensitize these cells. This result is in agreement 
with the results of Curtis et al. (1980) who isolated a mutant of S. aureus H lacking 
PBP4, selected on the basis of increased sensitivity to cefotaxime and a range of β  -
lactam antibiotics. PBP4 inactivation in this strain led to two-fold reduction of 
resistance in penicillin G, methicillin, and cefotaxime and one fold for cefoxitin. In 
another study, a S. aureus COL pbp4 knockout strain has been reported to be more 
susceptible than the parent strain to penicillin and ampicillin (Katamaya et al., 2003).  
 
Further, Henze and Berger Bächi (1996) reported that a mutant strain UT-39-1 
generated by Tn551-mediated insertional inactivation of pbp4 in a methicillin 
resistant strain, showed a reduction in MIC from 8µg/ml to 2.5µg/ml. It has been 
reported that a mutation in PBP4 in two strains of CA-MRSA led to a significant 
decrease in high-level resistance to oxacillin and nafcillin. mecA expression 
remained unchanged in PBP4 mutants and PBP2a did not contribute to oxacillin 
resistant in the absence of PBP4. Thus the authors concluded that PBP4 is an 
important factor in β-lactam resistance in CA-MRSA but not in HA-MRSA isolates 
(Memmi et al., 2008). However, more recently Navratna  et al., showed that MRSA 
COL strain, which have been selected for in vitro resistance to vancomycin, 
challenged with (1× MIC) of either  ampicillin or cefotaxime. Unlike other PBPs, the 
expression of pbp4 didn’t  alter  under  these  conditions  (Navratna  et  al., 2010). 
 
 There is evidence that PBP2, PBP2A and PBP4 act cooperatively in cell wall 
synthesis  under  antibiotic  pressure  and  that  PBP4  is  essential  for  β-lactam resistance 
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in community-acquired MRSA strains (Leski and Tomasz, 2005). This might 
suggest that when the PBP2 transpeptidase activity is inactivated in RS1/19, by 
penicillin G, the transpeptidase activity of overproduced PBP4 would replace the 
transpeptidase activity of PBP2. This is supported by data which shows that 
overexpressed PBP4 is necessary for the expression of penicillin and methicillin 
resistance, in this strain, though it is not sufficient for the observed resistance on its 
own.  
 
The results obtained by Sieradski and Tomasz, showed that in vitro selection for 
vancomycin and teicoplanin caused an altered peptidoglycan composition due to 
decrease in highly cross-linked peptidoglycan (Sieradski and Tomazs, 1997; 
Sieradski and Tomazs, 1998). Subsequently they showed that the disrupted 
peptidoglycan was due to inactivation of PBP4 in the mutant strains. Inactivation of 
PBP4 leads to increased monomeric muropeptide in the cell wall (Sieradzki et al., 
1999). The free D-Ala-D-Ala residues in the mature peptidoglycan strands constitute 
a potential nonlethal target for vancomycin (Sieradzki and Tomasz, 1997). Binding 
of large vancomycin molecules to nonlethal targets would further blocks the 
movement of the vancomycin molecules to their lethal target, D-Ala-D-Ala residue 
of the lipid linked peptidoglycan precursor (Hiramatsu, 2001). This is explains 
decreased   sensitivity  of  RS1/19(Δpbp4) to vancomycin antibiotics with a four-fold 
increase in MIC. It has been reported that only a thickened cell wall with inactivated 
PBP4 lead to vancomycin resistance (Cui et al., 2003). 
 
To find out what proteins, in addition to PBP4 overproduction, contribute to this 
mechanism of resistance a number of allelic replacement studies were initiated. 
Monofunctional TGase  mgt which is responsible for Mgt production (Terrak and 
Nguyen- Distĕche,  2006) was deleted; To date there is little information about the 
relationship of this gene to antibiotic resistance. Although microarray data shows no 
change in the relative expression of this gene, but it was necessary to remove the 
activity to determine if it plays an active part in the resistance mechanism. Following 
inactivation of this gene, antibiotic sensitivity showed no alteration in the MIC to the 
antibiotics used in this study. This result is similar to the results demonstrated by 
Reed et al., who indicated that MGT inactivation has no effect on oxacillin 
sensitivity. They suggested that TGase activity of PBP2 and SgtA can replace the 
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monofunctional TGase activity of MGT (Reed et al., 2011). Therefore it was 
concluded that monofunctional TGase MGT has no effect on the resistance in 
RS1/19. 
 
7. 4. Implications for understanding resistance in MRSA strains 
Experiments performed in this study indicate that the underlying resistance 
mechanism   in   RS1/19   is   different   to   previously   reported   β-lactam resistance 
mechanisms and appears to involve mutations in multiple genes (or regulatory 
regions). Data presented here prove that PBP4 over-production is an essential 
component of this resistance. These data are consistent with reports from other 
workers showing that PBP4 can work co-operatively with PBP2 and PBP2A in 
building cell walls (Leski and Tomasz, 2005) and that it contributes to the resistance 
seen in CA- but not HA-MRSA strains  (Memmi et al., 2008). Recent work by Farha 
et   al.,   shows   a   dual   function   of   PBP2   and   PBP4   in  mediating   β-lactam resistance 
(Farha et al., 2013), confirming a central role for PBP4 in metnicillin resistance in 
mecA negative S. aureus strains. The data presented here clearly shows that PBP4 is 
not the only factor involved in resistance in RS1/19, but that it is necessary for the 
full expression of resistance.  Future studies of RS1/19 are likely to uncover other 
factors that are essential for full expression of methicillin resistance in mecA 
negative strains of S. aureus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
183 
 
Future Work 
Further studies are needed to answer the question about the role of the other cell wall 
biosynthesis enzymes like PBPs (1-3), and the mono-functional TGase SgtA in 
expression   of   β-lactam resistance in the background of RS1/19.  Transductants of 
RS1/19   pMAD(∆pbp1),      RS1/19   pMAD   (∆pbp2),      RS1/19   pMAD   (∆pbp3), and  
RS1/19  pMAD  (∆sgtA) were made for deletion of these genes in RS1/19. However, 
each of these relied upon spectinomycin selection (Arnaud et al., 2004), which did 
not work as expected in these cells. In spite of considerable effort; it was not possible 
to identify the required strains using the PCR analysis method. However, all of the 
tools needed to continue this part of the project are available and by swapping the 
spc gene with another antibiotic resistance selectable marker e.g. chloramphenicol it 
should be possible to obtain deletions in the target genes and determine whether they 
are necessary for full expression of -lactam resistance in RS1/19.  
 
 It  would  also  be  interesting  to  determine  if  RS1/19(Δpbp2) could be isolated, which 
would highlight an important role of overproduced PBP4 that can replace the 
transpeptidase activity of PBP2, which prove a coordinating function of PBP2 and 
PBP4, but in the time available it was not possible to analyse.  
 
Another important area that requires further experimentation is comparison of the 
genomes of Oxford and pencillin resistant lines by genome re-sequencing and 
bioinformatics to identify mutations potentially involved in resistance. 
 
We have repeatedly been able to isolate stable penicillin and methicillin resistant 
lines from the Oxford strain (ATCC9144), in liquid cultures (T12) and Fuller et al., 
isolated the strain from solid media (RS1/19). However, the methods used in 
generating these lines may introduce changes to the genome, which are not directly 
related to the resistance mechanism. Therefore sequencing two independently 
generated lines (RS1/19 and T12) and compares these to the sequence of the Oxford 
parental line to identify candidate genes for further study.  
 
Another interesting point for future work would be replacement of mutated regions 
in strain RS1/19 with wild-type equivalents and replacement of wild-type DNA in 
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Oxford with mutated regions from RS1/19. The contribution of each potential 
mutation, identified from genome re-sequencing, would be investigated by swapping 
that genome region between RS1/19 and the parental line. That is to say, a mutated 
region identified in RS1/19 be transferred into Oxford and the equivalent region 
from Oxford would be transferred into RS1/19. In this way it would be possible to 
build up a library of strains of RS1/19 and Oxford to determine the contribution of 
each mutation to overall resistance. Regions that show an effect could then be 
combined to see if any additive or synergistic effect is achieved with multiple 
regions. This approach would be equally useful in determining the effect of 
mutations in non-coding regions of the genome as it is in investigating mutations in 
structural genes. 
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Appendix 1 
Genes up-regulated by penicillin G at least twofold in RS1/19 compared to 
Oxford strain (P < 0.05) 
 
Gene Fold 
change 
Product or putative function  Functional category  
pbp4 18.56 penicillin-binding protein 4 Translation, ribosomal 
structure and biogenesis 
sdrE 10.06 bone sialoprotein-binding 
protein [conserved region] 
Translation, ribosomal 
structure and biogenesis 
clfB 9.256 fibrinogen and keratin-10 
binding surface anchored protein 
Translation, ribosomal 
structure and biogenesis 
SAR2532 5.207 hypothetical protein Translation, ribosomal 
structure and biogenesis 
sdrD 4.676 Ser-Asp rich fibrinogen-binding, 
bone sialoprotein-binding 
protein 
Translation, ribosomal 
structure and biogenesis 
argG 4.646 putative argininosuccinate 
synthase 
Translation, ribosomal 
structure and biogenesis 
thiI 4.128 putative thiamine biosynthesis 
protein 
Translation, ribosomal 
structure and biogenesis 
pyrAA 4.11 putative carbamoyl-phosphate 
synthase, pyrimidine-specific, 
small chain 
Translation, ribosomal 
structure and biogenesis 
pyrC 4.105 putative dihydroorotase Amino acid transport 
and metabolism 
rpsS 4.081 30S ribosomal protein S19 Translation, ribosomal 
structure and biogenesis 
pyrAB 4.054 putative carbamoyl-phosphate 
synthase, pyrimidine-specific, 
large chain 
Translation, ribosomal 
structure and biogenesis 
rpsN 4.023 30S ribosomal protein S14 Translation, ribosomal 
structure and biogenesis 
icaA 4.006 glucosaminyltransferase Translation, ribosomal 
structure and biogenesis 
SAR0841 3.888 putative acetyltransferase Translation, ribosomal 
structure and biogenesis 
rplN 3.841 50S ribosomal protein L14 Translation, ribosomal 
structure and biogenesis 
SAR0343 3.738 putative Sec-independent protein 
translocase protein 
Translation, ribosomal 
structure and biogenesis 
 
SAR0345 
 
3.737 
 
conserved hypothetical protein 
 
Translation, ribosomal 
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structure and biogenesis 
rpsC 3.703 30S ribosomal protein S3 Translation, ribosomal 
structure and biogenesis 
SAR2083 3.683 putative single-strand DNA-
binding protein 
Translation, ribosomal 
structure and biogenesis 
    
rplR 3.603 50S ribosomal protein L18 Translation, ribosomal 
structure and biogenesis 
secY 3.57 preprotein translocase SecY 
subunit 
Translation, ribosomal 
structure and biogenesis 
rpsQ 3.549 30S ribosomal protein S17 Translation, ribosomal 
structure and biogenesis 
rpmC 3.466 50S ribosomal protein L29 Translation, ribosomal 
structure and biogenesis 
rplX 3.459 50S ribosomal protein L24 Translation, ribosomal 
structure and biogenesis 
rplP 3.433 50S ribosomal protein L16 Cell envelope synthesis 
or location 
SAR1794 3.425 aminotransferase class-V protein Cell envelope synthesis 
or location 
rplO 3.36 50S ribosomal protein L15 Nucleotide transport and 
metabolism 
rpsH 3.334 30S ribosomal protein S8 Carbohydrate transport 
and metabolism 
rplF 3.304 50S ribosomal protein L6 Amino acid transport 
and metabolism 
rplV 3.255 50S ribosomal protein L22 Translation, ribosomal 
structure and biogenesis 
icaD 3.234 intercellular adhesion protein D Cell envelope synthesis 
or location 
SAR2082 3.23 putative phage regulatory 
protein (pseudogene) 
Cell envelope synthesis 
or location 
rpsE 3.225 30S ribosomal protein S5 Methyl group transfer 
rnhB 3.209 putative ribonuclease HII Poorly characterised 
infA 3.204 translation initiation factor IF-1 Poorly characterised 
SAV0855 3.18 hypothetical protein Poorly characterised 
rpmD 3.173 50S ribosomal protein L30 Poorly characterised 
rpsM 3.168 30S ribosomal protein S13 Poorly characterised 
rplW 3.141 50S ribosomal protein L23 Poorly characterised 
rpsK 3.065 30S ribosomal protein S11 Poorly characterised 
SAR0773 3.039 ABC transporter ATP-binding 
protein 
Poorly characterised 
SAR0344 3.012 putative Sec-independent protein 
translocase protein 
Poorly characterised 
rplD 2.987 50S ribosomal protein L4 Poorly characterised 
rpmJ 2.977 50S ribosomal protein L36 Cell envelope synthesis 
or location 
SAR2207 2.963 putative thymidine kinase DNA replication, 
recombination and repair 
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adk 2.923 adenylate kinase DNA replication, 
recombination and repair 
sdrC 2.921 putative surface anchored 
protein 
DNA replication, 
recombination and repair 
rplC 2.918 50S ribosomal protein L3 DNA replication, 
recombination and repair 
clfA 2.852 clumping factor DNA replication, 
recombination and repair 
glpD 2.844 aerobic glycerol-3-phosphate 
dehydrogenase 
Cell envelope synthesis 
or location 
prfA 2.804 peptide chain release factor 1 Cell envelope synthesis 
or location 
SAR1635 2.754 putative helicase Cell envelope synthesis 
or location 
SAR2189 2.745 putative membrane protein Cell envelope synthesis 
or location 
SAR0271 2.744 putative transport protein Lipid metabolism 
SAR0554 2.741 putative peptidase Poorly characterised 
SAR2086 2.74 hypothetical phage protein Poorly characterised 
SAR2205 2.69 conserved hypothetical protein Poorly characterised 
SAR0212 2.684 putative membrane protein Carbohydrate transport 
and metabolism 
SAR2168 2.672 putative helicase Poorly characterised 
SAR1702 2.655 putative cysteine desulfurase Poorly characterised 
8325-2691 2.648 hypothetical protein Poorly characterised 
icaB 2.646 intercellular adhesion protein B Poorly characterised 
argH 2.645 putative argininosuccinate lyase Poorly characterised 
rplE 2.615 50S ribosomal protein L5 Poorly characterised 
rpoA 2.614 DNA-directed RNA polymerase 
alpha chain 
Poorly characterised 
SAR1024 2.562 putative membrane protein 
(pseudogene) 
Poorly characterised 
def 2.556 putative polypeptide 
deformylase 
Poorly characterised 
fnb 2.551 fibronectin-binding protein 
precursor [conserved region] 
Cell envelope synthesis 
or location 
rpsJ 2.541 30S ribosomal protein S10 Cell envelope synthesis 
or location 
rplQ 2.525 50S ribosomal protein L17 Cell envelope synthesis 
or location 
murA1 2.522 putative UDP-N-
acetylglucosamine 1-
carboxyvinyltransferase 
Amino acid transport 
and metabolism 
SAR1083 2.516 BipA family GTPase Poorly characterised 
 
mutS 
 
2.511 
 
DNA mismatch repair protein 
MutS 
 
Cell envelope synthesis 
or location 
SAR2170 2.462 D-alanine--D-alanine ligase Translation, ribosomal 
structure and biogenesis 
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SAR1219 2.443 putative GTPase protein Amino acid transport 
and metabolism 
8325-2694 2.413 hypothetical capsid protein Cell envelope synthesis 
or location 
coa 2.4 staphylocoagulase precursor 
[conserved region] 
Secretion 
SAR1192 2.39 methionyl-tRNA 
formyltransferase 
Carbohydrate transport 
and metabolism 
SAR1701 2.387 conserved hypothetical protein Amino acid transport 
and metabolism 
8325-2689 2.381 hypothetical protein Poorly characterised 
SAR1429 2.378 putative membrane protein Poorly characterised 
SAR0918 2.372 NADH:flavin oxidoreductase / 
NADH oxidase family protein 
Amino acid transport 
and metabolism 
fnb 2.368  Amino acid transport 
and metabolism 
SAR1404 2.351 ABC transporter ATP-binding 
protein 
Energy production 
SAV1997 2.349 hypothetical protein Energy production 
8325-2690 2.341 hypothetical protein Amino acid transport 
and metabolism 
grlB 2.34 topoisomerase IV subunit B Amino acid transport 
and metabolism 
glpK 2.323 glycerol kinase Poorly characterised 
SAR1653 2.315 conserved hypothetical protein Energy production 
SAR0120 2.31 putative ornithine 
cyclodeaminase 
Nucleotide transport and 
metabolism 
murG 2.31 putative UDP-N-
acetylglucosamine-N-
acetylmuramyl-
(pentapeptide)pyr ophosphoryl-
undecaprenol N-
acetylglucosamine transferase 
Poorly characterised 
SAR2076 2.309 hypothetical phage protein Poorly characterised 
sdrD 2.308  Cell envelope synthesis 
or location 
SAR1431 2.303 putative acetyltransferase Poorly characterised 
upp 2.302 uracil phosphoribosyltransferase Poorly characterised 
mnaA 2.251 UDP-GlcNAc 2-epimerase Poorly characterised 
SAR1173 2.245 putative RNA pseudouridylate 
synthase 
DNA replication, 
recombination and repair 
SAR1634 2.238 putative endonuclease DNA replication, 
recombination and repair 
 
SAR2505 
 
2.238 
 
putative transport system protein 
 
Lipid metabolism 
SAR2542 2.237 putative transport protein Cell envelope synthesis 
or location 
murA2 2.207 putative UDP-N-
acetylglucosamine 1-
Cell envelope synthesis 
or location 
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carboxyvinyltransferase 
8325-2692 2.202 hypothetical protein Cell envelope synthesis 
or location 
grlA 2.199 topoisomerase IV subunit A Cell envelope synthesis 
or location 
polC 2.193 DNA polymerase III PolC-type Cell envelope synthesis 
or location 
SAR2297 2.177 putative acetolactate synthase Cell envelope synthesis 
or location 
rplB 2.171 50S ribosomal protein L2 Cell envelope synthesis 
or location 
fabZ 2.162 putative hydroxymyristoyl-(acyl 
carrier protein) dehydratase 
Amino acid transport 
and metabolism 
lytM 2.16 peptidoglycan hydrolase Amino acid transport 
and metabolism 
SAR1193 2.159 hypothetical protein Protease 
SAR1675 2.153 conserved hypothetical protein Poorly characterised 
SAR0276 2.143 putative membrane protein Poorly characterised 
SAR2202 2.138 conserved hypothetical protein Poorly characterised 
SAR2368 2.135 putative ferrichrome-binding 
lipoprotein precursor 
Poorly characterised 
fus 2.135 translation elongation factor G Nucleotide transport and 
metabolism 
atpH 2.132 putative ATP synthase delta 
chain 
Nucleotide transport and 
metabolism 
sbi 2.125 IgG-binding protein Poorly characterised 
SAR0893 2.123 putative membrane protein Poorly characterised 
topA 2.121 DNA topoisomerase I Poorly characterised 
pgm 2.121 putative 2,3-
bisphosphoglycerate-
independent phosphoglycerate 
mutase 
Secretion 
SAR1674 2.119 putative GTPase DNA replication, 
recombination and repair 
SAR1059 2.115 putative cytochrome ubiquinol 
oxidase 
Cell envelope synthesis 
or location 
SAN1789 2.112 hypothetical protein Amino acid transport 
and metabolism 
dnaG 2.101 DNA primase Nucleotide transport and 
metabolism 
SAR1484 2.099 putative GTPase Cell envelope synthesis 
or location 
aroA 2.098 3-phosphoshikimate 1-
carboxyvinyltransferase 
Cell envelope synthesis 
or location 
SAR1654 2.09 conserved hypothetical protein Cell envelope synthesis 
or location 
SAR0623 2.09 putative membrane protein Aminosugar metabolism 
SAR2151 2.087 putative RNA binding protein Cell envelope synthesis 
or location 
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gatC 2.082 glutamyl-tRNA 
amidotransferase subunit C 
Cell envelope synthesis 
or location 
SAR1265 2.081 putative pyruvate 
flavodoxin/ferredoxin 
oxidoreductase 
Cell envelope synthesis 
or location 
SAR1209 2.08 putative ribonuclease III Amino acid transport 
and metabolism 
SAR1227 2.067 conserved hypothetical protein Cell envelope synthesis 
or location 
8325-2686 2.066 hypothetical protein DNA replication, 
recombination and repair 
glyA 2.063 serine hydroxymethyltransferase DNA replication, 
recombination and repair 
tpiA 2.055 triosephosphate isomerase Translation, ribosomal 
structure and biogenesis 
SAR0186 2.034 putative ornithine 
aminotransferase precursor 
Translation, ribosomal 
structure and biogenesis 
SAR2139 2.029 conserved hypothetical protein Carbohydrate transport 
and metabolism 
SAR2175 2.014 conserved hypothetical protein 
(pseudogene) 
Aminosugar metabolism 
SAR1194 2.013 conserved hypothetical protein DNA replication, 
recombination and repair 
SAR0277 2.012 putative exported protein Cell envelope synthesis 
or location 
SAR1195 2.012 putative protein phosphatase Cell envelope synthesis 
or location 
msrA2 2.005 peptide methionine sulfoxide 
reductase II 
Cell envelope synthesis 
or location 
atpF 2.005 putative ATP synthase subunit b Cell envelope synthesis 
or location 
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 Genes down-regulated by penicillin G in RS1/19 compared to Oxford strain 
 (P < 0.05) 
Gene  Fold 
change  
Product or putative 
function 
Functional category  
narT 0.0921 nitrite transport protein Amino acid transport and metabolism 
narG 0.0976 nitrate reductase alpha 
chain 
Amino acid transport and metabolism 
narH 0.129 nitrate reductase beta 
chain 
Amino acid transport and metabolism 
nasD 0.182 nitrite reductase large 
subunit 
Amino acid transport and metabolism 
cudA 0.224 putative betaine aldehyde 
dehydrogenase 
Amino acid transport and metabolism 
SAR0523 0.286 SNO glutamine 
amidotransferase family 
protein 
Amino acid transport and metabolism 
cudB 0.301 putative choline 
dehydrogenase 
Amino acid transport and metabolism 
SAR2641 0.397 putative aminotransferase Amino acid transport and metabolism 
SAR2640 0.45 D-isomer specific 2-
hydroxyacid 
dehydrogenase 
Amino acid transport and metabolism 
SAR2679 0.451 putative alpha-
acetolactate 
decarboxylase 
Amino acid transport and metabolism 
SAR1337 0.452 putative aspartate kinase Amino acid transport and metabolism 
thrC 0.453 threonine synthase Amino acid transport and metabolism 
ilvD 0.453 putative dihydroxy-acid 
dehydratase 
Amino acid transport and metabolism 
SAR0131 0.16 putative sugar transferase Carbohydrate transport and 
metabolism 
SAR0130 0.174 NAD dependent 
epimerase/dehydratase 
family protein 
Carbohydrate transport and 
metabolism 
SAR0558 0.403 conserved hypothetical 
protein 
Carbohydrate transport and 
metabolism 
ldh2 0.444 L-lactate dehydrogenase 
2 
Carbohydrate transport and 
metabolism 
SAR0129 0.476 putative short chain 
dehydrogenase 
Carbohydrate transport and 
metabolism 
SAR0924 0.492 putative glucose-6-
phosphate isomerase 
Carbohydrate transport and 
metabolism 
SAR0133 0.22 putative membrane 
protein 
Cell envelope synthesis or location 
SAR0954 0.233 transport system 
extracellular binding 
lipoprotein (pseudogene) 
Cell envelope synthesis or location 
SAR0132 0.268 galactosyl transferase Cell envelope synthesis or location 
SAR2743 0.297 putative capsule synthesis 
protein 
Cell envelope synthesis or location 
SAR2745 0.297 putative capsule synthesis 
protein 
Cell envelope synthesis or location 
SAR2744 0.299 putative capsule synthesis 
protein 
Cell envelope synthesis or location 
SAR0199 0.301 putative transport system 
permease 
Cell envelope synthesis or location 
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SAR0145 0.341 putative lipoprotein Cell envelope synthesis or location 
SAR0390 0.348 putative lipoprotein Cell envelope synthesis or location 
SAR2651 0.349 putative membrane 
protein 
Cell envelope synthesis or location 
lrgB 0.361 holin-like protein Cell envelope synthesis or location 
opuCB 0.394 putative glycine 
betaine/carnitine/choline 
transport system 
permease protein 
Cell envelope synthesis or location 
opuCA 0.394 putative glycine 
betaine/carnitine/choline 
transport ATP-binding 
protein 
Cell envelope synthesis or location 
SAR0139 0.403 putative transport system 
protein 
Cell envelope synthesis or location 
SAR1066 0.438 putative lipoprotein Cell envelope synthesis or location 
SAR2462 0.441 putative membrane 
protein 
Cell envelope synthesis or location 
rlp 0.443 RGD-containing 
lipoprotein 
Cell envelope synthesis or location 
lrgA 0.447 holin-like protein Cell envelope synthesis or location 
SAR0182 0.449 putative membrane 
protein 
Cell envelope synthesis or location 
SAR0794 0.471 putative lipoprotein Cell envelope synthesis or location 
yycJ 0.471 metallo-beta-lactamase 
superfamily protein 
Cell envelope synthesis or location 
SAR0781 0.474 putative proton-dependent 
oligopeptide transport 
protein 
Cell envelope synthesis or location 
SAR0637 0.487 sodium/hydrogen 
exchanger family protein 
Cell envelope synthesis or location 
SAR0013 0.495 putative membrane 
protein 
Cell envelope synthesis or location 
opuCC 0.496 putative glycine 
betaine/carnitine/choline-
binding lipoprotein 
precursor 
Cell envelope synthesis or location 
ribD 0.209 bifunctional riboflavin 
biosynthesis protein 
Cofactor biosynthesis 
ribA 0.299 riboflavin biosynthesis 
protein 
Cofactor biosynthesis 
SAR0522 0.35 putative pyridoxine 
biosynthesis protein 
Cofactor biosynthesis 
ribE 0.415 riboflavin synthase alpha 
chain 
Cofactor biosynthesis 
SAR0917 0.315 putative S1 RNA binding 
domain 
DNA replication, recombination and 
repair 
recR 0.378 putative recombination 
protein 
DNA replication, recombination and 
repair 
SAR0452 0.483 putative NADH-
Ubiquinone/plastoquinone 
(complex I) protein 
Energy production 
plc 0.405 1-phosphatidylinositol 
phosphodiesterase 
Lipid metablism 
SAR2351 0.262 hypothetical protein Poorly characterised 
SAR2520 0.334 hypothetical protein Poorly characterised 
SAR1326 0.337 conserved hypothetical 
protein 
Poorly characterised 
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SAR2113 0.339 hypothetical protein Poorly characterised 
SAR2768 0.341 conserved hypothetical 
protein 
Poorly characterised 
SAR2115 0.343 hypothetical protein Poorly characterised 
SAR0383 0.371 hypothetical protein Poorly characterised 
SAR1688 0.394 conserved hypothetical 
protein 
Poorly characterised 
SAR1683 0.406 putative membrane 
protein 
Poorly characterised 
SAR2498 0.422 conserved hypothetical 
protein 
Poorly characterised 
SAR0111 0.427 putative myosin-
crossreactive antigen 
Poorly characterised 
SAR0405 0.428 hypothetical protein Poorly characterised 
SAR1784 0.435 putative universal stress 
protein 
Poorly characterised 
SAR2482 0.439 hypothetical protein Poorly characterised 
SAR0012 0.443 putative hydrolase Poorly characterised 
SAR1914 0.45 hypothetical protein 
(pseudogene) 
Poorly characterised 
SAR2688 0.45 hypothetical protein Poorly characterised 
SAR2381 0.451 hypothetical protein Poorly characterised 
SAR0985 0.452 conserved hypothetical 
protein 
Poorly characterised 
SAR0969 0.457 conserved hypothetical 
protein 
Poorly characterised 
SAR2380 0.46 hypothetical protein Poorly characterised 
SAR2497 0.466 conserved hypothetical 
protein 
Poorly characterised 
SAN0930 0.472  Poorly characterised 
SAR1279 0.481 conserved hypothetical 
protein 
Poorly characterised 
SAR2120 0.484 conserved hypothetical 
protein 
Poorly characterised 
SAR0666 0.49 hypothetical protein Poorly characterised 
SAR1684 0.495 conserved hypothetical 
protein 
Poorly characterised 
SAR0342 0.497 putative membrane 
protein 
Poorly characterised 
SAR2487 0.213 tetrapyrrole 
(corrin/porphyrin) 
methylase family protein 
Porphyrrin metabolism 
sodM 0.496 superoxide dismutase Reactive oxygen species metabolism 
SAR2382 0.384 putative transcriptional 
regulator 
Signal transduction mechanisms 
srrB 0.413 sensor kinase protein Signal transduction mechanisms 
SAR2026 0.432 GntR family regulatory 
protein 
Signal transduction mechanisms 
SAR2481 0.465 putative histidine kinase Signal transduction mechanisms 
icaR 0.486 ica operon transcriptional 
regulator 
Signal transduction mechanisms 
SAR2480 0.488 putative response 
regulator 
Signal transduction mechanisms 
agrA 0.493 autoinducer sensor 
protein response regulator 
protein 
Signal transduction mechanisms 
SAR0806 0.233 putative S30EA family Translation, ribosomal structure and 
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ribosomal protein bogenesis 
miaA 0.481 putative tRNA delta 2-
isopentenylpyrophosphate 
transferase 
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Alignment   of   pbp4   gene   sequence   between   wild-type   Oxford   and   mutant   strain  
RS1/19   and   T12.      No  mutations   have   been   detected.  Wild-type,   RS1/19,   T12   are  
indicated  on  the  left 
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Alignment  of  intergenic  region  between  pbp4  and  abcA  genes  sequences,  including  
portions  of  each  open  reading  frame.    No  mutations  have  been  detected.  Wild-type,  
RS1/19,  T12  are  indicated  on  the  left 
 
 
 
 
 
 
 
 
 
 
 
  
